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Abstract
The ability of a cell to polarise and move is governed by re-modelling of the cellular 
adhesion/cytoskeletal network that is in turn controlled by the Rho family of small 
GTPases. However, it is not known what signals lie downstream of Racl and Cdc42 
during peripheral adhesion re-modelling that are required for directional migration.
We show here that individual members of the Rho family, RhoA, R acl and Cdc42, direct 
the specific intracellular targeting of c-Src tyrosine kinase to focal adhesions, lamellipodia 
or filopodia, respectively, and that the adaptor function of c-Src (the combined SH3/SH2 
domains coupled to green fluorescent protein) is sufficient for targeting. Furthermore, 
Src’s catalytic activity is absolutely required at these peripheral cell-matrix attachment 
sites for adhesion re-modelling that converts RhoA-dependent focal adhesions into smaller 
focal complexes along Raci-induced lamellipodia or Cdc42-induced filopodia. 
Consequently, cells in which kinase-deficient c-Src occupies peripheral adhesion sites 
exhibit impaired polarisation towards migratory stimuli and reduced motility.
Our findings demonstrate that individual Rho GTPases specify Src’s exact peripheral 
localisation, and that RhoA, Racl and Cdc42 cannot co-ordinate cell structural changes 
and directed cell migration when Src is present at adhesion sites in an inactive form. Src’s 
role, which involves phosphorylation of adhesion substrates including FAK, is to induce 
the necessary adhesion re-modelling downstream of Racl and Cdc42 during migratory cell 
responses.
2
Acknowledgements
I would like to thank the following people without whom this thesis would never have 
been completed:
I would like to give a special thanks my supervisors Margaret Frame and Val Brunton who 
have provided endless advice and support over the past three years and whom along with 
Val Fincham have acted as my surrogate mother throughout my PhD. Thanks also to all 
members of R1 and R ll .  I would also like to thank all PhD students, past and present, for 
making my social life at the Beatson one to remember. I also wish to thank my friends and 
family for their continuous help and support during my constant thesis writing complaints!
Finally, I wish to thank the Beatson Institute, the CRC and Art Alberts for giving me the 
valuable opportunity to spend time learning about Diaphanous proteins at the Van Andel 
Institute in Michigan earlier last year.
3
Table of Contents
Title Page .............................................................................................................................1
Abstract....................................................................................   2
Acknowledgements............................................................................................................ 3
Table of Contents................................................................................................................4
List of Figures..................................................................................................................... 7
Abbreviations.........................................................................................................................11
1 Introduction............................................................................................................................14
1.1 S rc ...................................................................................................................................14
1.1.1 Structure of S rc ......................................................................................................14
1.1.2 Regulation of S rc .................................................................................................. 16
1.1.3 Allosteric regulation of S rc..................................................................................16
1.1.4 Factors influencing the enzymatic regulation of S rc ....................................... 17
1.1.5 Regulation of Src by protein tyrosine phosphatases....................................... 19
1.1.6 Regulation of Src by C-terminal Src kinase Csk.............................................19
1.1.7 Regulation of Src by altered protein stability or expression levels.............. 20
1.1.8 Regulation of Src by the Src kinase domain.................................................... 21
1.1.9 Regulation of Src by the unique domain.......................................................... 22
1.1.10 Regulation of Src by molecular displacement................................................. 22
1.2 Spatial regulation of Src............................................................................................... 23
1.2.1 Src domains involved in spatially regulating Src..............................................27
1.2.2 Potential binding partners involved in spatial regulation of Src.....................29
1.2.3 Spatial location of Src during various cellular processes.................................30
1.2.4 Src’s intracellular targeting within the cell........................................................ 31
1.3 RhoGTPases................................................................................................................... 32
1.3.1 Regulation of RhoGTPases.................................................................................. 33
1.3.2 RhoGTPases act as a link between extracellular stimuli and the remodelling 
of the actin cytoskeleton...................................................................................................... 37
1.3.3 Link between extracellular signalling and RhoGTPases................................. 41
1.4 RhoGTPases and their effectors.................................................................................. 45
1.4.1 Rho effectors.......................................................................................................... 45
1.4.2 Cdc42 and Rac effectors....................................................................................... 48
1.4.3 Cross-talk between RhoGTPases.........................   51
1.4.4 Cross-talk between small family subgroups......................................................54
1.5 Cell motility and migration..........................................................................................54
1.5.1 A role for Racl in cell migration....................................................................... 55
1.5.2 A role for Cdc42 in cell migration.....................................................................56
1.5.3 A role for RhoA in cell migration......................  57
1.6 Regulation of adhesion dynamics during cell migration..........................................62
1.6.1 A role for Src in cell migration.......................................................................... 63
1.6.2 Src induced modulation of RhoGTPases during cell migration..................... 65
1.7 Aim.................................................................................................................................. 66
2 Materials and methods......................................................................................................... 68
2.1 Cell culture reagents......................................................................................................68
2.2 Cell culture plasticware.................................................................................................68
2.3 Inhibitors.........................................................................................................................69
2.4 Growth factors................................................................................................................69
2.5 Antisera and associated materials............................................................................... 70
2.6 Protein reagents and m aterials.....................................................................................72
2.7 Stock solutions and buffers.......................................................................................... 73
4
2.8 Protein extraction and processing............................................................................... 73
2.9 Cells and plasm ids........................................................................................................ 75
2.10 Methods...........................................................................................................................76
2.10.1 Experimental protocol for serum starvation.....................................................76
2.10.2 Microinjection and transfection of plasmids....................................................76
2.10.3 Immunofluorescence........................................................................................... 76
2.10.4 Preparation of protein extracts from adherent fibroblasts..............................77
2.10.5 Protein electrophoresis........................................................................................ 77
2.10.6 Immunoblotting....................................................................................................78
2.10.7 Antibody incubation and detection by ECL.....................................................78
2.10.8 Removing bound antisera from immunoblots..................................................78
2.10.9 Immunoprecipitation of extracted proteins.......................................................79
2.10.10 Random cell migration.................................  79
2.10.11 Dunn chamber polarisation assay.................................................................. 79
2.10.12 Primary antisera dilutions used for immunofluorescence...........................80
2.10.13 Secondary antisera dilutions used for immunofluorescence.......................81
2.10.14 Primary antisera dilutions used for immunoblotting and
immuonprecipitation.............................................................................................................81
2.10.15 Secondary antisera dilutions used for Immunoblotting.............................. 81
2.10.16 Bacterial transformation and DNA extraction..............................................81
2.10.17 Routine Swiss 3T3 propagation...................................................................... 82
2.10.18 Swiss 3T3 fibroblast cyropreservation and recovery...................................82
3 Characterisation of Swiss 3T3 cells and Src251-GFP as tools to monitor c-Src 
targeting within the cell..................................................................................................................85
3.1 Purpose............................................................................................................................ 85
3.2 Results............................................................................................................................. 85
3.2.1 Manipulation of the actin cytoskeleton in Swiss 3T3 cells............................. 85
3.2.2 Characterisation of Src251-GFP as a tool to monitor c-Src localisation in
Swiss 3T3 cells.....................................................................................................................102
3.2.3 Translocation of Src251-GFP to focal adhesions is dependent on the actin
cytoskeleton......................................................................................................................... 102
3.2.4 Discussion............................................................................................................. 110
3.3 Summary....................................................................................................................... 112
4 Co-ordinated regulation of the actin cytoskeleton by RhoGTPases spatially regulates 
Src targeting to the cell periphery.............................................................................................. 114
4.1 Purpose...........................................................................................................................114
4.2 Results............................................................................................................................114
4.2.1 Localisation of Src251-GFP to specific peripheral sites is under the control
of Rho family GTPases....................................................................................................... 114
4.2.2 Localisation of endogenous or wt-Src by RhoGTPases is indistinguishable
from the targeting of Src251-GFP.....................................................................................123
4.2.3 Molecular or pharmacological inhibition of RhoA blocks Src targeting to
focal adhesions..............................................................................................  123
4.2.4 Co-ordinated regulation of the actin cytoskeleton by RhoGTPases controls
the intracellular targeting of Src to lamellipodia............................................................. 134
4.2.5 Co-ordinated regulation of actin cytoskeleton by RhoGTPases controls the
intracellular targeting of Src to filopodia......................................................................... 142
4.3 Discussion......................................................................................................................152
4.4 Summary........................................................................................................................161
5 Src kinase activity participates in the efficient remodelling of focal adhesions to focal 
complexes during lamellipodia and filopodia formation........................................................ 163
5.1 Purpose...........................................................................................................................163
5.2 Results............................................................................................................................163
5.2.1 Src251-GFP interferes with the efficient formation of uniform lamellipodia 
163
5.2.2 Src mutants used as tools to determine the role Src kinase activity plays in
adhesion remodelling..........................................................................................................167
5.2.3 c-Src kinase activity is required for complete remodelling of the actin
cytoskeleton during lamellipodia formation....................................................................175
5.2.4 c-Src kinase activity is required for remodelling of focal adhesions during
lamellipodia formation........................................................................................................176
5.2.5 c-Src kinase activity is also required for complete remodelling of the actin
cytoskeleton and focal adhesions during filopodia formation.......................................183
5.2.6 Expression of Src251-GFP or SrcMF in focal adhesions prevents Y-27632
induced focal adhesion disassembly................................................................................. 191
5.2.7 c-Src kinase activity is required for cell motility and polarity......................196
5.3 Discussion.....................................................................................................................201
5.4 Summary...................................................................................................................... 209
6 Identification of potential binding partners/substrates of Src specifically linked to
focal adhesion remodelling......................................................................................................... 211
6.1 Purpose..........................................................................................................................211
6.1.1 Scar family proteins as potential candidates involved in focal adhesion
remodelling...........................................................................................................................211
6.1.2 The effect of Src kinase activity on Scar-1 function...................................... 224
6.1.3 FAK as a candidate in Src induced focal adhesions remodelling.................232
6.2 Discussion.....................................................................................................................242
6.2.1 Scar as a candidate in Src induced focal adhesions remodelling..................242
6.2.2 FAK as a candidate in Src induced focal adhesions remodelling.................243
6.3 Summary.......................................................................................................................246
7 Conclusion............................................................................................................................ 248
7.1 Summary and future work...........................................................................................248
7.1.1 Summary.............................................................................................................. 248
7.1.2 Future studies........................................................................................................252
7.1.3 Potential candidates involved in Src’s perinuclear to peripheral targeting252
7.1.4 Potential candidates involved in Src’s focal adhesion remodelling during
lamellipodia or filopodia formation.................................................................................. 254
Appendices...................................................................................................................... 257
List of References.......................................................................................................... 258
6
List of Figures
Figure 1 Schematic representation of (c) and (v) -Src..............................................................15
Figure 2 Schematic representation of c-Src activation.............................................................18
Figure 3 Schematic representation of Src's spatial localisation during various cellular
processes................................................................................................................................ 26
Figure 4 Regulation of RhoGTPases.......................................................................................... 36
Figure 5 Schematic representation of the specific morphological changes induced by
activation of the respective RhoGTPases in Swiss 3T3 cells .........................................40
Figure 6 Signalling pathways involved in actin cytoskeletal remodelling induced by
RhoGTPases...........................................................................................................................44
Figure 7 Schematic representation of adhesion dynamics during migration induced by
Cdc42, Racl and RhoA........................................................................................................ 61
Figure 8 Disruption and breakdown of the actin cytoskeleton by serum starvation............88
Figure 9 Specific activation of RhoGTPases using constitutively active RhoGTPases leads
to distinct actin rearrangements.......................................................................................... 90
Figure 10 Activation of RhoGTPases using external growth factors to manipulate the actin
cytoskeleton........................................................................................................................... 93
Figure 11 Disruption and breakdown of the actin cytoskeleton by pharmacological
intervention............................................................................................................................ 95
Figure 12 Y-27632 specifically inhibits RhoA mediated actin remodelling without
effecting Rac-1 or Cdc42.................................................................................................... 99
Figure 13 Expression of dominant negative RhoA, Racl and Cdc42 in cells inhibit the 
respective morphological actin structure induced by serum, PDGF or bradykinin
stimulation respectively......................................................................................................101
Figure 14 Src251-GFP construct................................................................................................ 105
Figure 15 Translocation of Src251-GFP to focal adhesions is dependent on the actin
cytoskeleton......................................................................................................................... 107
Figure 16 In the presence of serum Src251-GFP associates with focal adhesions.............. 109
Figure 17 Src localisation to focal adhesions is under the control of RhoA mediated stress
fibres......................................................................................................................................118
Figure 18 Src localisation to lamellipodia is under the control of Rac-1 mediated actin
remodelling..........................................................................................................................120
Figure 19 Src localisation to filopodia is under the control of Cdc42 mediated actin
remodelling..........................................................................................................................122
Figure 20 Localisation of endogenous Src by RhoGTPases is indistinguishable from the
targeting of Src251-GFP.................................................................................................... 126
Figure 21 Localisation of wt-Src by RhoGTPases is indistinguishable from the targeting of
Src251-GFP..........................................................................................................................128
Figure 22 Expression of dominant negative RhoA in cells blocks Src targeting to focal
adhesions.............................................................................................................................. 130
Figure 23 The Rho-kinase inhibitor Y-27632 blocks RhoA-dependent targeting of Src to
focal adhesions.................................................................................................................... 133
Figure 24 Addition of the Rho-kinase inhibitor Y-27632, prior to PDGF stimulation or 
Racl expression impairs stressfibres and retains Src251-GFP in a perinuclear location
during lamellipodia form ation.......................................................................................... 137
Figure 25 Removal of the inhibitory effect of Y-27632 allows stress fibre re-formation and
PDGF induced targeting of Src to lamellipodia..............................................................139
Figure 26 Inhibition of Racl blocks the formation and targeting of Src to lamellipodia but 
has no effect on Src’s peripheral targeting from a perinuclear location to focal
adhesions.............................................................................................................................. 141
Figure 27 Addition of the Rho-kinase inhibitor Y-27632, prior to bradykinin stimulation 
impair stress fibres and retains Src251-GFP in a perinuclear location during filipodia 
formation..............................................................................   145
7
Figure 28 Addition of the Rho-kinase inhibitor Y-27632, prior to Cdc42 expression 
impaires stress fibres and retains Src251-GFP in a perinuclear location during
filopodia formation............................................................................................................ 147
Figure 29 Removal of the inhibitory effects of Y-27632 allows stress fibre re-formation
and bradykinin induced targeting of Src to filopodia.................................................... 149
Figure 30 Inhibition of Cdc42 blocks the formation and targeting of Src to filopodia but 
has no effect on Src’s peripheral targeting from a perinuclear location to focal
adhesions.............................................................................................................................. 151
Figure 31 Schematic representation of the co-ordinated actin remodelling proposed to be 
involved in Src’s sequential targeting from the perinuclear region of the cell to
lamellipodia..........................................................................................................................156
Figure 32 Schematic representation of the co-ordinated actin remodelling proposed to be 
involved in Src’s sequential targeting from the perinuclear region of the cell to
filopodia............................................................................................................................... 158
Figure 33 Schematic representation of Src’s sequential targeting from the perinuclear
region of the cell to lamellipodia or filopodia................................................................. 160
Figure 34 Src kinase activity at focal adhesions is required for remodelUng of the actin
cytoskeleton during lamellipodia formation....................................................................166
Figure 35 c-Src constructs........................................................................................................... 170
Figure 36 Translocation of SrcY527F to focal adhesions is indistinguishable from Src251-
G F P ....................................................................................................................................... 172
Figure 37 Translocation of SrcMF to focal adhesions is indistinguishable from Src251-
G FP ....................................................................................................................................... 174
Figure 38 Src kinase activity is required for remodelling of the actin cytoskeleton during
lamellipodia formation........................................................................................................178
Figure 39 SrcMF expression in focal adhesion prior to PDGF stimulation inhibits actin
cytoskeletal remodelling during lamellipodia formation............................................... 180
Figure 40 Src kinase activity is required for the disassembly of focal adhesions during
lamellipodia formation........................................................................................................182
Figure 41 Src kinase activity is required for re-modelling of the actin cytoskeleton during
filopodia formation.............................................................................................................186
Figure 42 Src kinase activity is required for the disassembly of focal adhesions during
filopodia formation.............................................................................................................188
Figure 43 SrcMF expression in focal adhesions prior to bradykinin stimulation inhibits
actin and focal adhesion remodelling during filopodia formation................................190
Figure 44 Stabilisation of focal adhesions in cells expressing Src251-GFP........................193
Figure 45 Stabilisation of focal adhesions in cells expressing SrcM F.................................195
Figure 46 Src251-GFP and SrcMF inhibit random cell m igration....................................... 198
Figure 47 Src251-GFP and SrcMF inhibit cell polarisation..................................................200
Figure 48 Schematic representation of Src’s targeting from the perinuclear region of the
cell to lamellipodia or filopodia........................................................................................204
Figure 49 Scar co-localises with actin at focal adhesion and lamellipodia induced by LPA
and PDGF................................................................................  215
Figure 50 Scar co-localises with the focal adhesion protein vinculin at focal adhesions and
lamellipodia induced by LPA and PD G F........................................................................217
Figure 51 Myc-tagged Scar-1 co-localises with actin at focal adhesions as endogenous Scar
induced by the LPA and PDGF......................................................................................... 219
Figure 52 Scar co-localises with Src251-GFP and SrcY527F at focal adhesions induced by
RhoA activation................................................................  221
Figure 53 Scar co-localises with Src251-GFP and SrcY527F in lamellipodia induced by
Rac-1 activation.................................................................................................................. 223
Figure 54 Src kinase activity does not effect Arp2/3 binding to Scar-1..............................227
Figure 55 Src kinase activity does not effect actin monomer binding to Scar-1................229
Figure 56 Src kinase activity does not effect Grb2 binding to Scar-1................................. 231
8
Figure 57 PDGF stimulation increases FAK phosphorylation.............................................235
Figure 58 Phosphorylation of FAK is inhibited in cells expressing kinase defective Src.237 
Figure 59 FAK phosphorylated on tyrosine 925 is found in focal adhesions and
lamellipodia......................................................................................................................... 239
Figure 60 FAK phosphorylation on tyrosine-925 localises to discrete patches around the 
edge of the lamelipodia in Src251-GFP expressing cells and is continuous along the
lamellipodia in SrcY527F expressing cells..................................................................... 241
Figure 61 Schematic representation of Src’s intracellular targeting from the perinuclear 
region of the cell to lamellipodia or filopodia.................................................................251
9
Declaration
I declare that all the work in this thesis was performed personally unless otherwise 
acknowledged. No part of this work has been submitted for consideration for any other
degree or award.
10
Abbreviations
APS  ammonium persulphate
ATP  adenosine 5 "-triphosphate
AFAP ..............actin filament associated protein
BSA  bovine serum albumin
c-  cellular
CSF-1R  colony stimulating factor receptor
DH .............Dbl homology
DNA  deoxyribonucleic acid
ECL  enhanced chemiluminescence
ECM  extracellular matrix
EDTA  ethylenediamine tetraacetic acid, disodium salt
EGF(R)  epidermal growth factor receptor
EGTA  ethylene glycol-bis((3-aminoethyl ether)N,N,N",N"-tetraacetic acid
ERK  extracellular signal regulated kinase
ERM  ezrin moesin radixin
F ............phenylalanine
FF1  forming homology
FAK  focal adhesion kinase
FCS  foetal calf serum
FITC  fluorescein isothiocyanate
GAP  GTPase activating protein
GDI  guanine dissociation inhibitor
GDF  GDI displacement factor
GEF  guanine nucleotide exchange factor
GFP  green fluorescenct protein
GPCR  g-protein coupled receptor
GTP  guanosine 5'-triphosphate
HGF  hepatocyte growth factor
Ig  immunoglobulin
LPA  lysophosphatidic acid
mAb  monoclonal antibody
MBS  myosin binding subunit
MLC(K).......... myosin light chain kinase
MEM  modified eagles medium
MRCK .............myotonic dystrophy kinase-related Cdc42 binding kinase
PAK  p21-activated kinase
PAGE  polyacrylamide gel electrophoresis
PBS  phosphate buffered saline
PD G F(R)........platelet derived growth factor receptor
PH  Pleckstrin homology
PI3-kinase phophatidyl inositol 3-kinase
PIP  phophatidyl inositol monophosphate
PIP2  phophatidyl inositol- 4,5 bisphosphate
PIP3  phophatidyl inositol- 3,4,5 bisphosphate
PIX  PAK interacting exchange factor
PI5 kinase............. phophatidyl inositol 5-kinase
PKC  protein kinase C
PLC  Phospholipase C
POR  Partner of rac
PTP  protein tyrosine phophatase
RNA  ribonucleic acid
11
ROCK  rho kinase
SH2  src homology domain 2
SH3 .src homology domain 3
SDS  sodium dodecyl sulphate
TEM ED N,N,N',N'-tetramethylethylenediamine
Tris  tris-[hydroxymethyl]aminomethane
TRITC  tetramethyl rhodamine isothicyanate
ts  temperature sensitive
v-  viral
WASP  wiskott-Aldrich syndrome protein
w/v  weight for volume
Y-  tyrosine
Throughout this study, the names of genes are presented in italics (e.g. fyn) and the names 
of proteins are given in normal text beginning with a capital letter (e.g. Fyn).
Chapter 1
chapter 1
1 introduction
1.1 Src
Tyrosine phosphorylation has been implicated in a variety of biological responses, 
including cell migration, proliferation, differentiation and cell survival (Bolen & Brugge,
1997). Many protein tyrosine kinases have been characterised that do not contain 
extracellular or transmembrane domains. Among these non-receptor tyrosine kinases, are 
the Src protein tyrosine kinase family which are capable of phosphorylating a diverse 
range of cellular targets and are the best characterised of all protein tyrosine kinases. c-Src 
was first isolated as the cellular homologue of v-Src, the transforming gene of Rous 
Sarcoma virus (Stehelin, 1976). As the first proto-oncogene described and through the 
finding that Src possesses tyrosine kinase activity (Collett & Erikson, 1978; Levinson et 
al., 1978), Src serves as a prototype in our understanding of molecular mechanisms behind 
cellular processes involving tyrosine phosphorylation and has led to the discovery of many 
other proto-oncogenes and kinase families.
The Src family kinases have been identified on the basis of their transforming phenotype 
(Yes, Frg and Lck), while others have been identified by regions of homology not found in 
the receptor family tyrosine kinases (Fyn, Yrk, Hck, Lyn and Blk). Most members of the 
Src family kinases demonstrate restricted distribution, primarily in hematopoetic cells, 
while Src, Yes and Fyn display almost ubiquitous expression (Bolen & Brugge, 1997).
1.1.1 Structure of Src
Topographically Src consist of a short membrane anchor domain of 15-17 residues, a 
poorly conserved unique domain of 40-70 residues which defines family members, a Src 
homology 3 (SH3) domain of 50 residues which can bind to specific proline rich sequences 
and a Src homology 2 (SH2) domain of 100 residues found carboxy terminal to the SH3 
domain, which binds to tyrosine phosphorylated sequences. Following this the catalytic or 
kinase domain of Src encompasses 250 residues. Finally at the extreme termini of c-Src 
lies the carboxy-terminal regulatory region containing a conserved tyrosine residue (Figure 
1).
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Figure 1.
myristylation site Tyr 416 Tyr 527
4 r  t
M unique SH2 kinase dom ain tail c-Src
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Figure 1. Schematic representation of cellular (c-) and viral (v-) Src. Amino acids numbers 
correspond to the chicken c-Src sequence The molecule is composed o f an amino-terminal 
myristilation domain, a unique region, SH3 and SF12 protein interaction domains, a kinase 
domain that contains tyrosine-416 and a carboxy-terminal regulatory domain that contains 
tyrosine-527. In v-Src 19 C-terminal amino acids of c-Src are replaced by 12 amino acids in v- 
Src. The C-terminal amino acid deletions in v-Src includes tyrosine-527 which is critical for 
regulating the protein and as a result v-Src is rendered constitutively active.
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1.1.2 Regulation of Src
Most family members of the Src family kinases are highly regulated, exhibiting limited 
kinase activity in the absence of an activating stimulus. This tight regulation and the 
methods by which this is achieved will be highlighted here with particular interest paid to 
the spatial regulation of Src as a method of localising Src’s biological action and thus 
preventing aberrant effects of Src kinase activity within the cell. To begin addressing this, 
we describe the role of individual Src domains in regulating the enzymatic activity of Src 
and ultimately their collective role in Src’s spatial regulation and biological action.
1.1.3 Allosteric regulation of Src
Initial insights into the important role phosphorylation of Src plays in regulating its kinase 
activity came from a study, showing that the removal of phosphotyrosine from normal c- 
Src enhanced the kinase activity of Src (Courtneidge, 1985). Later it was demonstrated 
that the reduced transforming ability of c-Src compared to v-Src, which is dependent on 
Src kinase activity (Kmiecik & Shalloway, 1987; Snyder et al., 1985), was due to the 
presence of tyrosine-527 in c-Src, whose phosphorylation was responsible for the negative 
regulation of c-Src kinase activity and thus transforming capacity (Cooper et al., 1986). v- 
Src lacks this residue and mutations in c-Src at tyrosine-527 to phenylalanine or serine 
augmented the protein tyrosine kinase and transforming activity of c-Src (Figure 1) 
(Kmiecik & Shalloway, 1987; MacAuley & Cooper, 1989). Moreover point mutations in 
the SFI2 domain led to c-Src activation (Kato et al., 1986; Parsons & Weber, 1989), 
highlighting its importance in regulating c-Src activity, and led to the proposal of a model 
in which the SH2 domain participates in an intramolecular interaction with the 
phosphorylated tyrosine-527 carboxy domain, rendering the kinase domain inaccessible 
and therefore inactive in this ‘closed’ conformation (Figure 2). By conjecture, this model 
suggests that dephosphorylation of tyrosine-527 by cellular phosphatases for example, 
would abolish this interaction and allow c-Src to adopt an ‘open’ catalytically active 
conformation, as postulated for protein serine kinases (Soderling, 1990). When Src is in its 
‘open’ conformation, where restraints from the intramolecular interactions are disrupted, 
the phosphorylation of the activation loop at tyrosine-416 in the kinase domain, which is 
an autophosphorylation site (see Section 1.1.8), is required to allow full activation of the 
molecule (Kmiecik & Shalloway, 1987; Snyder et al., 1983) (Figure 2). The transforming 
capacity o f oncogenic c-Src mutants or v-Src are reduced in cells expressing point 
mutations in the activation loop (Kmiecik & Shalloway, 1987; Snyder et al., 1983).
16
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Until the recent elucidation of the three-dimensional crystal structure of regulated Src, the 
role of the SH3 domain of Src was thought to be in co-operation with the binding of the 
SH2 domain to tyrosine-527 by binding proline rich sequences in the kinase domain 
(Courtneidge et al., 1993). However, it is now clear that the kinase domain is exposed 
during interactions between the SH2 domain and the carboxy-terminal region and that the 
SH3 domain participates in regulating the kinase activity of Src by interacting with the 
linker region between the SH2 and catalytic domain (Figure 2) (Sicheri & Kuriyan, 1997; 
Xu et al., 1997). Moreover, elimination of the SH3 domain-linker interaction has been 
shown to induce the activation of the Src family member, Hck, thereby providing a direct 
connection between the SH3 interaction and kinase activity (Moarefi et al., 1997). This, 
along with the SH2/tyrosine-527 interaction, results in constraints on the free movement 
within the kinase domain, rendering it inactive (Sicheri et al., 1997; Xu et al., 1997; 
Yamaguchi & Hendrickson, 1996). Interactions between the SH3 and upstream linker 
sequences between the SH2 and the kinase domain, therefore both contribute to the 
regulation of Src (Figure 2).
1.1.4 Factors influencing the enzymatic regulation of Src
Given the current model (Figure 2), there are several ways in which Src can be regulated 
and any one or more of these might be responsible for the enzymatic activity of Src. These 
include deletion of tyrosine-527 for example, which has previously been described for v- 
Src (Reynolds et al., 1987), resulting in its constitutive activation. Similar results were 
seen in the case of mutating tyrosine-527 to phenylalanine or serine causing the 
constitutive activation of c-Src (Kmiecik & Shalloway, 1987). More recently there has 
been reports of activating mutations in the carboxy terminal region in human c-Src on 
tyrosine-530 which have similar functional consequences as mutating or deleting tyrosine- 
527 in chicken c-Src, including links to enhanced metastasis and cell transformation (Irby 
et al., 1999). Other regulatory mechanisms include de-phosphorylation of tyrosine-527 by 
tyrosine phosphatases, negative regulation by the related regulatory kinase Csk, 
displacement of SH3/SH2- mediated intramolecular interactions by higher affinity ligands 
or by altering the binding affinity of the SH domains to these ligands and finally 
phosphorylation of tyrosine-416, all of which are described in more detail below.
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Figure 2.
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Figure 2. Schematic representation o f c-Src activation by de-phosphorylation of 
tyrosine-527, which results in both the dissociation o f intramolecular interactions with the SH2 
and SH3 domains.
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1.1.5 Regulation of Src by protein tyrosine phosphatases.
Several protein tyrosine phosphatases (PTPs) have been implicated in the regulation of Src 
family kinases serving to de-phosphorylate the C-terminal tyrosine-527 residue and thus 
displace the intramolecular interaction with the SH2 domain rendering Src ‘open’ and 
active. For example, Cd45 is able to dephosphorylate the C-terminal regulatory site of Lck 
and Fyn resulting in kinase activation (Mustelin & Altman, 1990) and Cd45-deficient mice 
have impaired T-cell signalling which correlates with decreased catalytic activity of Lck 
and Fyn and increased phosphorylation of the C-terminal tyrosine-527 (Mustelin et al., 
1992; Ostergaard et al., 1989). However, it is not known whether Cd45-induced 
dephosphorylation of Lck or Fyn is primarily responsible for these effects, due to the fact 
that Lck and Fyn are already poorly phosphorylated in lymphocytes (Ostergaard et al., 
1989). Perhaps a more likely phosphatase would be PTP-a, which dephosphorylates 
tyrosine-527 in vitro (Zheng et al., 1992) and in cells such as A431 carcinoma cells 
(Harder et al., 1998; Ponniah et al., 1999; Su et al., 1999). Consistent with this, 
overexpression of PTP-a in fibroblasts is oncogenic and causes dephosphorylation of Src 
on tyrosine-527 in these cells (Zheng et al., 2000). The likely-hood of PTP-a being a 
major physiological regulator of Src however is unlikely due to the lack of specificity of 
PTP-a for the carboxy-terminal tyrosine-527 over other residues, such as the 
autophosphorylation site at tyrosine-416 (Smart et al., 1981). Other phophatases that can 
dephosphorylate Src include PTP1B, SHP-1 and SHP-2. PTP1B was found to be up 
regulated in breast cancer cell and when purified, like PTP-a, can dephosphorylate and 
activate Src in vitro and in cells (Bjorge et al., 2000). The regulation of Src may be 
achieved by the activity of a variety of protein tyrosine phosphatases and the level of PTP 
expression in different cell types may serve to regulate Src kinase family activity, on a cell- 
type specific basis (O'Connor et al., 1995; Zhao et al., 1992).
1.1.6 Regulation of Src by C-terminal Src kinase Csk.
In addition to the actions of phosphatases, the tyrosine kinase Csk and its homologue Chk 
are thought to be involved in controlling the activation status of Src family kinases by 
phosphorylating the C-terminal tyrosine-527 (Nada et al., 1993). Csk is structurally 
similar to Src comprising an SH2 and SH3 domain, but it lacks the regulatory tyrosine 
residue that critically controls Src activity (Nada et al., 1991). It also does not have a 
membrane anchorage domain and thus Csk is not membrane bound but is found 
predominantly in cytoplasmic pools (Bergman et al., 1995; Okada & Nakagawa, 1988;
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Okada & Nakagawa, 1989). One mechanism proposed for Src regulation by Csk is that 
access to Src by alterations in Csk localisation may influence its effect on Src regulation 
(Chow et al., 1994; Chow et al., 1993; Ford et al., 1994). Csk has a high affinity for 
sequences around tyrosine-416 of activated Src which may target Csk to areas of Src 
activation and thereby act in a negative feedback loop to regulate Src activity (Sabe et al., 
1995; Songyang et al., 1994b). Interestingly, Csk phosphorylates native Src more 
effectively than C-terminally mutated or denatured Src, suggesting that it recognises the 
tertiary structure of Src and that it is in close proximity to the SH2/SH3 and C-terminal 
domains before phosphorylation occurs (Okada & Nakagawa, 1988; Okada & Nakagawa, 
1989). It can therefore be postulated that protein interactions with the SH2/SH3 domain of 
Src could influence the likely-hood of Csk-induced Src phosphorylation and repression of 
its kinase activity (see Section 1.1.10). Finally as with PTPs, the level of Csk expression 
between different cell types may serve to regulate the relative activity of Src. As 
demonstrated in hepatocellular carcinomas, where Csk levels have been reported to be 
reduced compared to normal liver tissue, this altered level of expression correlates with 
enhanced Src activity (Masaki et al., 1999). Loss of Csk activity or reduced expression 
leads to activation of Src family kinases and results in the deregulation of many cellular 
and developmental processes (Masaki et al., 1999; Nada et al., 1993). Consistent with this, 
Csk null mice cause constitutive activation of Src family kinases (Nada et al., 1991; Nada 
et al., 1993). Moreover, overexpression of Csk has been reported to suppress metastasis of 
colon cancer in an animal model correlating to repression of Src kinase activity (Nakagawa 
et al., 2000). Another related mechanism of negatively regulating Src is the 
autophosphorylation of carboxy-terminal tyrosine-527, which has been demonstrated in 
vitro (Cooper et al., 1986; Osusky et al., 1995) and in fibroblasts (Bagrodia et al., 1991; 
Bagrodia et al., 1993) however the kinetics of this suggest that other kinases along with 
Csk are more physiologically relevant regulators of Src tyrosine-527 phosphorylation.
1.1.7 Regulation of Src by altered protein stability or expression levels.
As discussed above, control of the steady state levels of PTPs or Csk serve to regulate their 
activity and in turn regulate Src activity (Nada et al., 1991; Nada et al., 1993). Recent 
evidence suggests that Src is subject to ubiquitin-dependent degradation. Specifically, 
activated forms of Src, including that activated as a consequence of Csk loss, are turned 
over more rapidly than wild type or kinase-inactive Src proteins (Harris et al., 1999; 
Yokouchi et al., 2001). Consistent with this, previous work has demonstrated an increased 
susceptibility of dephosphorylated, ‘open’ Src, compared to repressed or ‘closed’ Src, to a 
spectrum of protease-induced degradation conditions (MacAuley & Cooper, 1989).
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Therefore, if the ubiquitin-proteosome degradation system in general is altered this could 
potentially effect the level of Src activity in the cell (Kamei et al., 2000). The ubiquitously 
expressed protease calpain (Fox et al., 1985) may also co-operate with proteosomes to 
regulate Src by calpain-induced cleavage of Src (Jang & Choi, 1999). Calpain is proposed 
to impair Src dependent activity by decreasing its kinase activity due to a reduction in its 
association with the cell membrane. Association with the cell membrane, as described 
later in Section 1.1.9, is essential for many of Src’s activities and therefore impairing this 
association may constitute a further mechanism of regulating Src within the cell (Oda et 
al., 1993). Irrespective of the mechanism involved, down regulation of Src activity by 
proteolytic pathways represents an additional mechanism by which Src family kinases can 
be regulated.
1.1.8 Regulation of Src by the Src kinase domain.
The kinase domain of Src is the most conserved region between family member and plays 
a role in substrate selection along with the SH3 and SH2 domains. Moreover, the preferred 
substrate sequence of the kinase domain shows similarities to the preferred binding 
sequence of the SH2 domain, suggesting cross-talk between these domains during substrate 
binding (Zhou et al., 1995). As discussed earlier (see Section 1.1.3) when Src is in its 
‘open’ conformation, where restraints from the SH2/SH3 intramolecular interactions are 
disrupted, the phosphorylation of the activation loop at tyrosine-416 is required to allow 
full activation of the molecule (Kmiecik & Shalloway, 1987; Snyder et al., 1983). Auto­
phosphorylation appears to occur mainly by intramolecular interactions and it is thought 
that phosphorylation of tyrosine-416 serves to stabilise the catalytically active 
conformation of Src (Feder & Bishop, 1990; MacAuley & Cooper, 1988; Osusky et al., 
1995; Sugimoto et al., 1985). Moreover, recent studies have also proposed a bi-directional 
regulatory mechanism involving the phosphorylation of tyrosine-416 in the kinase domain, 
where phosphorylation or mutations in the activation loop result in the increased 
availability of the SH3 domain for binding. By this mechanism the Src residues within the 
kinase domain control the accessibility of the regulatory domains (SH3/SH2), while as 
described previously (see Section 1.1.3), the regulatory domains control the accessibility of 
the kinase domain. The lysine residue at position 295 in the kinase domain is strictly 
conserved between family members and plays a role in the phosphotransfer reaction during 
ATP binding (Hunter & Cooper, 1985). Mutation of this residue results in a kinase- 
defective form of Src (Kamps & Sefton, 1986).
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Carboxy-terminal to the myristylation domain lies the unique domain (Figure 1). This 
domain is highly divergent and the least conserved between family members. There are 
protein kinase (PKC) dependent phosphorylation sites at residue 12 and 48 in this domain, 
and furthermore, serine-17 in the unique domain, is a major phosphorylation site for cyclic 
AMP-dependent protein kinase (Brown & Cooper, 1996; Courtneidge et al., 1993). 
Moreover, there have also been reports of cdc2/cyclin-dependent phosphorylation of Src’s 
unique domain (Kaech et al., 1993; Shenoy et al., 1992). The overall function and 
significance of the phosphorylation events in the unique domain however have still to be 
fully understood. Some studies have revealed potential functions of this domain in terms 
of protein interactions and in regulating Src family kinase activity itself. Cdc2/cyclin- 
dependent phosphorylation of Src’s unique domain for example, seems to disengage the C- 
terminal regulatory domain from the SH2 domain, rendering tyrosine-527 more accessible 
to phosphatases and therefore activation (Chackalaparampil & Shalloway, 1988). 
Interesting in the case of Lck, there are indications that serine-49 may regulate the 
specificity of the SH2 domain for ligands (Park et al., 1995; Shenoy et al., 1992), which, as 
will be discussed in more detail later, may serve to regulate Src kinase activity by 
interfering with the association of phosphorylated tyrosine-527 and the SF12 domain, 
rendering it ‘open’ and in the active conformation. Recently, auto-phosphorylation of 
tyrosine-29 in the Src family member, Hck’s, unique region has been shown to activiate 
Hck (Johnson et al., 2000). Therefore the unique domain may play a key role in regulating 
Src kinase activity during specific processes.
1.1.10 Regulation of Src by molecular displacement.
Carboxy-terminal to the unique domain is the SH3 domain followed by the SH2 domain 
(Figure 1). The SH3 domain binds proline-rich ligands with a left handed helical 
conformation and the SH2 domain preferentially binds to phosphotyrosine containing 
sequences with the consensus sequence YEEI (Songyang et al., 1994a; Yu et al., 1994). In 
both cases these domains are highly conserved amongst Src family members and other 
non-related proteins, however variations in the binding affinity of the SH2 and SH3 
domains between Src family members has been demonstrated. For example the SFI3 
domain of Src, Fyn and Yes have been shown to recognise a common motif, while Lyn 
demonstrates a distinct binding specificity (Rickies et al., 1995). Moreover, like the SH3 
domain, the binding affinity of the SH2 domain for its ligand has been demonstrated to be 
regulated by post-translational modification. -For example, tyrosine phosphorylation at
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tyrosine-192 increases the binding affinity of the SH2 domain for phospholipase C (PLC) 
(Couture et al., 1994).
Displacement of intramolecular SH3/SH2 interactions constitutes another mechanism for 
activating and thereby regulating Src kinase activity within the cell. A diverse class of Src 
interacting partners has been identified that could compete effectively with the 
intramolecular interactions and thereby disturb Src’s inactive state. The first indication 
that Src kinase as well as other family member such as Fyn (Ralston & Bishop, 1985) 
could be regulated by this mechanism, demonstrated that binding of the SH2 domain of Src 
or Fyn to the platelet-derived growth factor receptor (PDGFR) or to the colony stimulating 
factor receptor (CSF-1R) activates Src or Fyn’s kinase activity (Mayer et al., 1999; Ralston 
& Bishop, 1985; Songyang et al., 1994a). As stated above the SH2 domain preferentially 
binds to phosphotyrosine containing sequences and activation of Src has previously been 
observed following binding to a tyrosine phosphorylated peptide derived from the PDGFR 
(Mayer et al., 1999; Ralston & Bishop, 1985; Songyang et al., 1994a). In addition to 
actively competing for the Src SH2 domain, the PDGFR may activate Src by 
phosphorylation of the SH3 domain. Tyrosine-136 phosphorylation in the SH3 domain by 
the PDGFR has been shown to reduce the affinity of the SH3 domain for peptide ligands 
(Broome & Hunter, 1996), analogous to the effect of the unique domain of Lck on SH2 
binding (see Section 1.1.9). As the SH3 domain is partially involved in maintaining the 
‘closed’ conformation of Src this could lead to destabilisation and therefore activation of 
Src kinase activity. Interestingly, another non-receptor tyrosine kinase family member, 
focal adhesion kinase (FAK), that was first identified as a tyrosine phosphorylated protein 
in Src transformed cells (Kanner et al., 1990), is an example of a Src effector that can bind 
to the SH2 domains of Src and lead to Src kinase activation (Schaller et al., 1994; Thomas 
et al., 1998). Recently it was demonstrated that the FAK binding partner, p l30  Cas (Crk 
associated substrate), could activate Src via binding to its SH domains and displace the 
intramolecular interactions that regulate Src activity (Burnham et al., 2000). As described 
previously, (see Section 1.1.5), PTPa can activate Src by dephosphorylation of the C- 
terminal tyrosine-527 of Src. Recently PTPa has also been shown to regulate Src by the 
phosphotyrosine displacement mechanism described above (Zheng et al., 2000).
1.2 Spatial regulation of Src.
Conserved domains of Src are not only involved in regulating Src kinase activity by 
regulating the ‘open,’ or ‘closed’ conformation of Src but also serve a purpose in the
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correct intracellular localisation of Src during various cellular processes. For example early 
observations demonstrated that Src-family kinases are commonly found associated with the 
plasma membrane, as well as intracellular membranes including endosomes and the 
endoplasmic reticulum (Courtneidge et al., 1980; Garber et al., 1983). The amino-terminal 
myristylation of Src is required for the association with cellular membranes and is essential 
for the transforming function of oncogenic Src mutants (Resh, 1994). Consistent with this, 
myristylation defective alleles of v-Src, which are no longer associated with the membrane, 
are no longer transforming (Hamaguchi & Hanafusa, 1987). Similarly the perinuclear 
distribution of Src has been shown to be dependent on the myristylation domain and is 
thought to be retained there by association with the microtubule network, as demonstrated, 
by co-localisation studies in which both Src and tubulin co-localised in the perinuclear 
region of the cell (Fincham et al., 1996). Moreover the switch from a perinuclear to a 
cytoplasmic distribution of Src upon treatment with the microtubule disrupting drug 
nocodazole also demonstrated the microtubule association of Src in this region of the cell 
(Fincham et al., 2000; Fincham et al., 1996). Myristylation is an irreversible process 
mediated within the first seven residues of Src where the myristylation group is added to 
glycine at position two of the protein (Figure 1). In general myristylation is necessary for 
membrane localisation (Bagrodia et al., 1993) however some myristylated Src molecules 
are found to be cytoplasmic (Buss et al., 1984) suggesting that myristylation is not the only 
domain involved in membrane localisation of Src. Besides the myristylation domain 
providing a signal for membrane association, all Src family members except Src itself and 
Blk (Resh, 1994), undergo palmitylation of amino-terminal basic cysteine residues, which 
serves to stabilise membrane association by compensating for the absence of a positive 
charge on the N-terminal region of the protein (Lock et al., 1991; Robbins et al., 1995). 
Palmitylation is a reversible process and control of palmitylation has been proposed as a 
potential mechanism for the regulation of Src family kinase localisation within different 
membrane compartments such as caveolae in response to the certain stimuli (Kaplan & 
Simon, 1988; Robbins et al., 1995). Recently alterations in the palmitylation status of Lck, 
has been shown to block its normal function in T-cell signalling (Kabouridis et al., 1997) 
analogous to alterations in the myristylation of Src blocking oncogenic transformation 
(Buss et al., 1984; Resh, 1994). Therefore the myristylation domain plays an important 
role in c-Src distribution, by anchoring c-Src to various membrane locations. Furthermore, 
in association with other domains and modifications, myristylation regulates the trafficking 
of Src to specific membrane micro-environments (Buss et al., 1984; Kaplan et al., 1994).
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Figure 3
A schematic representation of Src’s spatial localisation during various cellular 
processes. Following translocation to the cell periphery Src can be found in focal 
adhesions where it may be involved in a number of signal transduction pathways or in 
focal adhesion turnover during cell migration. Src may also be localised to cell-cell 
junctions inducing cell-cell disruption.
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1.2.1 Src domains involved in spatially regulating Src.
The finding that the transforming activity of Src involves interactions between multiple 
domains and that myristylation-induced membrane association is necessary for this 
process, emphasises the importance of spatial regulation of Src in the biological action of 
Src. It is also clear however, that domains other than the myristylation domain of Src, 
besides contributing to Src’s allosteric regulation, also provide a role in Src localisation.
As stated previously, early observations demonstrate that Src is readily found in the 
perinuclear region of the cell where co-localisation and biochemical fractionation studies 
demonstrated that Src localises with endosomal markers and associates with endosomal 
membrane structures (David-Pfeuty & Singer, 1980; Kaplan et al., 1992; Nigg et al.,
1982). v-Src however, is abundant in both the perinuclear region of the cell and in focal 
adhesions, which are areas of adhesion, where the extracellular matrix can interact with 
transmembrane receptors and the actin cytoskeleton (see Section 1.3.2) (Burr et al., 1980; 
Kaplan et al., 1992; Nigg et al., 1982). The apparent difference in sub-cellular localisation 
of c-Src and v-Src led to the proposal that deletion of the C-terminal tyrosine-527 in v-Src 
may be responsible for this altered distribution of v-Src (Figure 1). In v-Src, 19 C-terminal 
amino acids of c-Src are replaced by 12 unique amino acids in v-Src (Takeya & Hanafusa,
1983). This includes tyrosine-527, which, as mentioned above, is critical for the regulation 
of the protein. This altered sub-cellular distribution of v-Src along with the fact that 
myristylation can confer membrane association led to investigations examining the 
contribution of each domain in controlling the intracellular targeting of Src. The role of 
each domain in this process was investigated by examining a series of deletions and point 
mutations of these sites in c-Src.
Mutation of tyrosine-527 to phenylalainine in c-Src, which results in catalytic activation, as 
well as release of constraints on the SH3 and SH2 domains (see Section 1.1.4), led to c-Src 
being constitutively associated with focal adhesions (Kaplan et al., 1994). Similarly, 
temperature sensitive ts variants of v-Src that are temperature sensitive for kinase activity, 
located to focal adhesions when activated by switch to permissive temperature (Fincham & 
Frame, 1998; Fincham et al., 1996; Welham & Wyke, 1988). Although the mechanism for 
temperature-induced activation of ts v-Src is not established, it is believed to mimic the 
conformational changes in c-Src upon release of the regulatory intramolecular interactions 
between the SH3/SH2 domains and the catalytic domain (Abram & Courtneidge, 2000; 
Thomas & Brugge, 1997).
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Subsequently, the role of the kinase domain in c-Src targeting to focal adhesions was 
examined in this context. Using the SrcY527F mutant with a point mutation in the ATP 
binding domain (K295M) (see Section 1.1.8) the translocation of c-Src to focal adhesions 
was shown to occur independently of kinase activity (Kaplan et al., 1994), consistent with 
the kinase-independent targeting of (ts) v-Src to focal adhesions (Fincham & Frame, 1998). 
Moreover, in addition to activating the kinase activity, mutation of tyrosine-527 to 
phenylalanine also alters the tertiary structure of c-Src to expose the N-terminal regulatory 
domains of Src (Figure 2) (Gonfloni et al., 2000).
The ability of focal adhesion targeting by the N-terminal domains of Src comprising the 
first 251 residues was therefore examined. The first 251 residues of c-Src readily associate 
with focal adhesions (Kaplan 1994), indicating that the N-terminal region of Src contains 
sufficient information to allow targeting of Src to focal adhesions. Deletion of the SH3 
domain residues 92-144 abolished Src targeting to focal adhesions along with a reduction 
in the detergent-insoluble (or membrane) fraction of c-Src (Kaplan et al., 1994). This, 
along with further mutational analysis of both c- and v-Src, including a single amino acid 
change in the SH3 domain which ablates SH3 binding (Erpel et al., 1995), revealed a 
critical role for the SH3 domain in the translocation of Src to focal adhesions (Fincham et 
al., 2000; Fincham & Frame, 1998; Kaplan et al., 1994). Mutations of the SH2 domain to 
block phosphotyrosine binding (Bibbins et al., 1993), or deletion of the C-terminal residues 
in the SH2 domain (residue 169-204, Figure 1), revealed that impairment of the SH2 
domain function has no significant effect on Src localisation to focal adhesions, resulting in 
only a slight increase in perinuclear staining. In contrast, previous reports by Fukui, 
demonstrated that deletions of the N-terminal residues (residues 149-169, Figure 1) of the 
SH2 domain reduced the association of v-Src with the membrane fraction of the cell 
(Fukui et al., 1991). This apparently paradoxical result can be explained however by the 
likely-hood that such large deletions in the N-terminal region of the SH2 domain (as 
opposed to the C-terminal region) may effect the conformational stability of the adjacent 
SH3 domain (Figure 1), which has been demonstrated to be necessary for Src translocation 
(Fincham et al., 2000; Kaplan et al., 1994). Furthermore, mutations in the SH2 domain 
have also been reported to effect the overall stability of the molecule making data 
interpretation difficult (Kaplan et al., 1994). It is likely that the SH2 domain plays a role in 
peripheral targeting by modulating the association of the SH3 domain with candidate 
mediators of Src’s peripheral targeting, such as the p85 regulatory domain of phophatidyl 
inositol 3-kinase (PI3-kinase). v-Src binds to PI3-kinase in normal growing cells via its 
SH3 domain, however upon activation of v-Src there is a rapid induction of binding to PI3- 
kinase via the SH2 domain of Src which is thought to serve in regulating the recruitment of
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PI3-kinase to Src which is required during Src translocation to the cell periphery (Fincham 
et al., 2000; Haefner et al., 1995). Furthermore the N-terminal region of the SH2 domain 
has been implicated as having a role in Src’s association with the actin cytoskelton, as N- 
terminal but not C-terminal deletions in this domain reduce cytoskeletal association (Fukui 
et al., 1991; Okamura & Resh, 1994). Deletions in the N-terminal region of the unique 
domain residues (residue 17-30, Figure 1) had no effect on focal adhesions targeting, while 
deletion in the C-terminal end of the unique domain (residues 30-92, Figure 1), disrupted 
the localisation of Src to focal adhesions, which, as above, was suspected to be due to 
interference in the SH3 related targeting processes. Clearly multiple domains in Src are 
involved in the targeting of Src to the cell periphery, whether it be via membrane 
association or by allowing recruitment of high affinity binding partners to specific sites. 
By this means, activation of Src induces the formation of SH2- and SH3- dependent 
complexes with proteins or lipids (Kaplan et al., 1990; Rameh et al., 1995) that can specify 
the targeting of Src during suitable cellular responses. As discussed previously for the 
activation loop (see Section 1.1.8), a bi-directional regulatory mechanism has been 
proposed, in which the intramolecular interactions involving the SH2/SH3 domains and the 
C-terminal region of Src, regulate kinase activity, as well as serving to regulate the 
availability of these N-terminal protein-protein interaction domains. By this mechanism 
the localisation of Src and the kinase activity can be simultaneously regulated (Gonfloni et 
al., 2000).
As discussed earlier in Section 1.1.6, one mechanism proposed for Src regulation by Csk is 
that access to Src by alterations in Csk localisation may influence its effect on Src 
regulation (Guan & Shalloway, 1992). In particular, Csk has been shown to translocate to 
focal adhesions and co-localise with Src during cell spreading and adhesion formation 
(Kaplan et al., 1995). It has been proposed that Csk may bind to various tyrosine 
phosphorylated chaperon proteins such as FAK or paxillin and therefore be brought to the 
cytoskeletal or focal adhesions fraction of the cell and locally inhibit Src, indicating that 
the spatial regulation of proteins such as Csk may serve a role in their biological function 
or efficacy within the cell.
1.2.2 Potential binding partners involved in spatial regulation of Src
The finding that the Src SH3 domain along with potential contributions from the SH2 
domain directs peripheral targeting of Src (Fincham et al., 2000; Kaplan et al., 1994), led 
to investigations to examine the nature of the SH3 binding partners involved in the 
peripheral targeting of Src. The binding of potential proteins involved in Src targeting to
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an SH3 binding mutant of (ts) v-Src, which inhibits SH3 binding (W118A) (Erpel et a l,
1995) and the targeting of Src to focal adhesions, was compared to the binding of normally 
targeting (ts) v-Src, to examine a variety of potential regulators of this process. The actin 
filament associated protein (AFAP) which is a Src substrate and binding partner (Flynn et 
al., 1993), the cytosolic chaperon HSP90 that binds to both c-Src and v-Src and is reported 
to be essential for membrane association of Src (Bijlmakers & Marsh, 2000; Brugge, 1986; 
Xu et al., 1999) and FAK which contains a C-terminal focal adhesion targeting sequence 
and binds to Src via the Src SH3 and SH2 domains (Hildebrand et al., 1993; Thomas et al.,
1998) were all examined. Both AFAP and HSP90 were ruled out as contributing to this 
process due to their ability to associate with v-Src independently of SH3 binding, as 
demonstrated by their binding to (ts) v-Src containing the SH3 domain binding mutation 
(W118A) (Erpel et al., 1995; Fincham & Frame, 1998). Similarly FAK was ruled out as a 
chaperon in the translocation of Src to focal adhesions as v-Src could translocate to focal 
adhesions in FAK -/- cells and over expression of FAK mutants that impair Src binding to 
FAK did not inhibit v-Src targeting (Fincham & Frame, 1998). PI3-kinase however, which 
is involved in regulation of vesicular transport (Clark & Brugge, 1993; Schuh & Brugge, 
1988) and has been recently detected in focal adhesions with similar dynamics as the 
activation of Src (Gillham et al., 1999; Guinebault et al., 1995), was shown to only 
associate with the targeting version of v-Src and not the targeting defective mutant 
(Fincham et al., 2000). This is consistent with previous work demonstrating the binding of 
PI3-kinase with the SH3 domain of activated Src in vitro (Haefner et al., 1995; Liu et al., 
1993). Subsequently, PI3-kinase dependent targeting of Src was demonstrated using the 
PI3-kinase inhibitor LY294002 which prevented the translocation of v-Src to focal 
adhesions (Fincham et al., 2000). This however does not rule out other possible binding 
partners involved in this process.
1.2.3 Spatial location of Src during various cellular processes.
Regardless of how Src kinase activity is regulated, Src’s contribution to cellular processes 
is almost certainly not confined to whether it is active or not. For example, upon 
activation, Src has been shown to translocate from a perinuclear localisation to the cell 
periphery within the cell. Src has been found in focal adhesion structures at the cell 
periphery where it is associated with various proteins resulting in the activation of a 
number of signal transduction pathways (Figure 3). Moreover Src’s localisation in focal 
adhesions is thought to lead to focal adhesion turnover and remodelling, a prerequisite for 
cell migration (see Figure 3 and Section 1.6.1). Src has also been shown to localise to 
areas of cell-cell contact in epithelial cells and its kinase activity at these sites is thought to
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function in the disruption of cadherin mediated cell-cell junctions during their normal 
dynamic regulation and upon cell scattering (Behrens et al., 1993; Matsuyoshi et al., 1992; 
Owens et al., 2000). Other roles for Src kinase activity at cell-cell junctions include the 
breakdown of gap junctions as demonstrated by the phosphorylation of connexin 43 
leading to gap junction dissociation (see Figure 3) (Crow et al., 1990; Filson et al., 1990). 
Src has also been shown to be re-located from cell-cell junctions to integrin adhesions 
during epidermal growth factor (EGF)-induced invasion (Brunton et al., 1997). Src 
induced disruption of cell-cell contacts has implications for cell migration and metastasis 
allowing cells to disperse from an epithelial sheet (Owens et al., 2000). Src can also be 
found associated with secretary vesicles indicative of a role in directed secretion (Grandori 
& Flanafusa, 1988; Linstedt et al., 1992). Moreover, Src is found in the nuclear 
compartment along with other Src family kinases such as Fgr and the related kinase Frk 
where it is thought to be involved in mRNA processing in association with Sam68 during 
mitosis (Taylor & Shalloway, 1994). Src as well as other family member such as Fyn and 
Lck can also be found associated with microtubules or pericentriolar vesicles respectively 
(Ley et al., 1994). The distinctive localisations of Src and Src family members, suggest 
that localisation is partially regulated by individual domains of Src and also highlights that 
intracellular localisation plays a major role in the biological action of Src family kinases.
1.2.4 Src’s intracellular targeting within the cell.
Despite our increasing understanding of the regulation of Src, and the importance of the 
SH3 and SH2 domains in binding to potential chaperon molecules, there is still little 
information on the mode of intracellular targeting of Src to the cell periphery and how this 
targeting is controlled. Earlier observation however, demonstrated that Swiss 3T3 cells 
expressing high levels of v-Src were surprisingly unable to induce morphological 
transformation or induce mitogenic signalling when deprived of serum (Fincham et al., 
1996). Resistance to the normal transforming effects of v-Src was found to be due to 
impaired peripheral targeting of Src, consistent with myristylation defective mutants of Src 
which fail to transform (see Section 1.2). The reason for the impaired peripheral targeting 
however, originates from previous observations by Ridley and Hall, that Swiss 3T3 cells 
lose their actin stress fibres upon serum starvation (Ridley & Hall, 1992). This observation 
in conjunction with demonstrations that activated Src in response to PDGF, EGF or 
thrombin translocates to the actin cytoskeleton (Burr et al., 1980; Clark & Brugge, 1993; 
Weernink & Rijksen, 1995), led to investigations into the actin dependence of Src targeting 
to focal adhesions. Addition of serum or microinjection of a constitutively active form of 
RhoA (see Section 1.3.2), both of which induce actin stress fibre formation, into serum-
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deprived Swiss 3T3 cells, restored actin stress fibres and the translocation of v-Src to focal 
adhesions thereby restoring the oncogenic potential of v-Src in these cells (Fincham et al.,
1996). v-Src initially localised along re-formed stress fibres and there was a time 
dependent re-distribution of Src to the stress fibre termini at the cell periphery (Fincham et 
al., 1996). Furthermore, treatment with the actin disrupting drug cytochalasin D prevented 
Src translocation in Swiss 3T3 cells (Fincham et al., 1996). Src has previously been 
shown to bind to polymerised actin (Lakkakorpi et al., 1997) and interestingly the v-Src 
SH3 mutant that was unable to target to focal adhesions was unable to bind to polymerised 
actin, implying that a potential role of the SH3 domain is to link Src to cellular actin 
filaments allowing translocation to the cell periphery (Fincham et al., 2000). Similar 
effects have been seen for the intracellular targeting of Src and other ubiquitously 
expressed family members such as Fyn and Yes in epithelial cells, in which treatment of 
cells with cytochalasin D prevented translocation to cadherin mediated cell-cell junctions 
(see Figure 3) (Owens et al., 2000). From this it has been concluded that regulation of 
Src’s intracellular targeting within the cell requires an intact actin cytoskeleton. 
Interestingly the PI3-kinase inhibitor LY294002 used to assess the role of PI3-kinase in 
Src’s peripheral targeting also reduced the number of actin stress fibres in cells, although 
peripheral actin was still observed, implying that one potential role of PI3-kinase as a 
chaperon is to maintain actin stress fibres in a state permissive for Src translocation 
(Fincham et al., 2000). In this regard, the report of PI3-kinase, Src and RhoA translocation 
to the actin cytoskeletal fraction upon osteoclast attachment helps implicate this action of 
PI3-kinase in Src’s targeting to the cell periphery (Lakkakorpi et al., 1997).
Based on the actin dependence of Src’s peripheral targeting we set out to examine whether 
intracellular regulators of the actin cytoskeleton (RhoGTPases, see below) could influence 
the intracellular location of Src and thereby serve to spatially regulate its biological action 
within the cell.
1.3 RhoGTPases
Over the past decade there has been a remarkable increase in our knowledge of the role 
RhoGTPases play in a diverse spectrum of cellular processes including regulation of the 
actin cytoskeleton, cell migration, membrane trafficking, cell growth and transformation 
(Ridley, 1996; Van Aelst & D'Souza-Schorey, 1997). Here we focus on actin cytoskeletal 
organisation and remodelling induced by RhoGTPases and the role they play in processes 
such as cell motility, cell-substratum adhesion and disruption, and highlight their potential 
role in facilitating the local effects of Src during cell migration.
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RhoGTPases are a subfamily of proteins belonging to the Ras superfamily of small 
GTPases (Hall, 1998; Van Aelst & D'Souza-Schorey, 1997). A great deal of our 
knowledge regarding RhoGTPases, stem from work on the prototype Rho family members 
RhoA, Cdc42 and Racl, each demonstrating distinct functions within the cell. As a result 
RhoGTPases can be subdivided into the following groups based on cellular function and 
sequence homology. The first of these include RhoA, RhoB and RhoC, which share 
similar cellular functions including the formation of stress fibres (see Section 1.3.2). The 
Rac family subgroup includes Racl, Rac2, Rac3 and RhoG which are thought to be related 
in function and have been shown to induce lamellipodia (see Section 1.3.2). A third class 
of RhoGTPases includes Cdc42 and TC10 which induce filopodia (see Section 1.3.2). A 
fourth class of RhoGTPases include the RhoE related GTPases RhoE, Rho6/Rndl and 
Rho7/Rnd2 which have been shown to reduce actin stress fibres (Guasch et al., 1998; 
Nobes et al., 1998). A final subclass of RhoGTPases include RhoD and TTF which are 
thought to be distinct from the other proteins and have been implicated in vesicular 
transport (Murphy et al., 1996). There are many more family members rapidly being 
identified (Ellis & Mellor, 2000), their function and role within the cell however remain 
poorly understood. Although members within these subgroups share similar cellular 
function they can also differ as a result of post-translational modification, such as 
alterations in lipid association (Adamson et al., 1992), which may regulate their subcellular 
location within the cell thereby serving to facilitate unique roles between members. 
Similarly, expression levels can also vary between cell types and family members, again 
adding to the diversity between members (Fritz et al., 1995; Hunter & Cooper, 1985; 
Jahner & Hunter, 1991).
1.3.1 Regulation of RhoGTPases
The Rho family GTPases are regulated in a similar manner as Ras family GTPases, serving 
as molecular switches by cycling between an inactive (GDP)-bound form and an active 
(GTP)-bound form, which in turn controls a number of cellular processes described above 
(Figure 4). The ratio of GTP bound (active) or GDP bound (inactive) RhoGTPases, is 
determined by three distinct regulatory proteins which include guanine nucleotide 
exchange factors (GEFs), which enhance the exchange of bound GDP for GTP (Ridley, 
1996; Whitehead et al., 1997); the GTPase activating proteins (GAPs), which serve as 
negative regulators of Rho family GTPases by increasing the rate of intrinsic hydrolysis of 
bound GTP (Cerione & Zheng, 1996); and guanine nucleotide dissociation inhibitors 
(GDIs), which inhibit both GTP exchange and the hydrolysis of GTP (Ueda et al., 1990a).
33
chapter 1
There has been a great increase in the number of GEFs discovered recently, the individual 
role of many in RhoGTPase signalling however, has yet to be fully established due to their 
cell type-specific expression and altered specificity for different RhoGTPases (Adra et al., 
1997; Zheng et al., 1996). GEFs share a tandem motif of Dbl homology (DH) domains 
(Cerione & Zheng, 1996), which is essential and sufficient for guanine exchange activity 
(Hart et al., 1992) and a pleckstrin homology (PH) domain, which is involved in 
intracellular localisation of activated GEFs via specific lipid or protein-protein interactions 
(Zheng et al., 1996). There are a number of Rho family specific GEFs such as Lsc for 
RhoA, Tiam for Racl and Fgdl for Cdc42 (Glaven et al., 1996; Habets et al., 1994; Olson,
1996), while others display activity towards many Rho family proteins, such as Vav which 
activates both RhoA and Racl (Crespo et al., 1997). Many GEFs have domains other than 
the DH and PH domains including SH3 domains, which suggests functions other than GEF 
activity (Cerione & Zheng, 1996). In this regard several GEFs have been reported to have 
effector functions such as PI3-kinase which via Vav may also act as an effector for Cdc42 
during the hierarchical cascade between Rho family members (Zheng et al., 1994a) (see 
Section 1.4.3).
In a similar manner many GAPs have been discovered with differences in their Rho family 
protein specificity (Ellis et al., 1990; Ridley et al., 1993). For example, pl22RhoGAP has 
specific activity towards RhoA (Homma & Emori, 1995), while a-chimerin (Leung et al., 
1993) and Ralbpl (Cantor et al., 1995) demonstrate specific activity towards Racl and 
Cdc42 respectively. Others however have a more promiscuous nature and effect a number 
of Rho family proteins, such as Abr, which has activity towards both Rac and Cdc42 (Tan 
et al., 1993). Moreover GAPs have been documented as having downstream effector 
functions as well as increasing the hydrolysis of GTP. For example expression of N-and (1- 
chimerin have been documented as inducing lamellipodia and filopodia (see Section 1.3.2) 
(Kozma et al., 1996).
Interestingly as well as maintaining the GDP-bound state of RhoGTPases by inhibiting 
both GTP exchange (Ueda et al., 1990b), RhoGDIs have a role in the spatial regulation of 
RhoGTPases. Active RhoGTPases are found associated with the cell membrane however 
RhoGDIs partially control their effects within the cell by maintaining them in the cytosol 
in the inactive state as opposed to the membrane (Isomura et al., 1991). RhoGDIs 
associate with GDP-bound Rho in the cytosol and upon activation it has been reported that 
Rho is released from RhoGDIs with the subsequent translocation of Rho to the membrane 
(Takahashi et al., 1997). RhoGDIs can also bind to GTP-bound Rho family proteins and 
serve to reduce the intrinsic or GAP-induced GTPase activity and hence protect the
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activated state of RhoGTPases (Hart et al., 1992). Until more recently the molecular 
mechanism underlying the dissociation of GDIs was unclear. However, RhoGDI 
dissociating factors (GDFs) such as the ERM (ezrin, radixin and moesin) family protein 
family have been implicated in this process (Hart et al., 1992; Tsukita et al., 1994). 
Radixin for example has been shown to bind to the RhoGDI/RhoGDP complex and induce 
dissociation thereby enhancing the ability of GEFs to induce GDP/GTP exchange 
(Takahashi et al., 1997).
It is clear that the role of individual GEFs, GAPs or GDIs can greatly influence many 
cellular processes via their control of RhoGTPases, although our understanding of their 
role in individual processes remains to be fully established. More is known however about 
the role of individual RhoGTPases in regulating the actin cytoskeleton and structures 
during various processes (Hall, 1998).
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Figure 4. Regulation of RhoGTPases. RhoGTPases act as molecular switches by cycling between 
an inactive GDP-bound form and an active GTP-bound form. This is regulated by a number of 
different proteins including GEFs, GAPs and GDIs. In the G4P bound state RhoGTPases can 
interact with their effector or target proteins and play a role in a diverse spectrum of cellular 
processes including actin remodelling.
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1.3.2 RhoGTPases act as a link between extracellular stimuli and the 
remodelling of the actin cytoskeleton
Several investigations have implicated the Rho family of small GTPases in linking external 
stimuli to the assembly and remodelling of the actin cytoskeleton. This was initially 
explored in Swiss 3T3 fibroblasts where the external stimulus, lysophosphatidic acid 
(LPA) induced stress fibre and focal adhesion formation in quiescent Swiss 3T3 cells 
(Ridley & Hall, 1992). Stress fibres consist of bundled contractile actin-myosin filaments 
that traverse the cell and provide cell attachment via focal adhesions to the extracellular 
matrix (Figure 5) (Chrzanowska-Wodnicka & Burridge, 1996). Focal adhesions can be 
defined as points of contact between cells and their extracellular environment, consisting 
of clustered integrins and proteins such as a-actinin, vinculin, paxillin cortactin and FAK 
that link the extracellular matrix to the actin cytoskeleton (Nobes & Hall, 1995; 
Schoenwaelder & Burridge, 1999). This stress fibre formation induced by LPA was 
ablated by the addition of C3-transferase which ADP-rybosylates and inactivates RhoA, B 
and C (Aktories & Hall, 1989; Narumiya et al., 1988; Ridley & Hall, 1992). Furthermore 
experiments using constitutively active and dominant negative RhoA proteins implicated 
RhoA in this process (Figure 5) (see section 3.2.4) (Paterson et al., 1990; Ridley & Hall, 
1992; Ridley et al., 1992). Subsequent investigations demonstrated that RhoA links other 
extracellular stimuli to actin assembly and organisation to form stress fibres, such as 
sphingosine-1-phosphate and thrombin (Jalink et al., 1994; Postma et al., 1996; Seufferlein 
& Rozengurt, 1995).
In similar experiments, PDGF was reported to induce actin polymerisation at the cell 
periphery resulting in the formation of lamellipodia (Nobes & Hall, 1995; Ridley et al., 
1992). Lamellipodia consist of rapidly turning over protrusive sheets of cross-linked actin 
filaments at the cell periphery, which develop between finger like protrusion known as 
filopodia (Figure 5). The formation of lamellipodia was blocked in cells expressing 
dominant negative Racl (Nobes & Hall, 1995; Ridley et al., 1992). Furthermore, 
microinjection of constitutively active Racl, induced lamellipodia formation (Ridley et al., 
1992), therefore establishing that Racl was responsible for relaying extracellular stimuli 
from the cell membrane to cause localised and co-ordinated actin rearrangements to form 
lamellipodia (Figure 5) (Ridley et al., 1992). Other growth factors such as insulin, EGF 
and bombesin have been reported to induce lamellipodia by a Racl-dependent mechanism 
in Swiss 3T3 and other cell types (Rodriguez-Fernandez & Rozengurt, 1996).
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Similarly, Bradykinin has been reported to induce actin polymerisation at the cell 
periphery resulting in the formation of filopodia (Kozma et al., 1995; Nobes & Hall, 1995). 
Filopodia, are finger like, transient structures protruding from the cell periphery, consisting 
of thin bundled actin filaments (Figure 5). Filopodia production was demonstrated to be a 
Cdc42 dependent mechanism as dominant negative Cdc42 ablated filopodia production 
while constitutively active Cdc42 caused induction of filopodia (Figure 5) (Kozma et al., 
1995; Nobes & Hall, 1995). Subsequent studies led to the discovery that bombesin 
stimulation is also linked to the rearrangement of the actin cytoskeleton in a Cdc42- 
dependent manner to induce filopodia formation (Rodriguez-Fernandez & Rozengurt,
1996).
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Figure 5
Schematic representation of the specific morphological changes induced by activation 
of the RhoGTPases in Swiss 3T3 cells. Bradykinin activates Cdc42 to induce 
filopodia formation, while PDGF and LPA activate Racl or RhoA to form 
lamellipodia or stress fibres respectively.
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1.3.3 Link between extracellular signalling and RhoGTPases
Investigations were carried out to determine how LPA, PDGF and bradykinin transduce 
signals to Rho family proteins resulting in organisation of the actin cytoskeleton. The 
manner in which LPA activates RhoA to create stress fibres, appears to involve a tyrosine 
kinase, as LPA, but not microinjection of constitutively active RhoA-induced stress fibres 
can be blocked by the tyrosine kinase inhibitor, tyrophostin (Nobes et al., 1995). Thus a 
tyrosine kinase may be acting upstream of RhoA during LPA-induced stress fibre 
formation. It has been proposed that the tyrosine upstream of RhoA maybe involved in 
RhoA activation by altering the activity of RhoGEFs although not know yet. This type of 
regulation however has been documented for the Racl GEF, Vav, which has been reported 
to be regulated by tyrosine phosphorylation via Lck and Sck (Gulbins et al., 1993; Han et 
al., 1997; Miranti et al., 1998). Furthermore, as the LPA receptor is a member of the 
hetrotrimeric G-protein coupled receptor family (GPCRs), GPCRs were potential 
mediators in relaying extracellular signals to the respective RhoGTPase. Consistent with 
this idea, microinjection of activated G protein sub-units of the LPA receptor, G a l3  and 
G al2 , induced stress fibres formation in Swiss 3T3 cell (Buhl et al., 1995; Hooley et al.,
1996). Subsequently a direct link between G a l3  and RhoA has been established in which 
the a  sub-unit, G a l3 , interacts with and activates the RhoGEF, L sc/p ll5  RhoGEF (Figure 
6) leading to RhoA activation and stress fibres formation (Gohla et al., 1998; Hall, 1998; 
Hart et al., 1998; Kozasa et al., 1998). PDZ RhoGEF also act as a direct target of G a 
12/13 to induced RhoA activation (Figure 6) (Fukuhara et al., 1999). Finally it has also 
been shown that the G a l3  subunit associates with the tyrosine kinase PYK2 to induce 
RhoA activation, while the Gj3y subunit which normally induces stress fibre disruption has 
been reported to play a role in signalling to RhoA to induce stress fibre formation in 
epithelial-like HeLa cells (Figure 6)(Shi et al., 2000; Ueda et al., 2000).
The bradykinin receptor is also a member of the GPCR family and a similar mechanism 
has been proposed as a potential link between the bradykinin receptor and Cdc42, however 
this has yet to be established. It has also previously been reported that during the 
pheromone signalling pathway in yeast, the Dbl related family protein Cdc24 acts 
upstream of Cdc42 activation (Zhao et al., 1995; Zheng et al., 1994b). Similarly, 
microinjection experiments have demonstrated that the GEF, Fgdl, specifically induces 
Cdc42 activation and filopodial extensions (Figure 6) (Olson et al., 1996).
41
chapter 1
A number of studies have proposed that PI3-kinase is involved in PDGF cytoskeletal 
remodelling during lamellipodia formation (Nobes et al., 1995; Wennstrom et al., 1994). 
This originates from studies using the PI3-kinase inhibitor wortmannin (Nobes et al.,
1995), which inhibits PDGF induced lamellipodia but not lamellipodia induced by 
microinjection of constitutively active Racl, indicating that PI3-kinase is acting upstream 
of Racl in this process (Figure 6) (Nobes et al., 1995; Wennstrom et al., 1994). Following 
this, it was demonstrated that constitutively active PI3-kinase could cause lamellipodia 
formation in a Racl dependent manner (Reif et al., 1996). The mechanism of PI3-kinase 
induced Racl activation is thought to be mediated by the Racl GEF, Vav (Figure 6) 
(Nobes et al., 1995).
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Figure 6
Signalling pathways involved in actin cytoskeletal remodelling induced 
RhoGTPases. Red dotted lines represent potential cross-talk between RhoGTPases.
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1.4 RhoGTPases and their effectors.
Over the past few years the characterisation and discovery of a number of proteins that 
bind to RhoGTPases in the GTP-bound state and act as effectors has provided a major 
insight into the molecular mechanisms by which RhoGTPases affect the actin cytoskeleton 
and regulate a variety of cellular processes.
1.4.1 Rho effectors
There are a large number of RhoA-binding proteins identified that are potentially involved 
in actin stress fibres formation or maintenance. The homologous serine/threonine protein 
kinases pl60 ROCK (also called ROCK-1 or ROK|3) and ROKa (also called Rho-kinase 
or ROCK D) are major downstream effectors of RhoA (Ishizaki et al., 1996; Leung et al., 
1995; Matsui et al., 1996). Initial studies demonstrated that expression of ROKa induced 
stress fibre-like clusters of actin, emanating from the middle of the cell and that expression 
of a kinase-deficient mutant could disrupt these stress fibre-like structures (Leung et al.,
1996). Similar results were subsequently observed for Rho-kinase in other cell systems 
(Amano et al., 1997). A further understanding of how Rho-kinase functions, stems from 
the finding that the myosin binding subunit (MBS) of myosin light chain kinase (MLCK) 
was a Rho-kinase substrate (Kimura et al., 1996; Matsui et al., 1996). Phosphorylation of 
MBS by Rho-kinase ablates myosin light chain phosphatase activity, resulting in an 
increase of phosphorylated MLC (Kimura et al., 1996). Moreover, Rho-kinase also 
directly phosphorylates MLC at the same site as MLCK (Amano et al., 1997). The 
conformational change induced by phosphorylation increases the binding of MLC to actin 
filaments and subsequently triggers induction of stress fibres (Chrzanowska-Wodnicka & 
Burridge, 1996; Fernandez et al., 1990; Lamb et al., 1988). In agreement with a role of 
MLC phosphorylation in stress fibres formation RhoA-induced stress fibres and focal 
adhesions could be blocked by MLCK inhibition (Chrzanowska-Wodnicka & Burridge, 
1996; Fincham et al., 2000). It has been proposed that a balance between MLCK induced 
phosphorylation and MLC phosphatase activity partially determines whether stress fibres 
form (Amano et al., 1996). Furthermore ERM proteins have been implicated in Rho- 
kinase induced stress fibres formation as Rho-kinase is thought to promote the interaction 
of ERM proteins with actin and transmembrane receptors by inducing a conformational 
change resulting in the ‘unfolding’ of ERM proteins via phosphorylation (Mackay et al., 
1997; Matsui et al., 1998).
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Other RhoA effector are the diaphanous related formin proteins m Dial/2 proteins which 
are the mammalian homologue of Bnip in yeast (Kohno et al., 1996; Watanabe et al.,
1997). mDial/2 belong to a family of formin-related proteins, including the drosophila 
diaphanous proteins and share two proline-rich, formin homology domains FH1 and FH2. 
These proteins have been shown to be involved in many actin based processes including 
cell migration, cytokinesis and cell morphology. These proteins can interact with the actin 
monomer binding protein, profilin and selectively bind to activated RhoA (Watanabe et al.,
1997). The co-localisation of mDia and profilin at the plasma membrane and at the tips of 
actin stress fibres has lead to the proposal that mDial/2 may be involved in the formation 
and maintenance of stress fibres. It has been suggested that profilin and mDia are involved 
in this process by localising ATP-bound actin monomers to areas of actin assembly and by 
interacting with other actin binding proteins such as VASP (Wasserman, 1998; Zigmond,
1996). Moreover, phosphatidylinositol 4,5-bis phosphate (PIP2) production via PI5-kinase 
can result in the removal of actin capping proteins such as gelsolin (Toker, 1998) and this 
together with the recruitment of m Dial/2 to these sites has been suggested to be involved 
in stress fibre formation. This may be necessary for the linkage of actin filaments during 
stress fibre formation or the long-term maintenance of stress fibres due to the intrinsic 
turnover of actin filament within the cell (Kirschner, 1980; Wegner, 1976). The role of 
mDia in RhoA-induced stress fibres has been demonstrated by work in which expression 
of activated mDial causes thin stress fibre-like actin structures, which are disorganised in 
the absence of Rho-kinase activity (Watanabe et al., 1999). Furthermore the Rho-kinase 
induced stress fibre structures described above, can be altered by the co-expression of 
activated mDial to form stress fibres that are more reminiscent of RhoA-induced stress 
fibres (Watanabe et al., 1999). It has therefore been proposed that mDia and Rho-kinase 
work together to co-ordinate actin stress fibre assembly. Interestingly, mutations in the 
human homologue hDia encoded by DFNA1 results in deafness, which is thought to be 
caused be a defect in the actin organisation in hair cells of the inner ear (Lynch et al.,
1997).
While Rho-kinase, as described earlier, serves in the maintenance of MLC contractility 
which is required for RhoA-induced stress fibres, expression of Rho-kinase induces stress 
fibre-like structures are disorganised and form in clusters from the centre of the cell (Leung 
et al., 1996) (Amano et al., 1997; Watanabe et al., 1999). Recently, this was shown to be 
due to the spatial regulation of MLC phosphorylation by Rho-kinase (Totsukawa et al., 
2000). It was shown that in the centre of the cell, Rho-kinase acts to phosphorylate MLC 
and inhibit MLC phosphatase activity, while at the cell periphery it acts only to inhibit 
MLC phosphatase activity, where MLCK phosphorylation of MLC can induce stress fibre
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formation. Thus the spatial regulation of RhoA effectors or actin binding proteins may 
serve to regulate the actin cytoskeleton during RhoA-induced stress fibre formation. 
Interestingly, mDia binds to Src’s SH3 domain via the FH1 domain of mDia and inhibition 
of Src/mDia binding blocks the co-operative effects of mDia and Rho-kinase, suggesting a 
role for Src and mDia in RhoA-induced processes (see Section 1.6.2) (Tominaga et al., 
2000).
As the Rho-kinase and mDia induced actin fibres were not identical to RhoA-induced 
stress fibres, it was proposed that other effectors may be involved in stress fibre formation 
(Hall, 1998; Sahai et al., 1998; Watanabe et al., 1999). PIP2 production by RhoA-induced 
PI5-kinase activity has profound effects on the actin cytoskeleton by regulating various 
actin binding proteins and controlling actin polymerisation (Figure 6) (Toker, 1998). In 
this regard, it is interesting that microinjection of an anti-PIP2 antibody ablates LPA or 
RhoA-induced stress fibre and focal adhesion formation suggesting that PI5-kinase has a 
role in the assembly of stress fibres (Gilmore & Burridge, 1996). This suggests that PIP2 
induced control of actin polymerisation may play a role in actin stress fibre formation. 
Interestingly, work by Machesky and Hall indicated that actin polymerisation although not 
ultimately responsible for stress fibres formation, is required for the long-term maintenance 
of RhoA-induced stress fibres (Machesky & Hall, 1997).
In addition to Rho-kinase, mDial/2 and PI5-kinase many other RhoA targets have been 
identified as potential effectors involved in RhoA-induced stress fibre formation. These 
include PRK1 (also known as PKN) and PRK2, which are both serine/threonine kinases, 
related to PKC (Amano et al., 1996; Palmer et al., 1995; Watanabe et al., 1996) having a 
broad spectrum of expression. PRK1 was thought to have a role in stress fibre formation 
as staurosporine, a potent inhibitor of PKC and possibly PRK1, blocks focal adhesion 
formation (Mosch et al., 1996). Moreover LPA stimulation results in the RhoA-dependent 
activation of PRK1 (Watanabe et al., 1996). Further experiments illustrate that PRK1 can 
bind to a-actinin, which provides a link between PRK1 and the actin cytoskeleton (Mukai 
et al., 1997). Similarly PRK2 was initially reported to bind to activated RhoA and Racl 
(Quilliam et al., 1996; Vincent & Settleman, 1997). The expression of a kinase-defective 
PRK2 caused disruption of actin stress fibres in NIH 3T3 cells thereby suggesting that 
PRK2 may serve as a Racl/RhoA effector, inducing the re-modelling of the actin 
cytoskeleton (Vincent & Settleman, 1997). Rhotekin and Rhophilin are two additional 
Rho effectors that lack a kinase domain but share homology with PRKs in the Rho-binding 
domain (Reid et al., 1996; Watanabe et al., 1996). Both interact with GTP-bound RhoA 
but their cellular function has yet to be fully established. One possibility is that they
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contain other putative binding domains such as PH and protein-protein interacting domains 
which may serve as docking regions or serve a purpose in the localisation of other effectors 
during RhoA induced actin re-modelling. No one effector, to date, seems capable of 
inducing stress fibres reminiscent of those caused by RhoA and therefore it is more likely 
that a combination of effectors work concurrently to form stress fibres.
1.4.2 Cdc42 and Rac effectors.
Rho family protein effectors have a number of consensus binding motifs including a 
minimal region of approximately 16-18 residues which has been identified as being 
required for the binding of Cdc42 or Racl, called the CRIB motif (Cdc42 /Racl interactive 
binding motif) (Burbelo et al., 1995). Both Cdc42 and Racl bind to some common 
effector which do not bind to RhoA as a result of the sequence homology between Cdc42 
and Racl. Using a computer based search a number of Cdc42/Racl-binding proteins were 
identified that contain the CRIB domain including the Wiskott-Aldrich syndrome protein 
(WASP) (Figure 6). WASP binds to GTP-bound Cdc42 and is preferentially expressed in 
hematopoietic cells. It is thought to be a major component in Cdc42-induced actin 
rearrangements, as WASP induced actin polymerisation is inhibited by expression of 
dominant negative Cdc42 (Ramesh et al., 1999; Symons et al., 1996). WAS patients have 
thrombocytopenia, which is thought to be due to abnormalities in T and B cell function as 
a result of impaired Cdc42 function (Kolluri et al., 1996; Snapper et al., 1998; Zicha et al.,
1998). Cdc42 is thought to be essential for T-cell polarity towards antigen presenting cells 
and WASP-deficient cells display both impaired cell migration and polarity in this process 
(Snapper et al., 1998; Stowers et al., 1995; Zicha et al., 1998). N-WASP, the ubiquitously 
expressed form of WASP also serves a similar function in other non-hematopoietic cell 
types (Miki et al., 1996). Over-expression of N-WASP induces filopodia and has been 
proposed to be involved in bradykinin-induced filopodia formation as an effector of Cdc42 
(Miki et al., 1996; Miki et al., 1998a). Both WASP and N-WASP bind to F-actin and 
profilin as well as the Arp2/3 complex. The Arp2/3 complex consists of seven components 
including Arp2, Arp3, p41-Arc, p34-Arc, p21-Arc, p20-Arc and p 16-Arc resulting in the 
stimulation of actin nucleation and polymerisation to allow actin remodelling to occur 
(Figure 6) (Machesky et al., 1997; Miki et al., 1998a; Rohatgi et al., 1999). Furthermore, 
N-WASP and WASP have a PH domain which is thought to serve in their localisation to 
the cell membrane and thereby function at this region of the cell (Rohatgi et al., 1999). 
Recently further members of the WASP family proteins such as Scar/WAVE, have been 
shown to be involved in Racl-dependent cytoskeleton remodelling events, serving to 
couple Racl activity to the Arp2/3 complex and thereby actin nucleation and lamellipodia
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formation (Machesky et al., 1997; Miki et al., 1998a). Various other proteins have been 
implicated in Cdc42 cytoskeleton re-organisation, including the non receptor tyrosine 
kinase, ACK and myotonic dystrophy kinase-related Cdc42 binding kinase (MRCK). Both 
ACK-1 and ACK-2 have been reported to bind to activated Cdc42 and can be 
phosphorylated as a results of bradykinin and EGF stimulation, implying that ACK may 
mediate the actions of Cdc42 (Kato-Stankiewicz et al., 2001; Yang & Cerione, 1997). 
MRCK has both a PH and a CRIB domain and over-expression of MRCK reflects Cdc42 
induced filopodia, while expression of kinase-dead MRCK blocks filopodia formation 
(Leung et al., 1998). Moreover, MRCK, like Rho-kinase (see Section 1.4.1) preferentially 
phosphorylates MLC at serine-19 in vitro (Leung et al., 1998) and it has been suggested 
that this regulates, in part, an acto-myosin contractile force at the site of filopodia 
formation.
Amongst the Cdc42 and Racl-binding protein that have been identified, p21 activated 
kinases (PAK1-5) have attracted a great deal of attention (Figure 6) (Manser et al., 1994; 
Martin et al., 1995a; Sells et al., 1997). PAK possesses a CRIB motif and an SH3 domain, 
and in general bind to Rac or Cdc42 in a GTP-dependent manner inducing PAK re­
localisation and PAK kinase activity. Expression of activated PAK induces remodelling of 
the actin cytoskeleton in a similar manner as activated Cdc42 or Racl (Manser et al., 1997; 
Sells et al., 1997). Moreover, expression of dominant negative PAK blocks Cdc42 or Racl 
induced actin rearrangements implicating PAK as a downstream effector of Cdc42 and 
Racl (Obermeier et al., 1998). More recent studies indicate that there may be isoform and 
cell type specific differences in PAK signalling with regards to Cdc42 and Racl-induced 
actin rearrangements. For example, PAK3 induced effects on the actin cytoskeleton can be 
inhibited by dominant negative Racl in PC12 cells, while PAK1 seems to induce its effect 
on the actin cytoskeleton in a Racl and kinase-independent manner in fibroblasts 
(Obermeier et al., 1998; Zhao et al., 1998). Moreover, PAK4 a novel effector of Cdc42, 
only binds to Cdc42 and has been implicated in Cdc42-induced actin remodelling to form 
filopodia (Abo et al., 1998), while the brain-specific PAK isoform PAK5, like Cdc42, 
promotes neurite outgrowth in N1E-115 cells (Dan et al., 2002). Recently, cortactin, 
which has actin cross-linking activity, is recruited to sites of cortical actin polymerisation 
in a PAK-dependent manner (Weed et al., 2000). Furthermore, PAK phosphorylates LIM- 
kinase, which phosphorylates and inactivates the actin depolymerising protein cofilin 
thereby promoting the stabilisation of actin filaments and providing a mechanism by which 
PAK can indirectly influence the formation of cytoskeletal strucutures such as filopodia or 
lamellipodia (Daniels & Bokoch, 1999). Interestingly expression of mutant forms of 
Cdc42 or Rac which cannot bind to PAK can still induce filopodia or lamellipodia
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respectively indicating that PAK may not be involved in Cdc42 or Racl-induced actin 
rearrangements (Lamarche et al., 1996; Westwick et al., 1997). Further studies 
demonstrate that GTPase binding-deficient mutants of PAK can still induce actin 
remodelling, thereby arguing against the requirement of PAK kinase activity and GTPase 
binding of PAK during PAK induced actin remodelling (Obermeier et al., 1998). These 
paradoxical results regarding PAK’s involvement in Racl or Cdc42-induced actin 
rearrangements may be partially explained by the involvement of an SH3 domain binding 
protein. As stated above, PAKs also contain a SH3 domain and it has been postulated that 
the actin remodelling induced by PAK may in some cases be mediated by the SH3 domain 
at the N-terminal of PAK, rather than via the CRIB motif (Manser et al., 1997; Sells et al.,
1997). PIX (PAK interacting exchange factor) was able to cause lamellipodia formation 
by interacting with the SH3 domain of PAK and acts as a Racl-specific GEF thereby 
providing a GTPase binding and kinase independent pathway for PAK induced actin 
remodelling (Obermeier et al., 1998; Sells et al., 1999), which may help explain the 
contradictory results described above regarding PAK’s role in R acl or Cdc42 induced 
actin remodelling.
Racl and Cdc42 -induced actin remodelling not only involves the formation of 
lamellipodia or filopodia respectively but is also associated with the disassembly of 
RhoA-induced stress fibres and focal adhesions. Cross-talk between RhoGTPases is 
thought to be involved in this process and is described in more detail later (see 
Sectionl.4.3) . In this regard, PAK is thought to not only be involved in the formation of 
actin structures induced by Cdc42 or Racl but may also play a key role in the disassembly 
of stress fibres and focal adhesions associated with Racl and Cdc42 (see section 1.4.3). 
Racl and Cdc42 -induced stress fibre and focal adhesion disruption is thought to be 
achieved via PAK induced phosphorylation and inhibition of MLCK, which results in the 
inhibition of MLC phosphorylation and the subsequent loss of actin stress fibres 
contraction (Figure 6) (Frost et al., 1998; Sanders et al., 1999). PAK is therefore thought 
to have an effector and antagonistic role in Racl and Cdc42 induced actin remodelling.
With respect to the induction of lamellipodia, several other effectors have been implicated 
including POR (partner of Rac), which was identified in a yeast-two hybrid screen (Van 
Aelst et al., 1996). POR interacts with activated Racl but not Cdc42 or RhoA. Consistent 
with a role for POR in lamellipodia production, mutants of PORI blocked Racl-induced 
lamellipodia. Moreover Ras induced lamellipodia formation was synergistically enhanced 
by co-expression of POR. Finally mutants of Racl that do not bind to POR block 
lamellipodia formation (Joneson et al., 1996).
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Another effector likely to play a key role in actin re-modelling and polymerisation is PI5- 
kinase, which binds to both Racl and RhoA and has been reported to be regulated by these 
Rho family proteins (Figure 6) (Hartwig et al., 1995; Ren et al., 1996). It has been 
demonstrated that Racl induces the uncapping of barbed ends of actin filaments, a 
prerequisite for actin re-modelling and polymerisation associated with lamellipodia 
(Hartwig et al., 1995). Furthermore this was shown to be enhanced by PI5-kinase induced 
PIP2 production (Hartwig et al., 1995). PIP2 has been shown to alter the folding and 
activity of many scaffolding and actin binding proteins such as a-actinin, ERM proteins, 
profilin, vinculin and WASP (Gilmore & Burridge, 1996; Rohatgi et al., 1999; Toker,
1998). For example, PIP2 binds and results in the unfolding of vinculin allowing it to 
associate with talin, which in turn can bind to the actin cytoskeleton (Gilmore & Burridge,
1996). PIP2 also increases a-actinin cross-linking activity and enhances uncapping of 
actin filaments from gelsolin (Toker, 1998), while profilin induces dissociation of actin 
monomers. Moreover activation of ERM proteins which serve as key regulators of both 
Racl and Rho-induced actin re-modelling, suggests that PI5-kinase-induced regulation of 
ERM proteins provides some role in lamellipodia and for that matter stress fibre formation 
(Gilmore & Romer, 1996; Mackay et al., 1997; Tsukita et al., 1994; Tsukita & Yonemura,
1997).
1.4.3 Cross-talk between RhoGTPases
As well as having individual roles in actin organisation there has been a great deal of 
evidence demonstrating cross talk between Rho family GTPases. Work in Swiss 3T3 cells 
in particular has suggested that they can act in concert forming a hierarchical cascade that 
links their activities, such that Cdc42 can activate Racl which in turn can activate RhoA 
(Figure 6) (Nobes & Hall, 1995). Expression of constitutively active Cdc42 results in the 
formation of filopodia as well as Racl induced lamellipodia (Kozma et al., 1995; Nobes & 
Hall, 1995). Furthermore dominant negative Cdc42 blocks bradykinin induced filopodia 
and lamellipodia, while dominant negative Racl only blocks lamellipodia (Nobes & Hall, 
1995). On a similar note activated Racl causes lamellipodia and RhoA-induced stress 
fibres, while dominant negative Racl blocks PDGF-induced lamellipodia and stress fibres, 
but dominant negative RhoA only blocks stress fibre formation (Nobes et al., 1995). 
Furthermore microinjection of constitutively active Cdc42, while blocking R acl by co­
expressing dominant negative Racl, or blocking RhoA, using C3-transferase (Narumiya et 
al., 1988), enhanced the rate of filopodia production in both cases, demonstrating a 
hierarchical cascade from Cdc42>Racl>RhoA (Nobes & Hall, 1995). This has also been 
demonstrated in neuroblastoma cells, where inactivation of RhoA, leads to increased
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activation of Cdc42 and Racl (Kozma et al., 1997). Similar hierarchical cascades have 
been observed in other cell types such as macrophages in relation to cell migration (Allen 
et al., 1997) as well as between other Rho family members. For example, RhoG-induced 
lamellipodia have been reported to form via a Raci-dependent mechanism (Roux et al.,
1997). Cross-talk has also been reported to occur between small G protein family 
subgroups such that Ras can activate Racl to induce lamellipodia and subsequently cause 
RhoA-induced stress fibres (Figure 6) (Fan et al., 1998; Hall, 1998; Nimnual et al., 1998).
The precise nature of how these GTPases relay signals to each other is poorly understood. 
The versatility of GEFs, GDIs and GAPs in controlling RhoGTPases and their ability to act 
as effectors along with their promiscuous nature, implicates their involvement in 
RhoGTPase cross-talk. Evidence for this potential link comes from a number of different 
sources including, the regulation and link between Cdc42 and R acl. In particular a 
mechanism for Cdc42-induced activation of Racl has been proposed in which the Cdc42 
effector PAK (see Section 1.4.2) regulates Racl by increasing the GEF activity of PIX for 
Racl (Figure 6) (Manser et al., 1998; Obermeier et al., 1998). Similarly, PI3-kinase could 
serve as an effector of Cdc42 and activate Racl via phophatidyl inositol- 4,5 bisphosphate 
PIP3-induced GEF activity towards Racl (Figure 6) (Zheng et al., 1994a). Leukotrienes 
have also been proposed to be involved in the cross-talk between Rho family proteins, 
where EGF or Rac-induced arachidonic acid production subsequently leads to the 
generation of leukotrienes which are sufficient for RhoA activity and stress fibre formation 
(Figure 6) (Peppelenbosch et al., 1995).
Even though a hierarchical cascade exists in Swiss 3T3 and other cell types, variations of 
this theme have been documented involving separate pathways or antagonistic behaviours 
between RhoGTPases. Cdc42 and Racl have been noted to disrupt both stress fibres and 
focal adhesions. The antagonism between Racl and RhoA has been demonstrated in both 
NIH3T3 and neuronal cells where Racl activity is able to downregulate RhoA activity 
(Leeuwen et al., 1997; Sander et al., 1999). In particular over-expression of T iam l, a Racl 
GEF, or PDGF-induced Racl activation, impaired RhoA-induced actin rearrangements in 
NIH3T3 cells (Sander et al., 1999). Moreover, downregulation of RhoA via Racl 
activation impairs their migratory phenotype and behaviour (Sander et al., 1999). In the 
same study, over-expression of constitutively active RhoA restored RhoA activity and 
resulted in the reversion of the epithelial-like morphology and behaviour induced by Racl 
activation (Sander et al., 1999). Similarly, in further studies down regulation of Racl 
activity has been reported to cause an increase in RhoA activity which was accompanied 
by an epithelial to mesenchymal transition in cell morphology (Zondag et al., 2000).
52
chapter 1
Interestingly, expression of V14RhoA or N19RhoA had no effect on Racl activity 
indicating the hierarchical cascade from Racl towards RhoA (Sander et al., 1999). In 
neuronal cells, neurite retraction and cell rounding, both of which are known RhoA- 
induced effects, were blocked by Racl activation and conversely, Racl induced neurite 
formation has been shown to be enhanced by RhoA inactivation (Leeuwen et al., 1997). 
Moreover, Cdc42-induced filopodia have also been observed to form at the expense of 
RhoA-induced stress fibres (Dan et al., 2002; Kozma et al., 1995; Sander et al., 1999) 
(Manser et al., 1997; Qiu et al., 1997).
It has been suggested that a reduction in GEF activity towards RhoA induced by Cdc42 or 
Racl could influence RhoA activity (Zohn et al., 1998). Similarly, alterations in both Rho 
GAP or GDI activity could be involved in the down regulation of RhoA. Interestingly 
CIP4, which was discovered as a Cdc42-binding protein has sequence homology with a 
number of RhoGAPs and causes a breakdown of stress fibres (Aspenstrom, 1997). CIP4 
does not induce filopodia and it has therefore been proposed that some effectors may serve 
in the formation of morphological actin structures while other act as antagonists towards 
other RhoGTPases during this process (Aspenstrom, 1997). Others propose that the 
antagonism is a product of competition between family members for a common pool of 
actin, actin binding partners or effectors. In this regard it has been suggested that the 
Cdc42 and Racl effector PAK may play a role in this antagonistic process. Expression of 
constitutively active PAK induces stress fibre and focal adhesion breakdown (Frost et al.,
1998) (Sanders et al., 1999; Zhao et al., 1998) which is thought to occur due to PAK 
induced MLCK phosphorylation leading to inhibition of MLC phosphorylation, 
contractility of actin-myosin and therefore inhibition of stress fibre formation (Figure 6). 
Others have shown the antagonism between RhoGTPases to occur further upstream, as 
down regulation of RhoA in NIH3T3 cells by R acl was shown to occur independently of 
Racl induced cytoskeletal rearrangements. Racl mutants that were defective in mediating 
cytoskeletal changes could still down regulate RhoA, suggesting that the antagonism 
observed here between Racl and RhoA occurs at the Rho family GTPase level (Sander et 
al., 1999; Zondag et al., 2000). Furthermore, evidence of antagonism between other Rho 
family members and RhoA has been documented to occur, for example, activated Radi 
and RhoE/Rad3 have been shown to cause stress fibre disruption (Guasch et al., 1998; 
Nobes et al., 1998). It has also been proposed that effectors can act as negative regulators 
of RhoGTPases in a negative feedback loop. One such effector, p ll6 (R ip ) identified as a 
RhoA-binding protein has similar effects as dominant negative RhoA or C3-transferase, 
indicating not only that RhoGTPase-induced effectors can influence the activity of other 
family members but that they can act in a negative feedback loop to reduce the effect of
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their respective RhoGTPases (Gebbink et al., 1997). Co-ordination between family 
members has also been reported to occur in controlling other cytoskeletal based processes 
such as the co-operation between Racl and RhoA in the formation of cadherin mediated 
cell-cell junctions (Braga et al., 1997; Hordijk et al., 1997; Kuroda et al., 1998; Takaishi et 
al., 1997). The cross-talk and co-operation between family members during processes 
such as cell migration will be discussed in more detail below.
1.4.4 Cross-talk between small family subgroups
A similar scenario of cross-talk has been proposed to be involved in cross talk between 
small G protein family subgroups. As stated earlier many GEF, GAPs and GDIs have a 
variety of functions that could potentially lead to cross talk between GTPases. It has been 
shown for example that Ras can activate Racl via the Ras-induced effector PI3-kinase, 
which enhances the activity of the Racl GEF Vav, by p56 Lck-induced tyrosine 
phosphorylation. Which increases GDP/GTP exchange activity of Vav and thereby 
enhances Vav induced Racl activity (Crespo et al., 1997; Han et al., 1997; Han et al.,
1998). Furthermore Ras is thought to be able to activate Racl via the Racl exchange 
factor activity of Sos (Nimnual et al., 1998). The PH domain of Sos normally inhibits its 
Racl GEF activity, however binding of the PH domain to PIP3 blocks this inhibitory 
effect, allowing Sos to have GEF activity for Racl (Nimnual et al., 1998). A further 
indication that this is a likely mechanism for cross-talk is that Sos and other Ras GEFs 
such as, Ras-GRF and Ras-GRF2 have been reported to have either Cdc42, Racl or RhoA 
GEF DH and PH domains (Fan et al., 1998; Nimnual et al., 1998).
1.5 Cell motility and migration
Cell migration is a key aspect of many cellular functions, including leukocyte migration in 
response to inflammation, cell migration during development or wound healing, and 
tumour cell metastasis and invasion (Lauffenburger & Horwitz, 1996). Cell movement has 
been described as a crawling motion, mediated by the dynamic remodelling of both cell- 
substratum sites and the actin cytoskeletal network. Here, we focus on how the co­
ordinated regulation of the actin cytoskeleton by RhoGTPases contributes to cell 
migration, acknowledging that other cytoskeletal networks including the microtubule 
network and intermediate filaments interact and play a role in this process.
1.5.1 A role for Racl in cell migration.
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Rac is thought to serve a role in cell migration by stimulating the formation of 
lamellipodia, which initially form weak attachment sites to the substratum referred to as 
focal complexes. Focal complexes are thought to be rapidly turning over focal adhesions 
(Schoenwaelder & Burridge, 1999; Small et al., 1995) composed of various actin binding, 
structural and signalling proteins such as a-actinin, vinculin, paxillin cortactin and FAK 
which to date have been reported to have the same protein composition as focal adhesions 
(Nobes & Hall, 1995). The rapid turnover and supply of free actin monomers and 
scaffolding proteins provides the protrusive force for lamellipodia formation and cell 
migration (Borisy & Svitkina, 2000). The supply of actin to new adhesion sites at the 
barbed end of actin filaments pointing towards the leading lamellae is thought to provide a 
protrusive force and cause extension of the membrane resulting in lamellipodia (Borisy & 
Svitkina, 2000). At the same time, real time microscopy using GFP-tagged vinculin 
demonstrated that as cells move small complexes that form at the base of lamellipodia 
remain static in relation to the cell substratum as the cell migrates forward over them 
(Figure 7) (Small et al., 1995; Small et al., 1999). It has been postulated that Racl 
mediated focal complex formation at the leading edge provides new immature adhesion 
sites in the direction of cell locomotion and as the cell moves these focal complexes 
gradually develop into focal adhesions as a result of their localisation behind the base of 
lamellipodia. This focal complex to focal adhesion transition is thought to provide an 
adhesive force required for traction during cell migration at the leading edge, while MLC 
contraction at the rear induces tail-retraction and cell translocation (Figure 7) 
(Chrzanowska-Wodnicka & Burridge, 1996; Small et al., 1999; Stossel, 1993). Racl 
induced actin remodelling is thought to be essential for cell migration as cells expressing 
dominant negative Racl fail to form a leading edge and migrate into the wound (Nobes & 
Hall, 1999).
Similarly the Rac GEF, Tiam l induces invasion of T-lymphoma cells and produces cell 
metastasis in nude mice (Habets et al., 1994; Michiels et al., 1995). Others however have 
shown Tiam l to block migration of NIH3T3 cells on fibronectin and laminin (Sander et al.,
1998). This can be explained by work demonstrating that the ability of Tiaml to induce or 
inhibit migration is dependent on the extra cellular matrix (ECM) components present 
(Mitchison & Cramer, 1996; Sander et al., 1998). For example, on collagen Tiaml 
increases migration, while on laminin or fibronectin Tiaml inhibits cell migration (Sander 
et al., 1998). Further evidence for Racl in migration can be seen as alterations in Racl 
activity increase human breast cell motility and invasion (Keely et al., 1997; Zohn et al.,
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1998). Moreover macrophage and fibroblast chemotaxis towards CSF-1 and PDGF has 
been documented to require Racl activity and lamellipodia formation (Allen et al., 1997; 
Anand-Apte & Zetter, 1997). It should be noted that in cells with focal adhesions and no 
lamellipodia, subsequent stimulation to form these structures induces the dynamic 
remodelling of focal adhesions to focal complexes as visualised using GFP tagged paxillin 
(Laukaitis et al., 2001), which provides the initial lamellipodia and leading edge required 
for directional migration. It is thought that Racl antagonises RhoA activity in cells via 
PAK (see Section 1.4.3) allowing these membrane extensions to form. It is therefore clear 
that both focal adhesions and focal complexes are transient structures whose function 
within the cell is critically governed by RhoGTPases during cell migration.
1.5.2 A role for Cdc42 in cell migration.
Cdc42 serves a role in cell migration by stimulating the formation of protrusive structures 
known as filopodia (Figure 7) (Hall, 1998; Kozma et al., 1995), which also contain focal 
complexes at the base and along their length. Filopodia are transient structures and like 
lamellipodia they are rapidly turning over (Borisy & Svitkina, 2000; Stossel, 1993). The 
supply of new actin and structural proteins provide the key components to extend the cell 
membrane and form these vital structures during directed cell migration (Allen et al., 1997; 
Borisy & Svitkina, 2000). Cdc42-induced filopodia are not essential for cell migration but 
are required for maintaining cell polarity during fibroblast movement and macrophage 
chemotaxis (Allen et al., 1997; Allen et al., 1998; Carney & Couve, 1989; Nobes & Hall,
1999). Using a Dunn chamber chemotaxis assay to examine directionality and persistence 
of cell movement, cells expressing dominant negative Cdc42 fail to maintain directed cell 
migration towards a chemotactic gradient (Allen et al., 1998). Interestingly, cells 
expressing dominant negative Cdc42 demonstrated an increase in migration velocity which 
has been proposed to be as a result of alleviated directionality normally induced by Cdc42 
(Allen et al., 1997; Allen et al., 1998). In this regard aberrant activity of Cdc42 has been 
linked to the increased motility of human breast epithelial cells (Keely et al., 1997). Thus 
factors other than cell contraction and cell adhesion are involved in controlling cell 
migration rates. Cdc42 activity has been proposed to direct lamellipodia protrusions 
induced by Racl to the leading edge during wound healing (Nobes & Hall, 1999). This 
orientation of a leading edge can also be seen in individually migrating fibroblasts where a 
number of filopodia eventually coalesce to form a leading edge and extend lamellipodia in 
the direction of cell locomotion (Figure 7). Similarly, in yeast, Cdc42 co-ordinates actin 
cytoskeleton remodelling and polarisation of budding yeast (Stowers et al., 1995). 
Interestingly the Cdc42 and Racl effector PAK has been demonstrated to be required for
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sustained polarisation of cells, as kinase-defective PAK expressing cells form lamellipodia 
but fail to sustain polarised cell migration (Sells et al., 1999). Finally as discussed in 
Section 1.4.1, Cdc42 activity is essential for T-cell polarity towards antigen presenting 
cells and cells deficient in the Cdc42 effector WASP display both impaired migration and 
polarity during this process (Snapper et al., 1998; Stowers et al., 1995; Zicha et al., 1998).
1.5.3 A role for RhoA in cell migration.
It has been suggested that RhoA may play a role in cell migration via myosin-based 
bundling of actin filaments into stress fibres and the maintenance of focal adhesions during 
cell movement. The contractile forces exerted by stress fibres results in the aggregation of 
integrins and their associated proteins to form focal adhesions which serve to stabilise 
adhesions and allow cell traction to occur from behind the leading edge (Chrzanowska- 
Wodnicka & Burridge, 1996). The contractile force also causes retraction of the cell rear 
and allows the cell to detach and translocate the cell body forward (Figure 7) (Chen, 1981). 
The extent of RhoA induced retraction has been clearly seen in neuronal cell lines, where 
RhoA-induced contraction leads to cell rounding in NE115 neuroblastoma cells and neurite 
collapse (Kozma et al., 1997; Leeuwen et al., 1997). This contractility generally 
antagonises cell extension, as demonstrated by the introduction of C3-transferase into cells, 
which blocks RhoA-induced contraction and has been reported to stimulate lamellipodia 
formation (Rottner et al., 1999). Similarly, expression of constitutively active RhoA or 
wild type RhoA blocks membrane protrusion and extension (Cox et al., 2001). Both 
temporal and spatial regulation of this antagonism is proposed to be co-ordinated during 
cell migration. Lamellipodia formation is a prerequisite for a cell to produce a leading 
edge however RhoA has been suggested to have a role in the selective orientation of the 
leading edge and plays a role in the contraction and collapse of lateral lamellipodia during 
directed cell motility (Stossel, 1993). Moreover, contractility can itself contribute to cell 
extension when sufficient adhesions are present and this has been proposed to partially be 
involved in the formation of both filopodia and lamellipodia (see Section 1.4.1) 
(Schoenwaelder & Burridge, 1999). Interestingly, as described earlier (see Section 1.4.3), 
Racl activity has been shown to lead to an increase in RhoA activity and in some cell 
types this increase in RhoA activity has been linked to the epithelial-mesenchymal 
transition which is thought to be one of the initial steps that occur during epithelial cell 
migration (Zondag et al., 2000).
Various experiments have resulted in an apparently paradoxical view on whether RhoA 
activity is important for cell motility. For example it has been reported that over­
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expression of constitutively active RhoA has inhibitory effects on migration, possibly due 
to the inhibition of the dynamic remodelling and turnover of focal adhesions and stress 
fibres during this process (Nobes & Hall, 1999; Ridley et al., 1995; Takaishi et al., 1994). 
Similarly inactivation of RhoA activity can enhance cell migration rates, as demonstrated 
using the Rho-kinase inhibitor Y-27632, which augments the migration rate of rat embryo 
fibroblasts during a wound healing assay (Nobes & Hall, 1999). In keeping with this, 
Rnd3/RhoE promotes cell migration in response to hepatocyte growth factor (HGF) 
(Guasch et al., 1998), consistent with the antagonism of RhoA by Rnd3/RhoE (Guasch et 
al., 1998; Nobes et al., 1998).
On the other hand, others have reported that inactivation of RhoA hinders cell migration, 
as treatment of cells with C3-transferase blocks T-cell lymphoma invasion as well as LPA- 
induced migration and invasion of hepatoma cells (Verschueren et al., 1997; Yoshioka et 
al., 1995), while expression of constitutively active RhoA in NIH3T3 cells confers the 
potential of cells to metastasise to the lung in a tail vein metastatic assay (del Peso et al.,
1997). Recently, RhoA has been implicated in colon carcinoma cell migration via the 
formation of lamellipodia as opposed to stress fibres and cell contraction, as demonstrated 
by the suppression of a6(34-dependent lamellipodia formation and cell migration by over 
expression of N19RhoA and not N17Racl (O'Connor et al., 2000). Therefore, the role of 
RhoA in cell migration is not as clear as was first thought and seems to be cell type or 
model specific. Nevertheless, as both activation and inhibition of RhoA activity can hinder 
migration, it has been proposed that the precise regulation of RhoA activity is required for 
efficient cell migration. In this regard, the temporal regulation of RhoA activity within the 
cell has recently been suggested to allow cell migration to occur. For example RhoA has 
been documented to be transiently inhibited during integrin engagement and it is thought 
that this inhibition may allow initial protrusion at the leading edge of the cell which would 
otherwise be antagonised by the contractile forces induced by sustained RhoA activity 
(Arthur & Burridge, 2001; Arthur et al., 2000; Ren et al., 1999). Co-ordination of this 
RhoA-induced contractility along with co-ordinated activity of other RhoGTPases (as 
previously discussed) has been postulated to allow cells to extend in the direction of cell 
migration while maintaining the ability to contract and lift the rear end of the cell body 
during cell locomotion. The spatial regulation of RhoGTPase activity is also evident, such 
that cell extension occurs at the leading edge while traction forces induced by RhoA occur 
directly behind the leading edge and along the bottom of the cell in contact with the 
substratum. RhoA-induced MLC contraction also provides the driving force behind tail- 
retraction at the rear of the cell to allow full translocation of the cell body. Recently, a
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related member of the RhoA family proteins, RhoC (see Section 1.3), was identified using 
microarray analysis, as a gene upregulated in metastatic melanoma cells in contrast to their 
poorly metastatic counterparts (Clark et al., 2000). Moreover, inhibition of RhoC blocked 
metastasis, while over-expression of RhoC in non-metastatic cells conferred an increased 
migratory and invasive behaviour in this cell line.
The precise temporal and spatial regulation of morphologically distinct structures induced 
by RhoGTPases has yet to be fully established. It does however provide an explanation as 
to why complete inactivation or sustained activation in various cell systems can lead to a 
misinterpretation regarding the importance of individual RhoGTPases in cell migration. A 
more likely explanation is that they all play a role in this process through their co-ordinated 
effect on contraction and extension at different times and places during cell migration.
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Figure 7
Schematic representation of adhesion dynamics during migration induced by Cdc42, 
Racl and RhoA.
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1.6 Regulation of adhesion dynamics during cell migration.
Cell locomotion ultimately relies on the spatial and temporal regulation of adhesion 
strength as well as the contractile or expansion forces induced on the cell body by 
RhoGTPases. The resistance that contractile forces have to overcome in order to 
accomplish translocation of the cell body is predominantly due to adhesive interactions 
between the cell and the substratum at focal adhesions or focal complexes. Alterations 
therefore by protein interactions in focal adhesions and focal complexes during this process 
will have profound effects on the overall adhesion of the cell to the substratum. 
Importantly the spatial and temporal localisation of proteins involved in focal adhesion 
dynamics, such as Src, will therefore serve a fundamental role in controlling cell migration.
Disruption and disassembly of focal adhesions occur at the rear of the cell during cell 
retraction, while the initiation of new attachment sites or the rapid turnover of focal 
complexes has to occur at the leading edge of the cell. Moreover, in order for efficient cell 
migration to occur there has to be an equilibrium between adhesion strength during cell 
traction and adhesion disruption during cell detachment. Finally, there has to be a spatial 
imbalance between these adhesion forces such that adhesions at the leading edge of the cell 
remain while cell attachments at the rear are released (Sheetz, 1994). Interestingly, the 
front of migrating neuronal and fibroblast cells have a significantly greater link to 
cytoskeleton based adhesions than the rear of the cell (Schmidt et al., 1993). A clear 
illustration of how cell adhesion effects migration can be seen in fish keratinocytes which 
generally have a low adhesion threshold to the substratum and as a result migrate much 
faster than their fibroblast counterparts which demonstrate a much greater adhesion 
strength (Harris et al., 1980; Oliver et al., 1994). In this regard, neutrophils have an 
intermediate adhesive strength and consequently exhibit a migration rate between that of 
fish keratinocytes and fibroblasts (Evans et al., 1993). It is clear then that an optimal cell- 
substratum adhesion strength exists for different cell types and that simple alterations in 
relative adhesion to the substratum at different times during cell migration can govern 
whether and how fast a cell migrates. As discussed earlier contractile forces by RhoA and 
directional influences via Cdc42 are also critical determinants of cell migration speed (see 
Section 1.5.2 and 1.5.3). We will focus here however, on the role and link between 
proteins present at adhesion sites, such as Src, and discuss the implication of molecular 
interactions at these sites with regards to cell motility.
62
1.6.1 A role for Src in cell migration.
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Several studies have suggested that Src family kinases play a role in cell motility. For 
example, c-Src deficient fibroblasts have a decreased random migration (Hall et al., 1996; 
Kaplan et al., 1995), and cells deficient in all three ubiquitously expressed family 
members, Src, Fyn and Yes are unable to migrate into a wound (Klinghoffer et al., 1999). 
Furthermore, Src -/- fibroblasts have a defect in cell spreading (Kaplan et al., 1995), while 
Src -/- osteoclasts have a defect in cytoskeletal organisation (Schwartzberg et al., 1997). 
Others have shown c-Src kinase activity to be required for growth factor induced migration 
and scattering in a number of cell types, providing definitive evidence that Src contributes 
to the control of cell migration (Liu et al., 1999; Rahimi et al., 1998; Rodier et al., 1995). 
The ability of Src to influence cell motility in fibroblasts has been primarily linked to the 
regulation of focal adhesion turnover. Cells lacking Src family members are able to 
assemble focal adhesions (Klinghoffer et al., 1999), indicating that Src is not required for 
their formation. However, cells in which kinase defective mutants of Src are expressed 
have enlarged focal adhesions (Fincham & Frame, 1998; Kaplan et al., 1994), suggestive 
of a role for Src kinase activity in the turnover of these structures that is needed for cells to 
move (Fincham & Frame, 1998). Moreover, linkages between integrin vitronectin 
receptors and the actin cytoskeleton are strengthened in Src-deficient fibroblasts 
(Felsenfeld et al., 1999), indicating that Src activity is required to weaken, or disrupt, links 
at the integrin-cytoskeleton interface thus modulating cell motility. The presence of 
functional SH2 and SH3 domains in these Src proteins suggests that, in addition to 
phosphorylating key substrates, Src may be acting as an adaptor protein allowing its 
recruitment into focal adhesion structures and/or the recruitment of cellular partners to 
these sites. In line with this, kinase-deficient Src mutants can rescue both defects in cell 
spreading and cytoskeletal organisation in fibroblasts and osteoclasts, as mentioned above 
(Kaplan et al., 1995; Schwartzberg et al., 1997), implying that at least some effects of Src 
on cell adhesions and the cytoskeleton are kinase-independent and may rely on the adaptor 
function of Src.
Src’s activity at adhesions however, ultimately results in their turnover, an effect that has 
been attributed to Src’s ability to influence cell migration. Much of the mechanistic 
information on how Src affects adhesions and regulators of the actin cytoskeleton has been 
generated from studies with v-Src. v-Src for example, leads to the disruption of cellular 
adhesions and loss of actin organisation, resulting in cell rounding and detachment 
(Fincham et al., 1999; Fincham et al., 1995). It is possible that the v-Src mediated cell 
detachment and rounding is an extreme version of a tightly controlled process that triggers
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adhesion turnover when cell/matrix adhesions are being dynamically regulated during Src 
dependent cell migration. Src has been reported to localise with a variety of adhesion 
components, including structural regulatory and signalling proteins such as, FAK, 
cortactin, paxillin and ERM proteins. The exact function of each individual protein during 
cell migration is not fully understood however the phosphorylation of many of these 
adhesion components may also be linked to cytoskeletal remodelling and adhesion 
turnover during cell motility.
There is convincing evidence for example that the linked activity of Src and FAK, control 
adhesion turnover and cell migration. In support of a role for FAK in cell migration, 
inhibition of FAK signalling by expression of dominant negative FAK constructs has been 
shown to decrease migration rates (Gilmore & Romer, 1996). Furthermore, cells derived 
from FAK -/- mouse embryos have enlarged focal adhesions and are relatively non-motile 
due to impaired focal adhesions turnover (Ilic et al., 1995; Ilic et al., 1996). Direct 
evidence of a link between FAK and Src comes from studies where over-expression of 
exogenous FAK in CHO cells stimulates cell migration, which is dependent on its ability 
to associate with Src family members (Cary et al., 1996). Furthermore, expression of FAK 
mutants unable to bind Src, hinder cell migration (Cary et al., 1996). Evidence that 
dominant-inhibitory Src proteins and the absence of FAK both give rise to enlarged 
cellular adhesions and impaired migration, strongly suggests that the critical role of their 
activity is to induce adhesion turnover. Recently, regulatory events that lead to Src- 
mediated adhesion disassembly via FAK have come from studies on v-Src-induced focal 
adhesion disruption in which v-Src induced tyrosine phosphorylation of FAK precedes 
calpain-mediated proteolytic cleavage of FAK, leading to the cleavage and loss of FAK 
protein, adhesion disassembly and cell detachment (Carragher et al., 2001; Carragher et al., 
1999; Fincham et al., 1995). In this regard mutants of Src that suppress cell motility, 
including kinase and myristylation defective Src, do not induce FAK proteolysis and 
adhesion turnover (Fincham & Frame, 1998; Fincham et al., 1995).
In addition, since FAK is unlikely to be the sole protein involved in cell migration, other 
potential Src substrates such as cortactin could be involved in Src induced focal adhesion 
turnover and remodelling during cell migration. Cortactin has been reported to localise to 
residual focal adhesions (Wu et al., 1991) and Racl activity has been documented to cause 
cortactin to localise to lamellipodia in Swiss 3T3 cells (Weed et al., 1998). Cortactin also 
binds to actin filaments (Wu et al., 1991) and has actin cross-linking activity that is 
regulated by Src (Huang et al., 1997). Furthermore, cortactin has been shown to co- 
localise and interact with Arp2/3 at sites of actin assembly (Weed et al., 2000).
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Interestingly, tyrosine phosphorylation of cortactin is linked to Src and cell motility 
(Huang et al., 1998; Kanner et al., 1990) and recently tyrosine phosphorylation of cortactin 
has been reported to promote its susceptibility to calpain cleavage (Huang et al., 1997). 
These properties suggest that cortactin, like FAK, is a potential substrate involved in Src- 
induced focal adhesions turnover and remodelling during cell motility.
Several studies have also suggested that paxillin may also be an important substrate in Src 
induced focal adhesion turnover during cell migration. For example, paxillin -/- 
fibroblasts have impaired cell migration and display defects in cortical actin and focal 
adhesions (Hagel et al., 2002). Moreover, tyrosine phosphorylation of paxillin has been 
demonstrated in a number of studies to be associated with cell migration, while VEGF 
induced cell migration was shown to enhance the binding of Src and paxillin (Burridge et 
al., 1992; Kintscher et al., 2001; Munshi et al., 2000; Petit et al., 2000). Finally, Src 
induced phosphorylation of ezrin may expose the actin binding site on ezrin and thereby 
effect membrane/cytoskeletal interactions leading to lamellipodia formation, as previously 
demonstrated by over-expression of ezrin (Krieg & Hunter, 1992; Martin et al., 1995b). 
There may be many other Src substrates potentially involved in cell migration which will 
be discussed in more detail later.
1.6.2 Src induced modulation of RhoGTPases during cell migration.
As well as mediating the adhesion and actin cytoskeletal dynamics during cell migration 
by interacting with focal adhesion proteins, Src has also been proposed to modulate the 
actin cytoskeleton dynamics during cell motility by directly regulating RhoGTPases. This 
can occur at several different levels including regulation of GEFs, GAPs and RhoGTPase 
effectors. Src family kinases such as Lck have been shown to influence the activity of the 
Racl, by tyrosine phosphorylation of Vav (Gulbins et al., 1993; Han et al., 1997). On the 
other hand, Src may also lead to the antagonism of RhoA via phosphorylation of 
pl90RhoGAP (Ellis et al., 1990), leading to its association with pl20RasGAP (Chang et 
al., 1995; McGlade et al., 1993). This association, in turn, results in an increase in RhoA 
GTPase activity, inhibition of RhoA activity and the disruption and disassembly of actin 
stress fibres (Chang et al., 1995; Fincham et al., 1999). The antagonism of RhoA as a key 
event in Src’s de-regulation of the actin cytoskeleton was highlighted by the RhoA-induced 
reversion of the Src-mediated actin changes in rat fibroblasts (Mayer et al., 1999). In 
keeping with this, the complex between pl90RhoGAP and pl20RasGAP is required for 
stress fibre turnover and efficient cell migration (Kulkarni et al., 2000). Interestingly, 
integrin signalling induces early Src-dependent tyrosine phosphorylation and activation of
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pl90RhoGAP that is thought to relieve RhoA-mediated contractile forces thus allowing 
protrusions to form at the leading edge of motile cells (Arthur et al., 2000). In keeping 
with this, further studies have demonstrated that inhibition of RhoA by pl90RhoGAP 
enhances cell spreading and migration by promoting cell protrusion and polarity (Arthur & 
Burridge, 2001). Src has also been implicated in modulating the activity of m Dial/2 with 
regards to stress fibre formation. As discussed previously in Section 1.4.1 (Figure 6), 
mDial/2 co-operate with Rho-kinase to mediate actin remodelling downstream of RhoA 
(Watanabe et al., 1999). Recently a direct association between c-Src and mDia, mediated 
by the SH3 domain of Src and the proline rich FH1 domains of Dia proteins, has been 
reported to be necessary for the co-operative effects of Dia and Rho-kinase in mediating 
stress fibre formation (Tominaga et al., 2000). Inhibition of Src and mDia binding by 
expression of a dominant inhibitory Src protein, or deletion of the FH1 domain of Dia 
proteins, was shown to block the co-operation between Dia and Rho-kinase and thereby 
block stress fibre formation (Tominaga et al., 2000). It is therefore possible that Src may 
influence actin/adhesion dynamics during cell migration by functionally interacting with 
and regulating RhoGTPases at a specific time and place during cell migration.
1.7 Aim.
Src can have both positive and negative effects on adhesion formation and may act as a 
switch between their assembly and disassembly placing it in a central position from which 
to co-ordinate the multi-faceted process of directed cell motility. The functional interplay 
between Src family members and the actin cytoskeleton with regards to RhoGTPases lead 
us to probe this relationship further and examine the link between these proteins and their 
function. Here we addressed how RhoA-, Racl- or Cdc42-induced changes in the actin 
cytoskeleton influence the intracellular localisation of c-Src, and Src’s biological effects 
within the cell. Furthermore, we address whether cross-talk between RhoGTPases is 
involved in Src’s intracellular targeting. Finally, as Src is known to be required for cell 
motility, we aim to establish whether Src’s catalytic activity functions in this targeting 
process and whether it plays a role in cell polarisation and migration.
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2 Materials and m ethods
2.1 Cell culture reagents
Supplier: Beatson Institute Central Services 
Sterile dH20
Sterile PBS (Dulbecco ‘A ’)
Sterile PBS/lmM EDTA 
Penicillin solution (10,000 units/ml)
Streptomycin solution (lOmg/ml)
Supplier: Gibco Europe Life Technologies Ltd., Paisley, UK.
lOx Dulbeccos MEM concentrate 
lx  sodium pyruvate 
200mM L-glutamine 
2.5% trypsin solution
Supplier: Qiagen, Crawley, UK
Polyfect transfection reagent 
Supplier: Sigma Chemical Co., Poole, UK..
Foetal calf serum (FCS)
2.2 Cell culture plasticware
Supplier: BD Biosciences, Oxford, UK 
Falcon tissue culture dishes
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Supplier: ERIE scientific, BDH Merke eurolab, Poole Dorset 
Supercell culture slides
Supplier: TCS biologicals, Botolph Claydon, UK.
Nunc Delta tissue culture flasks 
Nunc cryotubes
2.3 Inhibitors
Supplier: CN biosciences, Nottingham, UK 
PP2 Src-family kinase inhibitor
Supplier: Cytoskeleton, Inc, Northampton UK 
C3 -transferase 
Supplier: Sigma Chemical Co., Poole, UK.
Cytochalasin D 
Supplier: Sigma pool,UK 
Emetine
Supplier: Welfide Corporation, Japan 
Y-27632 Rho-kinase inhibitor
2.4 Growth factors
Supplier: Sigma Chemical Co, Poole, UK 
Bradykinin, LPA
69
chapter 2
S u p p lie r :  TCS Biologicals, Botolph Claydon, UK 
PDGF
2.5 Antisera and associated materials
Supplier: Amersham International, Little Chalfont, UK.
A n t i - m o u s e /h o r s e r a d is h  p e r o x id a s e  c o n ju g a te  
A n t i - r a b b i t / h o r s e r a d is h  p e r o x id a s e  c o n ju g a te
Supplier: BioRad Labs, Hercules, CA 
Confocal microscope MRC 600
Supplier: Biosource International, CA
Anti-FAK tyrosine-925 mAb 
Anti-phospho-Src-Y416 polyclonal
Supplier: Eppendorf Hamburg, Germany 
Microinjector eppendorf 5171 
Microinjector Femtotips 
Supplier: Jackson ImmunoResearch, Luton, UK.
FITC labelled sheep anti-mouse IgG 
TRITC labelled goat anti-rabbit 
TRITC labelled goat anti-mouse 
FITC labelled goat anti-rabbit 
FITC labelled goat anti-rat IgG
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L machesky, Birmingham University, UK 
Anti-Arp3 mAb
Supplier: PIERCE 
DMP
Supplier: Research Diagnostics, Inc, Flanders, NJ
Rhodamine conjugated anti-paxillin antibody
Supplier: Sigma chemical Co., Poole, UK.
2mM phenylmethylsulphonyl fluoride 
0.1% (v/v) aprotinin 
Protein A-sepharose beads 
Rhodamine-conjugated phalloidin 
Anti-vinculin mAb 
saponin
T Hunter, Salk Institute, CA 
Anti-Src mAb N2-17
Supplier: Transduction Laboratories, BD Biosciences, Oxford, UK
Phosphotyrosine antiserum, mouse monoclonal (PY20) 
Anti-FAK mAb
Supplier: Upstate Biotechnology, Lake Placid, NY
Anti-Grb2 mAb 
Anti-Scar polyclonal 
Anti-Src mAb EC10 
Anti-myc tag polyclonal Ab 9E10 
Anti-myc tag mAb 9E10
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Supplier: Vector Laboratories Ltd., Peterborough, UK.
Vectashield mounting medium for immunofluorescence.
2.6 Protein reagents and materials
Supplier: Amersham, Little Chalfont, UK.
High molecular weight rainbow markers (14.4kDa to 220kDa)
ECL reagent
Supplier: Beatson Institute Workshop.
Semi-dry blotting apparatus 
Supplier: Genetic Research Instrumentation, Dunmow, UK.
Atto protein electrophoresis apparatus
Supplier: PIERCE, CLB perbio Ltd.
Micro BCA protein assay kit 
Supplier: Schleicher and Schuell, London, UK.
Nitrocellulose membrane
Supplier: Severn Biotech Ltd., Kidderminster, UK.
Design-a-Gel 30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide solution
Supplier: Sigma Chemical Co., Poole, UK.
TEMED (N, N, N', N'-Tetramethylethylenediamine)
0.1% (w/v) Ponceau S solution in 5% acetic acid 
Bovine serum albumin (BSA), fraction V 
Ammonium persulphate (APS)
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Supplier: Unipath, Basingstoke, UK.
‘Oxoid’ phosphate buffered saline tablets (Dulbecco ‘A ’)
Supplier: Whatman, Maidstone, UK 
3MM filter paper
2.7 Stock solutions and buffers 
Cell culture solutions
Cell culture medium
lx  DMEM supplemented as follows:
10% (v/v) foetal calf serum 
ImM sodium pyruvate 
2mM L-glutamine 
50 units/ml penicillin 
lOgg/ml streptomycin
Trypsin solution for routine passaging
0.25% v/v Gibco trypsin in sterile PBS/lmM EDTA
2.8 Protein extraction and processing
RIPA buffer
50mM Tris/HCl, pH 7.6
150mM NaCl
1% Triton X-100
0.5% deoxycholate
0.1% sodium dodecyl sulphate (SDS)
2mM EGTA
lOmM sodium pyrophosphate
100pm sodium orthvanidate 
2mm phenylmethlsolphonylfluoride 
lOpg/ml aprotinin
3x sample bufferlOOpM sodium orthovanadate Glycine
150mM Tris/HCl, pH 6.7 
6% (w/v) SDS 
30% (v/v) glycerol 
15% (v/v) 2-mercaptoethanol 
bromophenol blue to colour
SDS-PAGE stacking gel buffer
0.5M Tris/HCl, pH 6.7 
0.4% (w/v) SDS
Stacking gel
4.0ml 30% acrylamide/0.8% bisacrylamide solution
6.0ml stacking gel buffer
14.0ml dH20
250pl 10% APS solution
20pi TEMED
SDS-PAGE resolving gel buffer
1.5M Tris/HCl, pH 8.9 
0.4% (w/v) SDS
Resolving gel (for a 7.5% gel):
9.0ml 30% acrylamide/0.8% bisacrylamide solution
9.0ml resolving gel buffer
18.0ml dH20
250pl 10% APS solution
20pi TEMED
nP ro te in  e l e c t r o p h o r e s i s  ta n k  b u f f e r  ( lO x  c o n c e n t r a te ) chapter 2
0.05M Tris
0.05M glycine 
0.1% (w/v) SDS
Semi-dry transfer buffer for immunoblotting
50mM Tris 
40mM glycine 
0.037 % (w/v) SDS 
20% methanol
Immunoblot wash buffer
0.2% Tween 20 in PBS 
Immunoblot stripping buffer
0.2M glycine 
1% (w/v) SDS
pH adjusted to 2.5 with hydrochloric acid
2.9 Cells and plasmids
CA10-Src251-GFP and CAlO-wtSrc were kind gifts from P Schwartzberg (NIH, Bethesda, 
MD) and CA10-SrcY527F and CAlO-SrcMF (K295M,Y527F) were a kind gift from K 
Kaplan (MIT, Cambridge, MA). All Src constructs were chicken c-Src. pEGFP 
(Clontech, Basingstoke, UK) was used for expression of green fluorescent protein. N19- 
and V14RhoA, V12- and N17Cdc42, and L61- and N17Rac, all in the pRK5myc plasmid 
were kindly provided by Alan Hall (UCL, London, UK).
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2.10 Methods
2.10.1 Experimental protocol for serum starvation
Swiss 3T3 cells were routinely grown in DMEM supplemented with 10 % foetal calf 
serum. Cells were grown for one day after plating and subsequently serum starved for 48 h 
in serum free medium to induce stress fibre disassembly. To reduce the heterogeneity in 
the population after growth factor stimulation, cells were placed in serum-free conditions 
overnight (16 h), which did not abolish stress fibres but acted to reduce the heterogeneity 
amongst the cell population. The transfection efficiency of cells was typically between 20- 
30 % and in each figure the cells shown are representative o f the cell morphology observed 
in over 80 % of cells examined. In each case experiments were repeated at least 3 times.
2.10.2 Microinjection and transfection o f plasmids
Plasmids were introduced into the cells by nuclear microinjection or transient transfection 
as indicated in the text. Following microinjection of the plasmids at 100 ng p i '1, the 
proteins were expressed within 3 to 5 h after which the analysis was carried out. 
Transfection of the cells was carried out using Polyfect according to the manufacturer’s 
protocol with 0.5 pg DNA per chamber of an 8 well chamber slide. Typical transfection 
efficiencies were around 30 %.
2.10.3 Immunofluorescence
Cells were plated onto glass chamber slides at a cell density o f lxlO4 24 h prior to 
transfection or onto glass coverslips 24 h prior to microinjection. For experiments in 
which cells were serum starved to remove stress fibres prior to expression of the proteins, 
the cells were grown for 48 h in serum-free conditions prior to microinjection of the 
appropriate plasmids and analysis carried out 3-5 h later after expression of the proteins. 
For all other experiments the proteins were expressed by transient transfection. Growth 
factor treatment of the cells were as follows, PDGF, 25 ng m l'1 for 30 min, bradykinin, 100 
nM for 5 min or LPA 200 ng m l'1 for 30 min. The Rho-kinase inhibitor Y-27632 (10 pM), 
PP2 (5 pM), cytochalasin D (0.1 pg m l'1) or emetine (55 pg m l'1) were added as indicated.
Cells were fixed and stained for confocal microscopy as follows:
1. Cells were washed twice with PBS and fixed in 3 % paraformaldehyde (20 min).
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3. Cell were then permeabilised with PBS containing 0.1% saponin and 20 mM glycine 
(20 min).
4. Cells were then blocked with PBS containing 0.1 % saponin and 10 % foetal calf 
serum for 1 h.
5. Subsequently, cells were incubated with the appropriate primary antibodies, 
rhodamine-conjugated phalloidin or rhodamine conjugated paxillin antibody for 60 
min.
6. Non-conjugated antibody detection was by reaction with a species specific FITC- or 
TRITC-conjugated antibodies for 45 min.
7. Cells were visualised using a confocal microscope.
2.10.4 Preparation of protein extracts from adherent fibroblasts.
Swiss 3T3 fibroblasts were lysed in RIPA buffer to extract cellular proteins as follows:
The flasks or dishes were transferred directly from the 37°C incubator onto ice and were 
rinsed twice with ice-cold PBS. The culture vessels were then inclined and allowed to 
drain for 10 min to minimise the amount of residual PBS on the cells. Ice-cold lysis buffer 
was then pipetted onto the cells (0.5ml per 9cm plate) which were allowed to lyse for 10 
minutes on ice. At the end of this time, the cells were scraped off the tissue culture plastic 
using a disposable cell scraper and the resulting suspension was transferred into 
microcentrifuge tubes. The lysates were then cleared of insoluble cell debris by 
centrifugation at 14,000g at 4°C for 15 min. The total protein concentration of the lysates 
was estimated using the BCA protein assay kit according to the manufacturers directions. 
The aborbance of the samples was then measured at 562nm using a Beckman DU 650 
spectrophotometer. Experimental values were compared to a standard curve (obtained 
using BSA) and the total protein concentration in each sample calculated.
2.10.5 Protein electrophoresis.
Lysates prepared in RIPA buffer were standardised for total protein content before adding 
3x sample buffer. The lysates were then boiled for 5 minutes and allowed to cool before 
loading onto SDS-polyacrylamide gels for electrophoresis. Protein samples were separated
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on discontinuous 2mm SDS-polyacrylamide gels comprising a short stacking gel for the 
initial stage of the electrophoresis and a longer resolving gel to separate the proteins. The 
resolving gels contained 10% or 7.5 % acrylamide. Gels were typically run at either 180V 
for 3-4 hours or 30V overnight under constant-voltage conditions until the dye-front had 
reached the bottom of the gel. All gels were run with molecular weight markers.
2.10.6 Immunoblotting
After electophoresis, proteins were transferred onto nitrocellulose membrane by 
electrophoretic semi-dry blotting. Briefly, the SDS-PAGE gel, nitrocellulose membrane 
and 12 pieces of 3MM paper were soaked in transfer buffer and arranged between the 
blotter electrodes with 6 sheets of 3MM paper on either side of the gel/membrane 
sandwich oriented with the membrane on the cathode side of the gel. After gently 
excluding air bubbles from the paper/gel/membrane stack, the proteins were transferred for 
1 h at a maximum current of 200mA and a maximum voltage of 20V for a gel of 140cm2.
2.10.7Antibody incubation and detection by ECL
Following the transfer, the nitrocellulose membrane was blocked in the appropriate 
blocking solution (either 5% (w/v) non-fat milk or 3% (w/v) BSA in wash buffer) for 1 hr 
at room temperature on a shaker. After blocking, the blots were probed with primary 
antibody diluted in blocking solution for either 1 h at room temperature or overnight at 
4°C. After incubation in primary antibody, the blots where washed 3 times in wash buffer 
(15 min per wash) and were then incubated in horseradish peroxidase conjugated 
secondary antibody for 1 h at room temperature. After washing as described above, the 
blots were drained and incubated in fresh ECL reagent for 1 min with gentle agitation and 
were then wrapped in Saran-Wrap. The blots were placed in contact with X-ray film for a 
period of time sufficient to detect the light produced by the ECL reaction and the film was 
then processed in a Kodak automated processor.
2.10.8 Removing bound antisera from immunoblots.
Nitrocellulose blots which had been previously incubated in antisera were treated as 
follows to remove these bound antibodies prior to incubation with a different antiserum. 
The blot was firstly washed with immunoblot wash buffer to remove spent ECL reagent 
and was then incubated in immunoblot stripping buffer for 30 minutes at room temperature
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on a gyratory shaker. At the end of this incubation, the blot was washed again and then 
blocked and incubated with the desired antibodies.
2.10.9 Immunoprecipitation of extracted proteins
Lysates prepared in RIPA where standardised for total protein content (0.25-1.0 mg). The 
IgG complexes were the collected by incubating for 1 hr at 4°C with 50pl of a 50% slurry 
of protein-A sepharose beads (coated with rabbit anti-mouse IgG for normal mouse IgG or 
left uncoated for rabbit serum). The immunoprecipitating IgG was incubated overnight at 
4°C before collecting the IgG complexes with coated or uncoated protein-A sepharose 
beads as described above. The collected immune complexes were washed 5 times in RIPA 
lysis buffer before resuspending in 20pl of 3x sample buffer prior to electrophoresis and 
blotting.
2.10.10 Random cell migration
Cells grown on glass cover slips were transfected with Src251-GFP or GFP or co­
transfected with SrcY527F and GFP or SrcMF and GFP to allow detection of the 
transfected cells. Following expression of the proteins microscopic images of the cells 
were acquired from a charged couple device camera and captured by Open Lab 
(improvision Software, UK) every 15 min over a 5 h period. The processed images were 
displayed rapidly as a movie and interactive tracking of cells with a mouse pointer resulted 
in the generation of cell trajectory. Calculations for the rate of cell migration were derived 
from the data set, with individual cell speed being calculated for each of the 20 consecutive 
images. The mean cell speed was then calculated for each lapse interval, and an overall 
figure derived for the 5 h period. Values are mean + S.E.M. of between 30 and 60 cells 
taken from at least 5 experiments.
2.10.11 Dunn chamber polarisation assay
Cells were co-transfected with SrcY527F and GFP or SrcMF and GFP for detection, or 
transfected with Src251-GFP or GFP alone. Cells were trypsinised 24 h post-transfection 
and plated onto coverslips at 1 x 105 in 35 mm plates for 1 h. Cells were then serum 
starved for 1 h and mounted on Dunn chambers with PDGF lOng ml 1 as chemoattractant 
(Allen et al., 1997; Allen et al., 1998). Microscopic images of the cells were acquired from
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a charged couple device camera and captured by Open Lab every 15 min over a 5 h period. 
Criteria for calculating cells that remodelled their actin cytoskeleton were as follows. Cells 
that undergo a morphological shape change to form a leading lamellipodia and elongated 
tail directed towards the chemical gradient were included in the data set as positive 
polarising cells. Cells already demonstrating a cell polarity towards the chemical gradient 
were not included in the data set to reduce any false positives. Only cells that had random 
polarisation i.e, any cell out with the above criteria, or those with no obvious polarity at the 
beginning of the experiment were assessed over the 5 h period. The mean percentage of 
cells polarising along the chemical gradient for each transfected cell type was used to 
construct an overall figure for the 5 h period. The percentage of cells able to polarise was 
calculated from at least 5 independent experiments
2.10.12 Primary antisera dilutions used for immunofluorescence
Vinculin Clone VIN-11-5...........1:100
Dunn chamber 
chemotaxis assay
O uter w ell 
chemoattractant medium
Inner w ell 
Serum free medium
Bridge (Cells)
N2-17 (endogenous Src) 1:1000
Grb2 clone 81 1:400
Scar 1:400
EC10 (Chicken specific Src) 1:500
Myc 9E10 1:500
Anti-phospho FAK-Y925 1:500
FAK clone 77 1:500
Conjugated Paxillin 1:400
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2.10.13 Secondary antisera dilutions used for immunofluorescence
Anti-mouse/FITC conjugated......................1:100
Anti-mouse/Texas red conjugated.............1:100
Anti-Rabbit/FITCconjugated..................... 1:100
Anti-Rabbit/Texas red conjugated.............1:100
2.10.14 Primary anti sera dilutions used for immunoblotting and
immuonprecipitation
Phosphotyrosine (PY20)...................... .................... 1:1000 (w)
S ca r........................................................ ....................1:1000 (w), 4ug (IP)
Anti-phospho-Src-Y416...................... ............................1:1000 (w)
EC10....................................................... ....................1:1000 (w) 2ug (IP)
9E10 Conjugated mAb, was cross linked using DMP as described by manufacturer
(PIERCE) (V Brunton) (200ug/ml)..................................... 10ug (IP)
FAK......................................................... ................1:1000 (w) 5ul (IP)
Grb2........................................................ ................. 1:1000 (w)
2.10.15 Secondary antisera dilutions used for Immunoblotting
Horseradish peroxidase (HRP) conjugated anti - mouse or rabbit 1:5000
2.10.16 Bacterial transformation and DNA extraction
20pi of competent DH5a bacterial cells were aliquoted into chilled microfuge tubes, lul 
of diluted DNA was added to the cells and shaken to mix. The tubes were then paced on 
ice for 30 min, heat shocked for 40 seconds in a 42°C water bath, then placed back on ice. 
80pi of L Broth was added to the cells and the microfuge tubes were left to shake at
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225rpm for 1 Hour at 37°C. Afterwards, the cells were plated onto a L Broth plate 
containing the antibiotic for which the resistence gene is carried by the the transfected 
DNA.
DNA extraction was carried out using Qiagen plasmid prep kits. The concentration and 
purity of solutions of isolated DNA fragments or plasmids was determined 
spectrophotometrically using a Beckman DU650 spectrophotometer.
2.10.17 Routine Swiss 3T3 propagation
Swiss 3T3 fibroblasts were routinely grown on tissue culture treated dishes or flasks using 
DMEM supplemented with 10% foetal calf serum with tice-weekly medium changes and 
were never grown to confluence. These cells were maintained in a humid 37°C/5% CO2 
incubator. Adherent Swiss3T3 cells were subcultured as follows:
Fristly, the medium was aspirated off the cells and the monolayer was rinsed with PBS. 
The cells were thenincubated in 10 % trypsin solution andwith occasional gentle agitation 
until the cells had detached. The cells were then resuspended in DMEM, counted and 
plated into cell culture flasks.
2.10.18 Swiss 3T3 fibroblast cyropreservation and recovery
Cyropreserved Swiss 3T3 fibroblasts were prepared as follows:
Swiss 3T3 were allowed to proliferate until they reached 70-80 % confluence. They were 
then trypsinised to remove then from culture plates. The cells were then rised with PBS 
and couted before resuspending in culture medium plus 7% DMSO at lxlO 6 cells/ml. This 
suspension was trasferred into cryotubes (1ml per vial) which were then wrapped in cotton 
wool and placed in a -70°C freezer overnight. The following day the cryotubes were 
immersed in liquid nitrogen for long term storage.
For recovery from storage in liquid nitrogen, cryotubes were rapidly immersed in water at 
approximately 37°C to thaw cells. The cell suspension was then immediately made up to a 
volume of 10 ml with culture medium and plated into a culture flask.
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3 Characterisation of S w iss  3T3 ce lls  and Src251- 
GFP a s  too ls  to monitor c-Src targeting within 
the cell.
3.1 Purpose
The temporal and spatial localisation of Src has implications for the biological actions of 
Src kinase within the cell. As described previously (Kaplan et al., 1992) c-Src normally 
associates with endosomal membranes in the perinuclear region of the cell and upon 
activation translocates from there to its site of action in cellular adhesions by an actin- 
dependent mechanism. The aim of this study was to examine whether the distinct 
rearrangements of the actin cytoskeleton mediated by Rho-GTPases could influence the 
intracellular localisation of c-Src within the cell. The regulation of the actin cytoskeleton 
by the Rho family of GTPases RhoA, Racl and Cdc42 is well documented and readily 
manipulated in Swiss 3T3 cells (Hall, 1998; Nobes & Hall, 1995), making them an ideal 
model system in which to study their role in the intracellular targeting of c-Src. In this 
chapter we set out to determine whether the Swiss 3T3 fibroblast model was appropriate 
for studying the actin dependent targeting of c-Src.
3.2 Results
3.2.1 Manipulation of the actin cytoskeleton in Swiss 3T3 cells
Activation of RhoA stimulates actomyosin-based contractility, which leads to the assembly 
of actin stress fibres and focal adhesions found at the end of stress fibres (Ridley & Hall, 
1992) (Chrzanowska-Wodnicka & Burridge, 1996; Nobes & Hall, 1995). As documented 
previously (Ridley & Hall, 1992), we found that Swiss 3T3 fibroblasts grown in the 
presence of serum contain actin stress fibres that traverse the cell, as visualised following 
incubation with conjugated phalloidin (Figure 8a). This was also associated with the 
presence of prominent focal adhesions which are tethered at the ends of stress fibres and 
contain a number of proteins including, vinculin, paxillin and FAK, as visualised here 
using an anti-vinculin antibody (Figure 8b, solid arrows). Previous reports have 
demonstrated that deprivation of serum in Swiss 3T3 cells results in the loss of actin stress 
fibres (Ridley & Hall, 1992). In our system, removal of serum form Swiss 3T3 cells for 48 
h induced the loss of actin stress fibres within the cells (compare Figure 8 c and d) and loss
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of focal adhesions (compare Figure 8b and 8e). We then used a molecular probe in cells 
serum starved for 48 h to confirm that stress fibre formation in Swiss 3T3 cells was a 
RhoA dependent event. Microinjection of a constitutively active Myc-tagged RhoA 
protein (V14RhoA), which is insensitive to RhoGAPs resulted in the formation of stress 
fibres in the absence of serum (Figure 9a,d compare broken arrows indicating cells 
expressing V14RhoA to solid arrows indicating non-injected cells). Cells expressing Myc- 
tagged V14RhoA were identified using an anti-Myc antibody (Figure 9a). It should be 
noted that manipulation of the actin cytoskeleton by RhoA had to be carried out in serum- 
free conditions as serum results in stress fibre assembly. We introduced RhoA, Racl and 
Cdc42 expression plasmids and Src251-GFP by transient transfection or microinjection 
and found there was no difference in the outcome between experiments using either 
method. Therefore, for convenience, transient transfection was used throughout, except in 
the experiments where we expressed the V14RhoA and N19RhoA proteins. Deprivation 
of serum in Swiss 3T3 cells results in the loss of actin stress fibres whose assembly is 
regulated by RhoA and manipulation of the actin cytoskeleton by Rho proteins was 
therefore carried out in serum-free conditions in which the transfection efficiency was very 
low. Expression of RhoGTPases was typically observed within 3-5 h post-microinjection.
Racl activation has been reported to lead to a distinct rearrangement of the actin 
cytoskeleton resulting in localised actin polymerisation at the cell periphery, and the 
formation of lamellipodia (Nobes & Hall, 1995; Ridley et al., 1992). Transfection of 
constitutively active Myc-tagged Racl (L61Racl) protein in growing cells (Figure 9b,e 
broken arrows) resulted in the rearrangement of the actin cytoskeleton to produce 
lamellipodia while non-transfected cells (Figure 9e, solid arrow) had no lamellipodia. 
Similarly, Cdc42 activation is known to stimulate the formation small actin rich 
protrusions known as filopodia which emanate from the cell body (Kozma et al., 1995; 
Nobes & Hall, 1995) and transfection of a constitutively active Myc-tagged Cdc42 
(V12Cdc42) protein in growing cells (Figure 9c,f broken arrows) resulted in the 
rearrangement of the actin cytoskeleton to produce filopodia (Figure 9f, broken arrow) 
while non-transfected cells (Figure 9f, solid arrow) had no filopodia.
Figure 8
Disruption and breakdown of the actin cytoskeleton by serum starvation. Cells grown 
the presence of 10 % serum (a-c) or were serum starved for 48 h to remove stress fibres (d, 
Solid arrows indicate vinculin staining. Actin was visualised with rhodamine-phalloidin (a,c 
and vinculin using an anti-viculin antibody (b,e). Scale bars 25 pm.
Figure 8
S e r u m
Act in
S e r u m
c
Actin
Vincul in
Figure 9
Specific activation of RhoGTPases using constitutively active RhoGTPases leads to 
distinct actin rearrangements. Cells were serum starved for 48h to remove stress fibres prior 
to microinjection of V14RhoA (a,d). Solid arrows indicate non-injected cells, while broken 
arrows indicate injected cell. Cells in the presence of serum were transfected with L61Rac 
(b,e), or transfected with V12Cdc42 (c,f). Broken arrows indicate expressing cells, while solid 
arrows indicate non-expressing cells. Cells expressing Rho-constructs were detected with a 
Myc-tag antibody (a-c), while actin was visualised with rhodamine-phalloidin (d-f). Scale bars 
25 pm.
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V U R h o A  L6I  Rac-1 V I 2 C d c 4 2
M y c  M y c  M y c
Actin Actin Actin
chapter 3
In fibroblasts activation of RhoGTPases by different transmembrane receptors has been 
reported to lead to distinct morphological rearrangements of the actin cytoskeleton (Hall, 
1998). Lysophosphatidic acid (LPA) for example, which is reported to be the active 
constituent in serum, causes stress fibre formation in a RhoA dependent manner (see 
section 1.3.2 Figure 5). We therefore addressed how activation of RhoA, using LPA, 
influenced the actin cytoskeleton in Swiss 3T3 cells and monitored adhesion complexes by 
staining cells with an anti-vinculin antibody. Treatment of cells with LPA resulted in 
stress fibre formation (Figure 10a), which was also associated with the localisation of 
vinculin at the cell periphery, in focal adhesions tethered at the ends of actin stress fibres 
(compare Figure lOd and Figure 8e). Both lamellipodia and filopodia contain focal 
complexes within their structures, which have been defined as small adhesion structures of 
indistinguishable protein composition from the larger focal adhesions as described above 
(Nobes & Hall, 1995). We therefore addressed how activation of Racl or Cdc42 using 
PDGF or bradykinin, could influence the actin cytoskeleton in Swiss 3T3 cells and 
monitored adhesion complex formation by staining cells with an anti-vinculin antibody. In 
our system cells were serum starved overnight for 16 h to reduce the heterogeneity 
amongst the cell population following growth factor stimulation. Cells serum starved for 
16 h show only a slight reduction in stress fibre formation (compare Figure 10a and 
Figure 10b) as opposed to 48 h serum starvation, which results in complete stress fibre loss 
(Figure 10c). The absence of serum 16 h prior to growth factor stimulation however 
enhances the actin remodelling induced by PDGF and Bradykinin resulting in a reduced 
heterogeneity amongst cells following stimulation (see Methods Section 2.10.1). 
Activation of Racl by PDGF resulted in the remodelling of the actin cytoskeleton to 
produce lamellipodia and a leading edge to the cell (Figure lOe, solid arrows) with small 
vinculin-containing complexes forming around the base of the lamellipodia (Figure lOh, 
solid arrows). Similar to these observations, we found that bradykinin stimulated the 
formation of actin microspikes at the cell periphery (Figure lOf, solid arrows) with small 
focal complexes forming at the base (Figure lOi, broken arrows) and along the length of 
the filopodia (Figure lOi, solid arrows).
We then set out to determine whether the actin cytoskeleton could be manipulated using 
pharmalogical intervention. Previous reports have demonstrated that similar to the effects 
of serum starvation, the addition of cytochalasin D which binds to the barbed end of actin 
monomers, disrupts the actin cytoskeleton and thereby results in the loss of actin stress 
fibres (Ridley & Hall, 1992Nobes, 1995 #402). Following treatment of cells with 
cytochalasin D, the reformation of stress fibres in response to serum (compare Figure 1 la 
and b) or LPA (compare Figure 1 lc and d) was prevented.
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Figure 10
Activation of RhoGTPases using external growth factors to manipulate the actin 
cytoskeleton. Cells serum-starved overnight to reduce heterogeneity amongst the cell 
population were stimulated with LPA (200 ng m l'1) for 30 min (a,d), PDGF (25 ng ml'1) for 30 
min (b,e) or bradykinin (100 nM) for 5 min (c,f). Actin was visualised with rhodamine- 
phalloidin (a-c) and vinculin using an anti-viculin antibody (d-f). Scale bars 25 pm.
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Figure 11
Disruption and breakdown of the actin cytoskeleton by pharmacological intervention
Cells serum starved for 48 h were stimulated with 10 % serum for 30 min (a) or LPA (200 ns
\ 1 m f ) for 30 min (c). Serum starved cells were pre-treated with 0.1 pg mL of cytochalasin D
prior to serum (b) or LPA (200 ng m l'1) (d) stimulation, (e-g) Cells in the presence of serum
were co-microinjected with C3-transferase and IgG (for detection of injected cell). Broken
arrows indicate injected cells, while solid arrows indicate non-injected cells. Actin was
visualised with rhodamine-phalloidin (a-d,f,g), while cells microinjected with C3 transferase
were detected using an anti-IgG antibody (e,g). Scale bars 25 pm.
Figure 1 1
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More specific methods of inhibiting RhoGTPase-induced actin rearrangements have been 
reported. The Clostridium botulinum exoenzyme C3-transferase for example, disrupts 
RhoA, B, and C induced stress fibres by ADP-ribosylation of Rho (Aktories & Hall, 1989; 
Verschueren et al., 1997). Co-microinjection of cells with C3-transferase protein and IgG 
(for detection of microinjected cells) (Figure l ie )  into the cytoplasm caused the loss of 
stress fibres in the presence of serum as previously reported (Figure llf ,g )  (Aktories & 
Hall, 1989). A more versatile method of inhibiting RhoA induced biological effects in the 
cell is by using the chemical inhibitor of ROCK Y-27632, which is a downstream effector 
of RhoA implicated in stress fibre formation (Kimura et al., 1996; Leung et al., 1996) (see 
Section 1.4.1). To verify the specificity of Y-27632 as an inhibitor of RhoA induced stress 
fibres, we treated cells with Y-27632 prior to serum, LPA, PDGF or bradykinin 
stimulation. Treatment of cells with Y-27632 caused the loss of stress fibres even though 
serum was present (compare Figure 12a and b). Moreover, cells incubated with Y-27632 
were devoid of stress fibres even after stimulation with LPA (compare Figure 12c,d). 
However, cells stimulated with PDGF were able to form lamellipodia even in the presence 
of Y-27632 (compare Figure 12e and f). Similar results were observed in cells stimulated 
with bradykinin where filopodia can be seen emanating from the cell body even in the 
presence of Y-27632 (compare Figure 12g and h). Thus the Rho-kinase inhibitor in our 
system demonstrates specificity towards RhoA and not the other RhoGTPases Racl or 
Cdc42.
Dominant negative inhibitory mutants of RhoGTPases have been used extensively to 
establish the involvement of various RhoGTPases in a number of processes (Feig, 1999). 
Point mutations in the nucleotide binding pocket results in dominant negative RhoGTPases 
which directly compete with the respective endogenous Rho family member for its 
nucleotide exchange factor and inhibit the GTP exchange required for activity (see 
Introduction Section 1.3.1). These mutations result in a higher affinity binding potential of 
dominant negative RhoGTPases over their endogenous counterparts, and as they cannot 
bind downstream effectors they block the effect of RhoGTPases within the cell. Cells 
were serum starved for 48 h to remove stress fibres prior to microinjection ot a dominant 
negative RhoA protein (N19RhoA). Expression of (N19RhoA), as detected by a Myc-tag 
antibody (Figure 13a), prevented the reformation of stress fibres in response to serum 
(Figure 13b, compare transfected cell, broken arrow to non-expressing cells, solid arrows). 
Expression of dominant negative Racl, as detected using a Myc-tag antibody (Figure 13c, 
broken arrow), blocked the formation of actin bundling and lamellipodia in response to 
PDGF, confirming that the dominant negative Racl construct was working and that PDGF 
is acting through Racl (Figure 13d, compare expressing cell broken arrow to non-
96
chapter 3
expressing cells, solid arrows). Furthermore, the expression of a dominant negative Cdc42 
protein (N17Cdc42) as detected using a Myc-tag antibody (Figure 12e, broken arrow), 
blocked the formation of filopodia in response to bradykinin (Figure 12f, solid arrow), 
confirming that the dominant negative Cdc42 is working and that bradykinin is acting 
through Cdc42 to form filopodia (Figure 12f, compare transfected cell broken arrow to 
non-transfected cells solid arrows).
Thus the regulation of the actin cytoskeleton by both external stimuli and the use of 
molecular and pharmacological probes to modulate the respective Rho-GTPases is 
indistinguishable from previous reports in Swiss 3T3 cells (Hall, 1998; Nobes & Hall, 
1995; Ridley & Hall, 1992). The ability to specifically manipulate the actin cytoskeleton in 
these cells provides a useful system in which to examine the influence of the actin 
cytoskeleton and in particular the role of RhoGTPases in c-Src localisation.
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Figure 12
Y-27632 specifically inhibits RhoA mediated actin remodelling without effecting Rac l 
or Cdc42. Cells were placed in serum-free conditions overnight, which did not abolish stress 
fibres but acted to reduce the heterogeneity in the population prior to stimulation. Cells were 
subsequently treated with (b,d,f,h) or without (a,c,e,g) Y-27632 prior to stimulation with serum 
for 30 min (a,b), LPA (200 ng m l'1) for 30 min (c,d), PDGF (25 ng m l'1) for 30 min (e,f) or 
bradykinin (100 nM) for 5 min (g,h). Arrows indicate lamellipodia or filopodia respectively. 
Actin was visualised with rhodamine-phalloidin. Scale bars 25 pm.
Figure 12
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Figure 13
Expression of dominant negative RhoA, R acl and Cdc42 in cells inhibit the 
morphological actin structure induced by serum, PDGF or bradykinin stimulation 
respectively. Cells were serum starved for 48 h to remove stress fibres prior to micro injection 
of N19RhoA (a,b). Cells in the presence of serum were transfected with N17Rac (c,d) or 
N17Cdc42 (e,f) and stimulated with PDGF (25 ng m l'1) for 30 min (c,d) or bradykinin (100 
nM) for 5 min (e,f). Solid arrows indicate non-expressing cells, while broken arrows indicate 
expressing cell. Scale bars 25 pm.
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3.2.2 Characterisation of Src251-GFP as a tool to monitor c-Src localisation 
in Swiss 3T3 cells.
Early observations demonstrate that c-Src is readily found in the perinuclear region of the 
cell where it co-localises with endosomal membrane structures (David-Pfeuty & Singer, 
1980; Kaplan et al., 1992; Nigg et al., 1982). v-Src however, is abundant in both the 
perinuclear region of the cell and in focal adhesions (Burr et al., 1980; Nigg et al., 1982). 
The apparent difference in sub-cellular localisation of c-Src and v-Src led to the proposal 
that mutations, particularly in the C-terminal sequences of v-Src may be responsible for the 
altered distribution of v-Src (see Figure 1). Mutation of tyrosine-527 to phenylalainine in 
c-Src, which results in catalytic activation, as well as release of constraints on the SH3 and 
SH2 domains, led to c-Src being constitutively associated with focal adhesions (Kaplan et 
al., 1994). However, mutational analysis revealed that the kinase activity of c-Src was not 
required for its focal adhesion localisation and that domains within the first 251 residues of 
c-Src (Src251) were sufficient for its focal adhesion targeting. When expressed in cells, 
Myc-tagged Src251 was constitutively associated with focal adhesions (Kaplan et al.,
1994). We have used a green fluorescent protein (GFP) fused to the first 251 amino acids 
of c-Src (Src251-GFP), to monitor Src localisation within the cell by direct fluorescence. 
This construct comprises the c-Src myristylation site, unique region and Src homology 
domains (SH3 and SH2), coupled to GFP, which replaces the kinase and regulatory 
domains at the carboxy-terminus (Figure 14). In this section we set out to characterise the 
behaviour of Src251-GFP in our Swiss 3T3 cells and to determine whether the localisation 
of Src251-GFP is regulated by the actin cytoskeleton, as has been previously described for 
v-Src in fibroblasts (Fincham et al., 1996). Moreover we wanted to establish whether the 
coupling of Src251 to GFP interferes with its targeting within the cell.
3.2.3 Translocation of Src251-GFP to focal adhesions is dependent on the 
actin cytoskeleton
The translocation of Src251-GFP to the cell periphery is not regulated by intramolecular 
constraints and under culture conditions in which serum is present, Src251-GFP is 
therefore found at the cell periphery. As described earlier removal of serum from Swiss 
3T3 fibroblasts for 48 h, results in a loss of actin stress fibres (Figure 11a and 15b). When 
Src251-GFP was micro-injected into serum-starved Swiss 3T3 fibroblasts, which have no 
stress fibres, it was located in the perinuclear region of the cell (Figure 15a,c, broken 
arrow). Treatment of serum starved cells with the actin disrupting drug cytochalasin D,
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prevented both the reformation of the actin stress fibres in response to serum (compare 
Figure 15e to Figure 16a) as well as the translocation of Src251-GFP from the perinuclear 
region of the cell to peripheral focal adhesions (Figure 15g, broken arrow). In the presence 
of serum Src251-GFP was found in sites at the ends of actin stress fibres (Figure 16a,c), 
where it co-localised with the focal adhesion protein vinculin (Figure 16d-f) and paxillin 
(Figure 16g-i). This demonstrates that the targeting of Src251-GFP to focal adhesions is 
dependent on an intact actin cytoskeleton.
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Figure 14
Src251-GFP construct. Schematic representation of the structural domains of Src251-GFP 
(a). Anti-Src western blot of lysates derived from Swiss 3T3 cells expressing Src251-GFPo: 
empty vector (b).
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Figure 15
Translocation of Src251-GFP to focal adhesions is dependent on the actin cytoskeleton 
Cells were serum starved for 48 h prior to microinjection of Src251-GFP (a-c). Cells serum 
starved for 48h were microinjected with Src251-GFP and were pre-treated with 0.1 pg ml'1 of 
cytochalasin D for 2 h before protein expression and serum stimulation (e-g). Solid arrows 
indicate non-expressing cells, while broken arrows indicate expressing cells. Actin was 
visualised with rhodamine-phalloidin (b,c,f,g) and Src251-GFP was localised by direct 
fluorescence (a,c,e,g). Scale bars 25 jam.
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Figure 16
In the presence of serum Src251-GFP associates with focal adhesions. Cells were serum 
starved to remove stress fibres prior to microinjection of Src251-GFP. Cells serum-starved for 
48 hr were microinjected with Src251-GFP and following expression of the protein were 
stimulated with 10% serum for 30 min (a-i), where it was found at the ends of actin fibres (a-c) 
or co-localising with vinculin (d-f) or paxillin (g-i). Arrows indicate Src251-GFP and vinculin 
staining. Actin was visualised with rhodamine-phalloidin (b,c), while vinculin (e,f) or paxillin 
(h,i) were visualised using anti-vinculin or anti-paxillin antibodies. Src251-GFP was detected 
in the same cell by direct fluorescence. Scale bars 25 jim.
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3.2.4 Discussion.
The regulation of the actin cytoskeleton by both external stimuli and the use of molecular 
probes to modulate the respective RhoGTPases in this study was indistinguishable from 
previous reports in Swiss 3T3 cells (Hall, 1998; Nobes & Hall, 1995; Ridley & Hall, 
1992). Different protocols were used in previous studies; cells were plated at low density 
and after 6-10 days, when the cell were quiescent, they were serum starved in 0.2 % serum 
overnight (16 h) which resulted in the loss of stress fibres. In this study, cells were grown 
for one day after plating and subsequently serum starved for 48 h in serum free medium to 
induce stress fibre disassembly. Both methods appear to induce similar morphological 
changes in the actin cytoskeleton.
The disruption and breakdown of the actin cytoskeleton by serum starvation or 
pharmocological intervention by cytochalasin D have been validated in our system (Ridley 
& Hall, 1992). Treatment of cells with the Rho-kinase inhibitor blocked both LPA and 
serum induced stress fibres as previously described by others (Kimura et al., 1996; Leung 
et al., 1996). Y-27632, however, has also been reported to inhibit protein kinase C related 
kinase 2 (PRK2) in vitro as effectively as ROCK (Kimura et al., 1996; Leung et al., 1996; 
Uehata et al., 1997). PRK2 is also a RhoA effector (see Figure 6 Section 1.3.3) but with 
different substrate specificity to ROCK. We cannot therefore rule out the possibility that 
Y-27632 is inhibiting other kinases than ROCK. However, in the context of these 
experiments we have shown that treatment with Y-27632 results in the loss of stress fibres 
and does not effect Racl or Cdc42-induced actin remodelling, implying that it is a suitable 
and versatile tool to block RhoA activity without altering Racl or Cdc42-induced actin 
rearrangements. Dominant negative inhibitory mutants of RhoGTPases have been used 
extensively to elucidate the involvement of various RhoGTPases in a number of processes 
(Feig, 1999). The use of dominant negative RhoGTPases and interpretation of results 
using these mutants however has to be met with some caution. Dominant negative 
RhoGTPases directly compete with the respective endogenous Rho family member for its 
nucleotide exchange factor (see Introduction section 1.3.1). Due to the high affinity 
binding potential of dominant negative RhoGTPases over their endogenous counterparts, 
they block the effect of RhoGTPases in the cell, by inhibiting GTP exchange required for 
activity. One concern therefore, is that these mutants inhibit the GEF activity towards 
RhoGTPases rather than the RhoGTPases themselves. As discussed in the introduction 
(see Section 1.3.1) many of the nucleotide exchange factors for RhoGTPases activate 
multiple Rho family members. Therefore, expression of one dominant negative Rho-
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family member may be expected to block the activation of other members. Other methods 
of RhoGTPase activation have been reported to bypass this GEF-dependent activation 
pathway (Feig, 1999) and therefore using dominant negative mutants to block this pathway 
may lead to a misinterpretation of results, without caution. RhoA for example, has been 
shown to be activated by the RhoGEF, p i 15 RhoGEF however recent evidence has shown 
RhoA can also be activated directly by Gaa or PYK2 thereby bypassing the GEF- 
dependent activation pathway leading to an ineffective inhibition of RhoA (see Section 
1.3.3) (Shi et al., 2000; Ueda et al., 2000). In the context of our experiments, however, 
expression of individual inhibitory mutants such as N19RhoA, N17Racl and N17Cdc42 
has resulted in a remarkably specific phenotype, a property which has been frequently 
reported by others (Feig, 1999; Hall, 1998).
The external stimuli LPA, PDGF and bradykinin are well documented to specifically 
induce the activity of the respective RhoGTPases RhoA, Racl, and Cdc42 by modulating 
the activity of GEFs (see Section 1.3.1), which have specific GDP-GTP exchange activity 
towards the specific Rho family members. The specificity of these external stimuli 
towards their respective RhoGTPase has previously been illustrated, both by the distinct 
actin structures produced upon stimulation and by directly measuring the GTP-bound 
(active) state of each family member after stimulation (Hall, 1998; Nobes & Hall, 1995; 
Ren et al., 1999; Ridley & Hall, 1992; Ridley et al., 1992). The external stimuli used here 
are therefore suitable to modulate the activity of RhoGTPases within Swiss 3T3 cells and 
thereby serve as versatile tools to examine their influence on c-Src localisation. To 
compliment this, a more specific method of altering the individual RhoGTPase activity 
was also employed by expressing constitutively active mutants of the respective 
RhoGTPases. These mutants mimic the permanently active GTP-bound state of the 
proteins, as a result of insensitivity to GAP activity, (Van Aelst & D'Souza-Schorey, 
1997). As described above the morphological rearrangements of the actin cytoskeleton 
were indistinguishable from earlier reports in which constitutively activated RhoGTPase 
proteins were microinjected into the cytoplasm ot serum starved, quiescent cells.
We can therefore conclude that manipulation of the cytoskeletal network in the Swiss 3T3 
fibroblast cells in our hands is comparable to previous reports used to assess and analyse 
the role of RhoGTPases and is therefore a suitable model in which to examine the 
influence of the actin cytoskeleton and in particular the role ot RhoGTPases in c-Src 
localisation.
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The use of GFP to detect proteins by direct fluorescence has provided unprecedented 
insight into the localisation of proteins, that may otherwise, not have been observed by 
more conventional methods. The fusion of GFP to proteins has been shown in most cases 
not to interfere with the behaviour of the proteins in question. GFP tagged vinculin or 
actin for example, have frequently been used to monitor adhesion and actin dynamics in 
real time during cell migration (Small et al., 1995; Small et al., 1999; Small et al., 2002; 
Westphal et al., 1997). The potential for examining Src251-GFP localisation in real time 
during cell migration and stimuli-induced actin remodelling will be discussed later 
(Chapter 7, Future work). Here we conclude, firstly, that the addition of GFP to the C- 
terminal end of Src251, like the addition of a Myc tag (Kaplan et al., 1994), did not 
interfere with its translocation to focal adhesions. Moreover, a recent study monitoring 
integrin-dependent traction forces important for cell migration, utilised Src251-GFP and 
did not report any alterations in the known activity and behaviour of this protein compared 
to Src251 alone (Felsenfeld et al., 1999).
The localisation of v-Src and c-Src to the cell periphery in fibroblasts and the localisation 
of c-Src to cell-cell junctions in epithelial cells requires an intact actin cytoskeletal network 
(Fincham et al., 1996; Owens et al., 2000). Moreover, other ubiquitously expressed family 
members such as Yes and Fyn have also been shown to translocate to cell-cell adhesions in 
an actin dependent manner (Owens et al., 2000). In this study we have shown that the 
peripheral localisation to focal adhesions of Src251-GFP, a fusion protein that contains the 
Src SH3 and SH2 domains but has no kinase domain, is also dependent on an intact actin 
cytoskeleton. These results imply that Src251-GFP is a useful tool to monitor the control 
of c-Src intracellular targeting by direct fluorescence.
3.3 Summary
In this chapter we have demonstrated that the Swiss 3T3 fibroblasts can be used to 
examine the influence of the actin cytoskeleton and in particular the role RhoGTPases play 
in c-Src localisation. Furthermore, we have characterised Src251-GFP in these cells and 
demonstrated it to be a valuable tool to monitor c-Src within the cell. We therefore set out 
to assess whether RhoGTPases play a key role in the spatial regulation ol c-Src.
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4 Co-ordinated regulation of the actin 
cytosk eleton  by RhoG TPases spatially regulates  
Src targeting to the cell periphery.
4.1 Purpose
We have shown in the previous chapter, that the Rho family GTPases Cdc42, Racl and 
RhoA can be manipulated in Swiss 3T3 fibroblasts, by stimulation of transmembrane 
receptors or by molecular intervention to produce morphologically distinct actin structures. 
Co-ordination of this actin remodelling and these structures has been implicated in cell 
motility by providing both the protrusive and contractile forces required for cell migration 
(Chrzanowska-Wodnicka & Burridge, 1996; Hall, 1998). The role however of 
RhoGTPases in controlling the temporal and spatial localisation of proteins has not been 
fully elucidated. The purpose of this chapter was to test the hypothesis that RhoGTPases 
serve a central role in the spatial regulation of proteins, such as Src, thereby serving to 
regulate their action within the cell.
4.2 Results
4.2.1 Localisation of Src251-GFP to specific peripheral sites is under the 
control of Rho family GTPases.
Previously we demonstrated that the translocation of v-Src to focal adhesions is under the 
control of RhoA (Fincham et al., 1996). Furthermore, as treatment with serum, which 
activates RhoA, resulted in translocation of Src251-GFP from a perinuclear location to 
focal adhesions (Figure 16), we used molecular and pharmacological intervention to 
determine whether this was a RhoA-dependent event. Expression of a constitutively active 
RhoA protein (V14RhoA) in cells resulted in the formation of stress fibres in the absence 
of serum (Figure 17a). In Figure 17, the broken arrow indicates a cell expressing 
V14RhoA where stress fibres are present whereas the non-expressing cell (solid arrow) had 
no visible stress fibres. Cells expressing Src251-GFP and V14RhoA where detected using 
direct fluorescence by Src251-GFP. Co-expression of V14RhoA with Src251-GFP was 
sufficient to localise Src to the cell periphery (Figure 17b, broken arrow), were it targeted 
to the ends of actin stress fibres (Figure 17c, broken arrow). Expression of V14RhoA in
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serum starved cells also induced the formation of prominent focal adhesions (Figure 17d). 
The broken arrow indicates a cell expressing V14RhoA where the focal adhesion protein 
vinculin was located, whereas the non-expressing cells (solid arrows) had weak focal 
adhesion staining. Co-expression of Src251-GFP with V14RhoA (Figure 17e) resulted in 
the co-localisation of Src with the focal adhesion protein vinculin (Figure 17f).
As described in Chapter 3 (see Section 3.1.1), Racl activation leads to localised actin 
polymerisation at the cell periphery resulting in the formation of lamellipodia (Figure 9b,e) 
(Nobes & Hall, 1995; Ridley et al., 1992). We therefore addressed how activation of Racl 
influenced the localisation of Src251-GFP within the cell. Cells in the presence of serum 
(i.e. a RhoA stimuli) were co-transfected with L61Racl and Src251-GFP. Expression of 
an activated Racl protein (L61Racl) resulted in the formation of lamellipodia (Figure 18a, 
broken arrow) and co-expression of Src251-GFP with L61Racl resulted in the localisation 
of Src251-GFP to the Raci-induced peripheral lamellipodia (Figure 18b,c, broken arrows). 
Both lamellipodia and filopodia contain small focal complexes within their structures, 
which have been defined as small focal adhesion structures (see Chapter 3) (Nobes & Hall,
1995). In conjuction with the actin rearrangement described for Racl and Cdc42 (see 
Chapter 3 Figure 9b,e and c,f) there is also thought to be a dynamic remodelling and 
breakdown of focal adhesions to focal complexes during lamellipodia or filopodia 
formation (Laukaitis et al., 2001). In cells expressing activated Racl protein, vinculin 
localised to small focal complexes at the leading edge of the cell (Figure 18d, broken 
arrows) (Nobes & Hall, 1995) where it co-localised with Src251-GFP (Figure 18e,f, 
broken arrows). However, in cells not expressing activated Racl (Figurel8d, solid arrow) 
vinculin was located in larger discrete structures representing focal adhesions due to the 
presence of serum, which as described above induces RhoA activity causing both stress 
fibres formation and focal adhesion assembly. This therefore demonstrates that in parallel 
with the remodelling of the actin cytoskeleton, lamellipodia formation is associated with 
the loss of focal adhesions and the formation of smaller focal complexes to which Src251- 
GFP is located.
Similar to these observations we found that expression of a constitutively active Cdc42 
protein (V12Cdc42) induced the formation of filopodia (Figure 19a, broken arrows show 
expressing cell) and co-expression of Src251-GFP with activated Cdc42 induced some of 
the expressed Src251-GFP to move from the perinuclear region of the cell to membrane 
regions at the base of filopodia (Figure 19b). At enhanced resolution (Figure 19c, inset) it 
can be seen in distinct complexes spaced along the actin filopodia (solid arrows, inset).
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Similar to the observations with the expression of activated Racl, we found that activated 
Cdc42 induced focal adhesion re-modelling to produce focal complexes along the base and 
length of the filopodia (Figure 19 d,e and see Chapter 3 Figure 10). Src251-GFP co­
localised with vinculin (Figure 19f), in both focal adhesion complexes at the base of 
filopodia (Figure 19f, broken arrows, inset) and in complexes spaced along filopodia 
(Figure 19f, solid arrow).
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Figure 17
Src localisation to focal adhesions is under the control of RhoA mediated stress fibres 
Cells were serum starved for 48 h to remove stress fibres prior to co-microinjection of 
V14RhoA and Src251-GFP (broken arrows). Solid arrow indicates non-injected cells. Actin 
was visualised with rhodamine-phalloidin (a), while vinculin (d) was visualised using an anti- 
vinculin antibody. Src251-GFP was detected in the same cells by direct fluorescence (lye) with 
merged images shown in (c, f). Scale bars 25 pm.
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Figure 18
Src localisation to lamellipodia is under the control of Rac mediated actin remodelling
Cells in the presence of serum were co-transfected with L61Rac and Src251-GFP. Broken 
arrows indicate transfected cells while solid arrows indicate non-transfected cells. Actin was 
visualised with rhodamine-phalloidin (a,c), while vinculin (d,f) was visualised using an anti- 
vinculin antibody. Src251-GFP was detected in the same cells by direct fluorescence (b,e,c,f). 
Scale bars 25 pm.
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Figure 19
Src localisation to filopodia is under the control of Cdc42 mediated actin remodelling
Cells in the presence of serum were co-transfected with V12Cdc42 and Src251-GFP. Broken 
arrows indicate transfected cells while solid arrows indicate filopodia. Actin was visualised 
with rhodamine-phalloidin (a,c), while vinculin (d,f) was visualised using an anti-vinculin 
antibody. Src251-GFP was detected in the same cell by direct fluorescence (b,e,c,f). S c a le  bars 
25 [im.
Figure 19
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4.2.2 Localisation of endogenous or wt-Src by RhoGTPases is 
indistinguishable from the targeting of Src251-GFP.
To eliminate the possibility that the localisation of Src251-GFP to the peripheral sites 
described above was a consequence of over-expression of a mutated c-Src protein, we set 
out to relate the observed targeting of Src251-GFP to the endogenous protein. We were 
able to demonstrate the presence of endogenous Src in focal adhesions in response to LPA 
(Figure 20a), where it was found at the ends of actin stress fibres (Figure 20b). Stimulation 
of cells with PDGF, which activates Racl, was sufficient to induce re-localisation of 
endogenous Src to lamellipodia (Figure 20c), where it co-localised with actin bundles 
(Figure 20d). It was difficult to visualise endogenous Src in filopodia following 
stimulation with bradykinin which is most likely due to problems in detecting low levels of 
endogenous proteins in such small structures. However, this could be over come by 
expressing full length wild type Src protein (wt-Src) in the cells (Figure 21a). Treatment 
of cells over-expressing wt-Src with bradykinin resulted in Src being readily seen at the 
base of filopodia (Figure 21b) and at enhanced resolution along the length of the filopodia 
(Figure 21b, inset). Treatment with LPA also resulted in the localisation of wt-Src at the 
cell periphery (Figure 2Id), at the end of actin stress fibres (Figure 21e), while PDGF 
stimulation of cells expressing wt-Src resulted in its localisation to lamellipodia (Figure 
21f), where it co-localised with actin bundles (Figure 21g).
In this section we have shown that the peripheral localisation of Src251-GFP, a fusion 
protein that contains Src’s SH3 and SH2 domains but has no kinase domain, to focal 
adhesions, is dependent on RhoA-mediated assembly of actin stress fibres. Furthermore 
the Rho family proteins Racl and Cdc42 direct the precise intracellular targeting of Src to 
other functional structures such as lamellipodia and filopodia respectively. The data 
presented here on the targeting of endogenous and wild type Src implies that the control of 
Src251-GFP targeting is the same as for endogenous Src or the expression of wild type Src. 
This validates the use of Src251-GFP as a tool for following c-Src targeting within the cell.
4.2.3 Molecular or pharmacological inhibition of RhoA blocks Src targeting 
to focal adhesions.
Experiments in which cells expressing the Myc-tagged N19RhoA, proteins were detected 
using a Myc-tag antibody revealed that in all cases co-injection or co-transfection ol 
Src251-GFP and the Rho family proteins resulted in the expression of both proteins, thus
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allowing the use of the GFP tag to visualise the expressing cells by direct fluorescence. 
Cells were serum starved for 48 h to remove stress fibres (see Chapter 3 Section 3.2.1), 
prior to microinjection of a dominant negative RhoA protein (N19RhoA) and Src251-GFP. 
As described in Chapter 3, expression of N19RhoA prevented the reformation of stress 
fibres in response to serum. Co-expression of Src251-GFP with N19RhoA resulted in the 
inhibition of stress fibre assembly in response to serum as a result of N19RhoA expression 
(Figure 22b). The broken arrow shows a cell expressing N19RhoA, which is consequently 
devoid of actin stress fibres and in which Src251-GFP remained perinuclear (Figure 22a,c), 
while non-expressing cells have reformed stress fibres in response to serum (Figure 22b,c 
solid arrows). This was in contrast to Src’s location at peripheral focal adhesions in cells 
stimulated with serum in the absence of N19RhoA (Figure 22d,f), where it was found at 
the ends of stress fibres (Figure 22e,f broken arrows).
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Figure 20
Localisation of endogenous Src by RhoGTPases is indistinguishable from the targeting of 
Src251-GFP. Cells were placed in serum-free conditions overnight, which did not abolish 
stress fibres but acted to reduce the heterogeneity in the population following growth factor 
stimulation. These cells were then stimulated with LPA (200 ng m l1) for 30 min (a,b) or 
PDGF (25 ng m l'1) for 30 min (c,d) and endogenous Src visualised using the N2-17 Src 
antibody (a,c) and actin was visualised with rhodamine-phalloidin (b,d). Scale bars 25 pm.
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Figure 21
Localisation of wt-Src by RhoGTPases is indistinguishable from the targeting of Src251- 
GFP. Anti-Src western blot of lysates derived from Swiss 3T3 cells expressing wt-Src and 
vector alone (a). Cells were transfected with wt-Src and following expression of the protein 
were placed in serum-free conditions overnight (b-g). Cells were then stimulated with 
bradykinin (100 nM) for 5 min (b,c), LPA (200 ng m l'1) for 30 min (d,e) or PDGF (25 ng ml1) 
for 30 min (f,g). Exogenously expressed Src was visualised using the chicken specific Src 
EC10 antibody (b,d,f) and actin was visualised with rhodamine-phalloidin (c,e,g). Scale bars 
25 |im.
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Figure 22
Expression of dominant negative RhoA in cells blocks Src targeting to focal adhesions 
Cells were serum starved for 48 h to remove stress fibres prior to microinjection of Src251- 
GFP and N19RhoA (a-c) or microinjection of Src251-GFP alone (d-f). Following expression  
of the proteins, cells were then stimulated with 10% serum for 30 min (a-f). Broken arrows 
indicate microinjected cells while solid arrows are non-expressing cells. Actin was visualised  
with rhodamine-phalloidin (b,c,e,f). Src251-GFP was detected by direct fluorescence (a,c,d,f). 
Scale bars 25 pm.
Figure 22
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As described in Chapter 3 (see section 3.2.1), Y-27632 is a chemical inhibitor of Rho- 
kinase (Uehata et al., 1997), which is a downstream effector of RhoA implicated in stress 
fibre formation (Kimura et al., 1996; Leung et al., 1996). We have described in this study 
that treatment of cells with Y-27632 specifically block RhoA-induced stress fibre 
formation, while Racl and Cdc42-induced actin rearrangements were unaffected in the 
presence of the inhibitor. We therefore used Y-27632 to further establish whether Src’s 
peripheral targeting was a RhoA dependent process. Following transfection, cells were 
treated with Y-27632 prior to expression of Src251-GFP. Under these conditions the cells 
were devoid of stress fibres even though serum was present (Figure 23a) and translocation 
of Src251-GFP to peripheral focal adhesions in response to serum was blocked (Figure 
23b,c, broken arrow). As in cells expressing N19RhoA, Src251-GFP remained in the 
perinuclear region of the cell. Furthermore treatment of cells with Y-27632 prior to 
expression of Src251-GFP and LPA stimulation resulted in the loss of stress fibres (Figure 
23d) and consequently blocked the translocation of Src251-GFP to peripheral focal 
adhesions in response to LPA stimulation (Figure 23e,f). This was in direct contrast to its 
localisation at peripheral focal adhesions in cells stimulated with LPA alone (Figure 23g), 
where it is found at the tips of actin stress fibres (Figure 23h,i). In Chapter 3 (see Section 
3.3) it was suggested that Y-27632 may inhibit other kinases than ROCK. However, in the 
context of these experiments we have shown that treatment with Y-27632 blocks RhoA- 
induced stress fibres without effecting Racl or Cdc42 induced actin remodelling (see 
Chapter 3 Section 3.2.1). Moreover, this taken together with the ability of N19RhoA to 
block the translocation of Src251-GFP to focal adhesions leads to the conclusion that the 
actin-dependent localisation of Src251-GFP to focal adhesions is controlled by RhoA.
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Figure 23
The Rho-kinase inhibitor Y-27632 blocks RhoA-dependent targeting of Src to focal 
adhesions. Cells were transfected with Src251-GFP and prior to expression were incubatet 
with Y-27632 (10 pM). Cells were then stimulated with 10% serum for 30 min (a-c) or LPA 
(200 ng ml’1) for 30 min (d-f). Cells serum starved for 48 h were microinjected with Src251- 
GFP and were stimulated with LPA (200 ng mF1) for 30 min in the absence of Y-27632 (g-i). 
Broken arrows indicate expressing cells. Actin was visualised with rhodamine-phalloidin 
(a,c,d,f,g,i) and Src251-GFP was detected by direct fluorescence (b,c,e,f,h,i). Scale bars 25
Figure 23
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4.2.4 Co-ordinated regulation of the actin cytoskeleton by RhoGTPases 
controls the intracellular targeting of Src to lamellipodia.
There has previously been a great deal of evidence demonstrating cross-talk between Rho 
family GTPases (see Introduction Section 1.4.3). Work in Swiss 3T3 cells in particular has 
suggested that a hierarchical cascade exists between these proteins such that Cdc42 can 
activate Racl which in turn can activate RhoA (Hall, 1998; Nobes & Hall, 1995), while 
others have reported antagonistic behaviour between Rho-GTPases (Zondag et al., 2000) 
(Leeuwen et al., 1997; Rottner et al., 1999; Sander et al., 1998). The role of the individual 
RhoGTPases in the sub-cellular targeting of c-Src was therefore investigated.
We and others have previously shown that PDGF stimulates the formation of lamellipodia 
at the cell periphery (Fincham et al., 1996; Hall, 1998) via a Racl dependent mechanism 
(Nobes & Hall, 1995; Nobes et al., 1995; Ridley et al., 1992). We have also demonstrated 
that both endogenous Src, wt-Src and Src251-GFP localise to lamellipodia following 
treatment with PDGF (see Chapter 3). To address the relationship between RhoA and 
Racl signalling in the localisation of c-Src to lamellopodia, we stimulated cells with PDGF 
to activate Racl, while inhibiting the formation of stress fibres and RhoA activity, by 
treating the cells with Y-27632. Y-27632 was added to the cells prior to expression of 
Src251-GFP resulting in loss of stress fibres (Figure 24a). After stimulation with PDGF, 
Src251-GFP remained perinuclear (Figure 24b,c, broken arrows) and did not translocate to 
lamellipodia at the cell periphery, although the shape of the cell did change in response to 
PDGF to form lamellipodia (Figure 24a,c, solid arrows). Consistent with this, when we 
co-expressed constitutively active Racl (V12Racl) with Src251-GFP, in the presence of 
Y-27632 there was no relocalisation of Src from the perinuclear region (Figure 24e,f, 
broken arrows), although the transfected cells were still able to form lamellipodia (Figure 
25d,f solid arrows). However, if Y-27632 was washed out prior to stimulation with PDGF, 
hence allowing RhoA-induced stress fibres to re-form, Src251-GFP localised to 
lamellipodia (Figure 25a, solid arrows), where it co-localised with actin bundles at the 
leading edge of the cell (Figure 25b,c). This implies that RhoA activity is partially 
involved in targeting of Src from a perinuclear location to lamellipodia. To verify that the 
Rho kinase inhibitor Y-27632 had been removed after the washing procedure, cells were 
incubated with Y-27632, fixed and incubated with conjugated phalloidin before (Figure 
25d) or after washing cells with serum (Figure 25e). Cells after the washing procedure had 
reformed stress fibres in response to serum (Figure 25e) in contrast to cells in the presence 
of Y-27632 that remained devoid of stress fibres (Figure 25d).
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To further investigate the relationship between RhoA and Racl in c-Src localisation, we 
stimulated cells with PDGF while inhibiting Racl activity in the presence of serum (ie 
RhoA stimuli). As demonstrated in the previous chapter (see Section 3.2.1) expression of 
dominant negative Racl blocked the formation of actin bundling and lamellipodia in 
response to PDGF. Co-expression of Src251-GFP with dominant negative N17Racl 
therefore blocked the formation of lamellipodia in response to PDGF (Figure 26a,b). No 
lamellipodia were formed in cells expressing N17Racl, (Figure 26a,b broken arrow as 
compared to the non-transfected cells, solid arrows). Although cells expressing N17Racl 
did not form lamellipodia, these cells still contained actin stress fibres (due to the presence 
of serum) and Src251-GFP was consequently located at the ends of these stress fibres in 
peripheral focal adhesions (Figure 26c, broken arrow). Thus Racl drives the targeting of 
c-Src to lamellipodia, but is not involved in the initial movement of c-Src from the cell 
interior to the cell periphery, which is mediated by RhoA-dependent formation of stress 
fibres.
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Figure 24
Addition of the Rho-kinase inhibitor Y-27632, prior to PDGF stimulation or Racl 
expression impairs stress fibre formation and retains Src251-GFP in a perinuclear 
location during lamellipodia formation. Cells were transfected with Src251-GFP an d  prior 
to expression of the protein were treated overnight with Y-27632 to abolish stress fibres. The 
cells were then stimulated with PDGF (25 ng m l'1) for 30 min (a-c). Cells were co -tr a n s fe c te d  
with Src251-GFP and L61Rac and prior to expression of the proteins were treated overnight 
with Y-27632 to abolish stress fibres (d-f). Solid arrows indicate the localisation of 
lamellipodia while the broken arrows show the perinuclear localisation of Src251-GFP. A ctin  
was visualised with rhodamine-phalloidin (a,c,d,f) and Src251-GFP was detected by d irec t 
fluorescence (b,c,e,f). Scale bars 25 pirn.
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Figure 25
Removal of the inhibitory effect of Y-27632 allows stress fibre re-formation and PDGF 
induced targeting of Src to lamellipodia. Cells were transfected with Src251-GFP and prior 
to expression of the protein were treated overnight with Y-27632 to abolish stress fibres. The 
cells were then stimulated with PDGF (25 ng ml"1) for 30 min following wash out of the Rho- 
kinase inhibitor Y-27632 (a-c). Cells were treated with Y-27632 fixed and incubated w ith 
conjugated phalloidin before (d) or after (e) removal of Y-27632 by washing the cells w ith 
serum containing medium. Arrows indicate Src251-GFP co-localising with actin in 
lamellipodia. Actin was visualised with rhodamine-phalloidin (b-e) and Src251-G FP  w as 
detected by direct fluorescence (a,c). Scale bars 25 pirn.
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Figure 26
Inhibition of R acl blocks the formation and targeting of Src to lamellipodia but has no 
effect on Src’s peripheral targeting from a perinuclear location to focal adhesions. Cells
in the presence of serum were co-transfected with Src251-GFP and N17Rac and then 
stimulated with PDGF (25 ng mF1) for 30 min. Solid arrows show the localisation of 
lamellipodia in non-transfected cells, while the broken arrow shows a cell expressing N 1 7 R a c  
and Src251-GFP. Actin was visualised with rhodamine-phalloidin (b,c). Src251-GFP was 
detected by direct fluorescence (a,c). Scale bars 25 pm.
Figure 26
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4.2.5 Co-ordinated regulation of actin cytoskeleton by RhoGTPases 
controls the intracellular targeting of Src to filopodia.
Based on work from the previous section we carried out similar experiments to define the 
relationship between RhoA and Cdc42. As discussed earlier bradykinin stimulates the 
formation of actin microspikes, known as filopodia, at the cell periphery, by a Cdc42- 
mediated pathway (Kozma et al., 1995; Nobes & Hall, 1995). Addition of bradykinin to 
Y-27632 treated cells resulted in the formation of filopodia seen as small actin microspikes 
(Figure 27a, solid arrows) or vinculin containing focal complexes protruding from the cell 
body (Figure 27d, solid arrows). Under these conditions Src251-GFP remained 
perinuclear (Figure 27b,c and e,f, broken arrows). Similarly, when we co-expressed 
constitutively active Cdc42 (V12Cdc42) with Src251-GFP, in the presence of Y-27632 
there was no relocalisation of Src from the perinuclear region (Figure 28a,c and d,f, broken 
arrows), although the transfected cells were still able to form filopodia (Figure 28b,e). 
Broken arrows show perinuclear Src localisation and solid arrows show actin containing 
filopodia. However, as shown previously for PDGF, removal of Y-27632 prior to addition 
of bradykinin, which allows stress fibres to re-form (Figure 25d,e), resulted in the 
translocation of Src251-GFP to filopodia in response to bradykinin (Figure 29, solid 
arrows). This implies that RhoA activity, at least in part is also involved in the targeting of 
Src from a perinuclear location to filopodia.
To further investigate the role of RhoA and Cdc42 in c-Src localisation we stimulated cells 
with bradykinin while inhibiting Cdc42 activity in the presence of serum (ie. RhoA 
stimuli). Again as described in Chapter 3 (Section 3.2.1) the expression of a dominant 
negative Cdc42 protein (N17Cdc42) blocked the formation of filopodia in response to 
bradykinin. The co-expression of Src251-GFP with dominant negative Cdc42 protein 
(N17Cdc42) therefore blocked bradykinin induced filopodia formation (Figure 30a-c, for 
actin co-staining and Figure 30d-f, for vinculin co-staining). Compare expressing cells in 
both cases (broken arrows) to non-expressing cells (solid arrows) that were able to induce 
filopodia in response to bradykinin. Furthermore, co-expression of Src251-GFP with 
N17Cdc42, blocked bradykinin-induced translocation of Src to filopodia, however Src251- 
GFP was not retained in the perinuclear region but was present in peripheral focal 
adhesions under these conditions (due to the presence of serum) (Figure 30c,f broken 
arrows). Thus, the RhoA pathway is also required to target Src from the perinuclear region 
of the cell periphery, prior to its localisation to filopodia induced by Cdc42.
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It is interesting that inhibition of Src251-GFP targeting to PDGF-induced lamellipodia or 
bradykinin-induced filopodia by N17Racl or N17Cdc42 respectively, did not result in Src 
being retained or ‘returned’ to the perinuclear region; instead Src251-GFP remained able to 
target to the cell periphery, specifically residing in focal adhesions, presumably because 
RhoA is active in the presence of serum. Thus, although dominant-negative Racl or 
Cdc42 proteins inhibit the translocation of Src to lamellipodia or filopodia respectively, 
these do not interfere with the RhoA-dependent transit from the cell interior to the cell 
periphery.
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Figure 27
Addition of the Rho-kinase inhibitor Y-27632, prior to bradykinin stimulation impairs 
stress fibre formation and retains Src251-GFP in a perinuclear location during filopodia 
formation. Cells were transfected with Src251-GFP and prior to expression of the protein 
were treated overnight with Y-27632 to abolish stress fibres. The cells were then stimulated 
with bradykinin (100 nM) for 5 min. Solid arrows indicate the localisation of filopodia whih 
the broken arrows show the perinuclear localisation of Src251-GFP. Actin was visualised with 
rhodamine-phalloidin (a,c) and vinculin was visualised using an anti-viculin antibody (d$ 
Src251-GFP was detected by direct fluorescence (b,c,e,f). Scale bars 25 pirn.
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Figure 28
Addition of the Rho-kinase inhibitor Y-27632, prior to Cdc42 expression impairs stress 
fibre formation and retains Src251-GFP in a perinuclear location during filopodia 
formation. Cells were co-transfected with Src251-GFP and V12Cdc42 and prior to expression 
of the proteins were treated overnight with Y-27632 to abolish stress fibres. Solid arrows 
indicate the localisation of filopodia while the broken arrows show the perinuclear loca lisa tio n  
of Src251-GFP. Actin was visualised with rhodamine-phalloidin (b,c) and v i n c u l i n  was 
visualised using an anti-vinculin antibody (d,f). Src251-GFP was detected b y  direi 
fluorescence (a,c,d,f). Scale bars 25 pm.
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Figure 29
Removal ot the inhibitory effects of Y-27632 allows stress fibre re-formation and 
bradykinin induced targeting of Src to filopodia. Cells were transfected with S r c 251-GFP
and prior to expression of the protein were treated overnight with Y-27632 to abolish stress 
fibres. The cells were then stimulated with bradykinin (100 nM) for 5 min following w ashout 
of the Rho-kinase inhibitor Y-27632. Arrows indicate filopodia and Src251-GFP localisation. 
Actin was visualised with rhodamine-phalloidin (b,c). Src251-GFP was detected b y  direct | 
fluorescence (a,c). Scale bars 25 pm.
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Figure 30
Inhibition of Cdc42 blocks the formation and targeting of Src to filopodia but has no 
effect on Src’s peripheral targeting from a perinuclear location to focal adhesions. Cells
in the presence of serum were co-transfected with Src251-GFP and N17Cdc42 and then 
stimulated with bradykinin (100 nM) for 5 min. The broken arrows indicate transfected cells, 
while filopodia in non-expressing cells are shown by the solid arrows. Vinculin was v is u a l is e d  
using an anti-vinculin antibody (e,f). Actin was visualised with rhodamine-phalloidin (b,c) and 
Src251-GFP was detected by direct fluorescence (a,c,d,f). Scale bars 25 pm.
Figure 30
bradykinin
N17Cdc42 + Src251-GFP Actin MergeH|
Src251-GFP
bradykinin
N 17Cdc42 + Src251 -GFP Vinculin Merge
Src251 -GFP
I
chapter 4
4.3 Discussion.
We have demonstrated that an inhibitor of Rho-kinase, as well as N19RhoA, inhibit the re­
localisation of Src251-GFP to focal adhesions, indicating the requirement for RhoA, its 
effector Rho-kinase and actin filaments in the peripheral targeting of c-Src. Moreover v- 
Src targeting to focal adhesions in Swiss 3T3 cells has been shown to require RhoA 
activity (Fincham et al., 1996). In keeping with the requirement for bundled actin stress 
fibres, the translocation of v-Src to focal adhesions has also been shown to require myosin 
activity, at least when the actin cytoskeleton is being dynamically regulated (Fincham et 
al., 2000). As well as RhoA-induced targeting of Src to focal adhesions, the Rho family 
proteins Racl and Cdc42 direct the precise intracellular targeting of Src to other functional 
structures such as lamellipodia and filopodia respectively. It is clear then that RhoGTPases 
play a pivotal role in the spatial regulation of Src and it is therefore possible that they 
regulate Src’s activity within the cell. As stated earlier (see Introduction Section 1.5.3 and
1.6.1), both RhoGTPases and Src have been implicated to be involved in regulating cell 
migration. RhoGTPases in particular have been thought to contribute to cell motility and 
polarisation by controlling cell contraction and protrusion, while Src is thought to be 
involved in focal adhesion turnover. In this study we highlight an additional method of 
how RhoGTPases can contribute to directional cell migration by spatially controlling Src 
activity during this process. RhoGTPase-induced actin structures could serve as tracks, 
directing Src, and for that matter other proteins reported to be involved in cell migration, 
towards adhesion sites, providing both, scaffolding proteins for the formation of adhesions 
as well as inducing adhesion turnover. A similar hypothesis has been proposed for the 
involvement of the microtubule network during cell migration (Kaverina et al., 1998; Nabi, 
1999). The co-ordination of Src activity and RhoGTPase-induced targeting of Src during 
cell migration and polarisation will be addressed and discussed in more detail in the next 
chapter.
One potential problem of over-expressing Src251-GFP to monitor c-Src localisation within 
the cell is that access to the SH3/SH2 domains of Src, which are conformationally 
unrestrained in Src251-GFP, may be acting as an adaptor protein non-specifically 
sequestering various binding partners and allowing its recruitment into the respective 
structures described. The data presented in this study however on the targeting ol 
endogenous and wild type Src implies that the control of Src251-GFP targeting is the same 
as for endogenous Src or the expression of wild type Src, helping to verify the use of 
Src251-GFP to monitor c-Src targeting within the cell. As yet little is known of the
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mechanism involved in the transport of Src from the perinuclear region to the cell 
periphery. We, and others, have demonstrated that it is not dependent on the catalytic 
activity of c-Src but does require the Src SH3 domain (Fincham et al., 2000; Fincham & 
Frame, 1998; Kaplan et al., 1994). In vitro experiments have demonstrated that the Src 
SH3 domain binds to a number of cellular partners and we have shown that the regulatory 
sub-unit of PI3-kinase is amongst the cellular targets of the v-Src SH3 domain that is 
important for its peripheral targeting (Fincham et al., 2000). Although we have shown that 
the catalytic activity of Src is not required for its localisation to peripheral adhesion sites, a 
number of stimuli which result in translocation of Src to these sites have also been reported 
to activate Src kinase activity (eg. LPA, PDGF and bradykinin) (Jalink et al., 1993; 
Rodriguez-Fernandez & Rozengurt, 1996). It seems likely therefore that these stimuli 
release constraints on both the kinase domain and the SH3 domain of c-Src thus ensuring 
that the activated protein is not aberrantly localised within the cell.
Although Src251-GFP was found in lamellipodia or filopodia following activation of Racl 
or Cdc42 respectively, data presented here using dominant negative RhoGTPases, 
surprisingly, indicate that the precise localisation of Src to these structures is not simply 
regulated by the individual RhoGTPase responsible for these actin based structures, but 
that co-ordination between Rho family members is required for this precise targeting of c- 
Src to these sites.
Firstly, PDGF- and Racl-induced targeting of Src251-GFP to lamellipodia, is inhibited by 
treatment with the Rho-kinase inhibitor, Y-27632. In this case, Src251-GFP is held in the 
perinuclear region of the cell and is unable to move to the cell periphery. Moreover, 
although formation of PDGF-induced lamellipodia, as well as the targeting of Src251-GFP 
to these sites, is blocked by dominant inhibitory Racl, Src251-GFP is still able to 
translocate from the perinuclear region of the cell to focal adhesions, presumably mediated 
by RhoA that is unaffected by N17Racl. This suggests that Src251-GFP translocates from 
the perinuclear region of the cell to the cell periphery via stress fibres to focal adhesions, 
and when Racl is stimulated, subsequently moves to much smaller focal complexes in 
lamellipodia (see Figure 31). Similarly, bradykinin- and Cdc42-induced targeting of 
Src251-GFP to filopodia, are also inhibited by treatment with the Rho-kinase inhibitor. 
Again, Src251-GFP is held in the perinuclear region of the cell and is unable to move to 
the cell periphery. Furthermore, although formation of bradykinin-induced filopodia, as 
well as the targeting of Src251-GFP to these sites, is blocked by dominant inhibitory 
Cdc42, Src251-GFP is still able to translocate from the perinuclear region of the cell to 
focal adhesions, which is mediated by RhoA and unaffected by N17Cdc42. Together these
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data suggest that Src251-GFP translocates from the perinuclear region of the cell to focal 
adhesions via stress fibres, and when appropriate stimuli is received, subsequently moves 
to much smaller focal complexes such as filopodia (see Figure 32). The activation of Racl 
has been reported to initiate the turnover and remodelling of existing focal adhesions into 
smaller focal complexes during lamellipodia formation (Laukaitis et al., 2001). This 
process has been shown for example, using GFP tagged paxillin to visualise the process in 
real time. In particular, when new lamellipodia protrusions form paxillin appears to 
remodel from older focal adhesions to new focal complexes at the leading edge of the cell. 
(Laukaitis et al., 2001; Small et al., 1995; Small et al., 1999). It is therefore possible that 
upon localisation of Src in focal adhesions, Racl can subsequently induce focal adhesion 
remodelling to form small focal complexes allowing Src to then relocate from focal 
adhesions to uniformly distributed focal complexes along the base of lamellipodia (Figure 
33). A similar mechanism can therefore be proposed for Src targeting to filopodia (Figure 
33). The involvement of Src kinase activity in the focal adhesions to focal complex 
transition is examined and discussed in detail in the next chapter.
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Figure 31
Schematic representation of the co-ordinated actin remodelling proposed to be in v o lv e d  
in Src’s sequential targeting from the perinuclear region of the cell to lamellipodia. Src
initially translocates form a perinuclear location to the cell periphery at focal adhesions via 
RhoA and following Racl stimulation subsequently moves to focal complexes in la m e l lip o d ia .
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Figure 32
Schematic representation of the co-ordinated actin remodelling proposed to be in v o lv e d ]  
in Src’s sequential targeting from the perinuclear region of the cell to filopodia. Src1
initially translocates form a perinuclear location to the cell periphery at focal adhesions via 
RhoA and following Cdc42 stimulation subsequently moves to focal complexes in filopodia.
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Figure 33
Schematic representation of Src’s sequential targeting from the perinuclear region o f  the 
cell to lamellipodia or filopodia.
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It should be noted that in these sequential stimuli experiments, RhoA activity was blocked 
to examine whether RhoA was involved in this process. Serum starvation of cells for 48 h 
to cause the loss of RhoA activity, and thereby stress fibres, was not a viable approach 
because expression of Racl or Cdc42 could potentially lead to RhoA activation via the 
hierarchical cascade described earlier (Hall, 1998; Nobes & Hall, 1995; Ridley & Hall, 1992; 
Ridley et al., 1992). This could have led to a misinterpretation of the role RhoA activity 
plays in this process. Thus, the reversible Rho-kinase inhibitor Y-27632, was used here to 
block RhoA-induced stress fibres, which allows rapid inactivation of RhoA, while leaving 
the option to relieve this inhibitory effect using the washing out procedure outlined earlier.
Various reports have demonstrated cross-talk to exist between Rho family members in a 
number of processes. In particular, the hierarchical cascade in Swiss 3T3 cells along with 
the proposed involvement of this cascade in macrophage migration, provides one example 
for potential cross-talk between RhoGTPases during cell migration such that Cdc42 is 
required for cells to polarise and migrate in the direction of a chemotatic gradient, while 
RhoA and Racl are required for cell migration (Allen et al., 1997). Moreover, antagonistic 
behaviour between RhoGTPases has frequently been reported and is thought to be 
responsible for neurite retraction or collapse as well as protrusion in neuroblastomas cell 
(Kozma et al., 1997). Co-operation or convergence of RhoGTPase activity has also been 
shown during cadherin mediated cell-cell junction formation (Braga et al., 1997), where 
both RhoA and Racl are required for the establishment of cadherin mediated cell-cell 
junctions, illustrating the importance of Rho family cross-talk in a number of celiular 
processes. Here we illustrate a new role of RhoGTPases in directing Src to 
morphologically functional structures and also report a novel co-operative role for 
RhoGTPases in this targeting process.
4.4 Summary
We have demonstrated that Src251-GFP is found in lamellipodia or filopodia following 
activation of the RhoGTPases Racl and Cdc42 respectively. Moreover data presented in 
this chapter indicates that the precise localisation of Src to these sites is not regulated by 
individual RhoGTPases, but that co-ordination between Rho family members is required 
for this targeting process. Both lamellipodia and lilopodia have been documented to be 
transient structures in which the actin cytoskeleton and adhesion contacts are rapidly 
remodelling and turning over. In the next chapter we assess whether Src plays a passive or 
active role in this remodelling process.
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5 Src kinase activity participates in the efficient 
remodelling of focal adhesions to focal 
com p lexes during lamellipodia and filopodia 
formation.
5.1 Purpose
We have shown that c-Src can localise to focal adhesions, lamellipodia and filopodia at the 
cell periphery. Lamellipodia and filopodia contain focal complexes within their structures, 
which have been defined as small adhesion structures of indistinguishable protein 
composition from larger focal adhesions as previously discussed (Nobes et al., 1995). It is 
the dynamic remodelling and interchange between focal adhesions and focal complexes 
that regulate cell motility. In this chapter, we therefore addressed whether the activity of c- 
Src at these cellular adhesions altered their remodelling and establish the influence this has 
on cellular processes such as cell migration and chemotaxis. Src kinase activity has 
frequently been linked to focal adhesions turnover (Fincham & Frame, 1998) and cell 
motility (Hall et al., 1996). We therefore tested the hypothesis that Src kinase activity is 
required for the dynamic remodelling of focal adhesions and focal complexes during cell 
migration.
5.2 Results
In this study, we introduced constitutively active- and inactive-Src mutants into cells to 
establish the importance of Src kinase activity during adhesion remodelling. Cells were 
transfected with the respective Src mutants and maintained in serum (ie. a RhoA stimuli) to 
localise Src to focal adhesions. Cells were subsequently incubated with the protein 
synthesis inhibitor emetine prior to PDGF or bradykinin treatment. This protocol allowed 
us to focus on ‘focal adhesions to focal complex’ remodelling events during lamellipodia 
or filopodia formation and address the role Src kinase activity plays in this process.
5.2.1 Src251-GFP interferes with the efficient formation of uniform 
lamellipodia
To address whether Src kinase activity plays a role in adhesion remodelling, Swiss 3T3 
cells were transfected with Src251-GFP in the presence of serum (Figure 34a). Under
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these conditions the kinase null Src251-GFP was localised to focal adhesions (Figure 34a) 
Subsequent treatment of these cells with PDGF, which leads to Racl activation, resulted in 
PDGF-induced shape changes and formation of lamellipodia. Although expression of 
Src251-GFP at focal adhesions did not significantly alter the number of cells able to form 
lamellipodia (around 80% of cells expressing Src251-GFP underwent shape changes 
associated with the formation of lamellipodia), we found that under these conditions the 
actin localised to discrete patches around the forming lamellopodia (Figure 34b, broken 
arrow). Src251-GFP also re-located to the forming lamellipodia, but remained in the same 
discrete patches or adhesion-like structures around the edge of the lamellipodia (Figure 
34c, broken arrow). Furthermore, the discontinuous actin staining in cells expressing 
Src251-GFP indicated that the lamellipodia were less uniform than in cells not expressing 
Src251-GFP (compare the solid arrow, which indicates a cell not expressing Src251-GFP, 
with the Src251-GFP expressing cell shown by the broken arrow in Figure 34b). This is in 
contrast to the uniform lamellipodia formed when Src251-GFP is held in the perinuclear 
region of the cell following treatment with Y-27632 (Figure 34d), prior to stimulation with 
PDGF (Figure 34e,f), where Src251-GFP is found in small structures continuous along the 
lamellipodia. As described above, cells were incubated with the protein synthesis inhibitor 
emetine prior to PDGF treatment in these experiments, implying that Racl activation led to 
re-localisation of Src that pre-existed in focal adhesions into complexes that are continuous 
along lamellipodia. This suggests that it is the presence of Src251-GFP at focal adhesions 
prior to addition of PDGF that interferes with the efficient formation of uniform 
lamellipodia.
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Figure 34
Src kinase activity at focal adhesions is required for remodelling of the actin cy to sk e le to n  I  
during lamellipodia formation. Cells were transfected with Src251-GFP and m a in ta in e d  in I  
10% serum containing medium (a). Cells were then placed in serum-free medium overnighi ■ 
and treated with the protein synthesis inhibitor emetine (55 |ig m l'1) for 30 min p r i o r  to |  
stimulation with PDGF (25 ng m l'1) for 30 min (b,c). This protocol allowed us to reduce the 
heterogeneity in the population following PDGF stimulation by removing the serum, whili ■  
maintaining Src251-GFP in the peripheral focal adhesions due to the incomplete loss of stress I 
fibres after this short time in serum-free conditions. Cells were transfected with Src251-OH 
and prior to expression of the protein were treated overnight with Y-27632 to a b o l i s h  strev ■  
fibres (d). The cells were then stimulated with PDGF (25 ng ml'1) for 30 min f o l lo w in g  wa> |  
out of the Rho-kinase inhibitor Y-27632 (e,f). Broken arrows indicate Src251-GFP e x p r e s s i n g  
cells while solid arrow indicate non-expressing cell. Actin was visualised with rhodami^ 
phalloidin (a,b,d,e). Src251-GFP was detected by direct fluorescence (a,c,d,f). Scale bar" - 
urn.
>Actin
PDGF
Src251 -GFP
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5.2.2 Src mutants used as tools to determine the role Src kinase activity 
plays in adhesion remodelling.
Since Src251-GFP lacks a c-Src kinase domain (see Figure 35a), we examined whether the 
presence of an activated c-Src kinase at focal adhesions facilitated the Raci-dependent 
formation of uniform, continuous lamellipodia. For this, we expressed a c-Src protein 
(Figure 35b), which has an activating tyrosine to phenylalanine mutation at position 527 in 
the c-Src coding sequence (SrcY527F) (Thomas & Brugge, 1997). We also expressed a 
kinase-defective Src mutant, SrcMF in cells, and examined the ability of these cells to form 
lamellipodia in response to PDGF. SrcMF has a point mutation in the kinase domain 
(K295M) (Figure 35c), rendering it kinase inactive. SrcMF also has the Y527F mutation 
in the regulatory carboxy-terminal region that results in an open confirmation with the SH2 
and SH3 domains available for protein-protein interactions (Figure 35c). As described in 
Section 1.1.3 autophopsphorylation on tyrosine-416 is required for full activation of Src 
kinase family members (Gonfloni et al., 2000). In these experiments we therefore used 
autophosphorylation on tyrosine-416 as a surrogate marker of Src kinase activity. Direct 
comparisons between phosphorylation of tyrosine-416 and Src kinase activity have verified 
the use of this site to reflect the biological changes in Src kinase activity within the cell 
(Chen et al., 2000; Hanke et al., 1996; Yoshizumi et al., 2000). Cells lysates expressing 
the respective Src constructs SrcY527F, SrcMF or Src251-GFP were probed with a 
phospho-Src-416 antibody (Figure 35d). Cells expressing SrcY527F demonstrated an 
enhanced autophosphorylation on tyrosine-416 compared to kinase null (Src251-GFP) or 
kinase defective (SrcMF) expressing cells, thereby confirming, as expected, their relative 
activity within the cell (Figure 35d). Initially, we characterised the behaviour of 
constitutively active SrcY527F in cells as previously described for Src251-GFP (see 
Chapter 3). When SrcY527F was microinjected into serum-starved Swiss 3T3 fibroblasts 
it was located in the perinuclear region of the cell (Figure 36a,c broken arrows). However, 
upon addition of serum, which resulted in reformation of stress fibres (Figure 36d-f), 
SrcY527F translocated to sites at the end of the actin cables (Figure 36d,f), where it co­
localised with the focal adhesion protein paxillin (Figure 36g-i). SrcMFs intracellular 
targeting to focal adhesions was also characterised. SrcMF, like Src251-GFP and 
SrcY527F remained perinuclear when microinjected into serum starved Swiss j T3 cells 
(Figure 37a,c, broken arrow). Upon serum stimulation it localised to focal adhesions 
(Figure 37d-f), where it co-localised with the focal adhesion protein paxillin (Figure 37g-i). 
Anti-paxillin staining was used for co-localisation studies with anti-SrcY527F or SrcMF 
because anti-vinculin and anti-Src sera used were from the same species, restricting co-
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localisation studies. Thus the actin-dependent translocation of SrcY527F or SrcMF is the 
same as for Src251-GFP (see Chapter 3).
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c-Src constructs. Schematic representation of the structural domains of Src251-G FP (all 
SrcY527F and SrcMF (b). Anti-phospho-Src-Y416 western blot of cell extracts from non-B 
transfected cells (lane 1), Src251-GFP (lane 2), SrcMF (lane 3) or SrcY527F (lane 4). The 
same blot was re-probed with anti-Src antibody (bottom panel).
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Figure 36
Translocation of SrcY527F to focal adhesions is indistinguishable from Src251-GFP
Cells were serum starved for 48 h to remove stress fibres prior to microinjection of SrcY52 F 
(a-c). Serum-starved cells were microinjected with SrcY527F and following expression of the 
protein were stimulated with 10% serum for 30 min (d-i). SrcY527F was visualised u s i n g  an 
anti-Src antibody (a,c,d,f,g,i). Arrows indicate perinuclear SrcY527F. Actin was v i s u a l i s e d  
with rhodamine-phalloidin (b,c,e,f). Paxillin was visualised with rhodamine-conjugated anti- 
paxillin (h,i). Scale bars 25 pm.
Figure 36
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Figure 37
I ranslocation of SrcMF to focal adhesions is indistinguishable from Src251-GFP. Cells!
were serum starved to remove stress fibres prior to microinjection of SrcMF (a-c). Serum-1 
starved cells were microinjec.ed with SrcMF and following expression of the protein w erl 
stimulated with 10% serum for 30 min (d-i). SrcMF was visualised using an anti-Src antibodvl 
(a,c,d,f,g,i). Arrows indicate perinuclear SrcMF. Actin was visualised with rhodaminc-l 
phalloidtn (b,c,e,f). Paxillin was visualised with rhodamine-conjugated anti-paxillin (h.ill 
Scale bars 25 (im.
r
Figure 37
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5.2.3 c-Src kinase activity is required for complete remodelling of the actin 
cytoskeleton during lamellipodia formation.
SrcY527F was localised to focal adhesions in the presence of serum (Figure 38a), as for 
Src251-GFP (Figure 34a). Following treatment with PDGF, SrcY527F was re-located 
from focal adhesions to lamellipodia that appeared continuous and relatively uniform 
(Figure 38c, broken arrows), in contrast to the discontinuous structures formed in cells 
expressing Src251-GFP (Figure 34c, broken arrow). This implies that the efficient re­
location of c-Src from RhoA-induced focal adhesions into Raci-induced structures along 
lamellipodia requires Src’s catalytic activity. To test whether a chemical inhibitor of c-Src 
kinase activity had a similar effect to Src251-GFP expression on PDGF/Racl-induced 
lamellipodia formation, we treated cells expressing SrcY527F with the Src kinase inhibitor 
PP2 (Hanke et al., 1996) at a concentration that inhibits autophosphorylation of c-Src on 
tyrosine-416 (Figure 38g). Under these conditions, SrcY527F was found in focal 
adhesions in the presence of serum (Figure 38d). However, upon PDGF stimulation, 
lamellipodia formation was fragmented (Figure 38e) and the re-localisation of c-Src from 
focal adhesions was to discrete larger complexes along the cell periphery (Figure 38f, 
broken arrow). At an enhanced resolution (Figure 38h), the edge of lamellipodia in cells 
expressing Src251-GFP, SrcY527F + PP2 or SrcY527F alone emphasises the requirement 
of Src kinase activity to induce uniform lamellipodia. This effect of a kinase inhibitor, 
which blocks c-Src activity, supports the interpretation that expression of Src251-GFP 
inhibited complete Racl-induced actin and adhesion remodelling due to its lack of kinase 
activity.
However, as PP2 is known to inhibit other kinases (see Discussion Section 5.3), we also 
expressed a kinase-defective Src mutant, SrcMF in the cells and examined the ability of 
these cells to form lamellipodia in response to PDGF. As described for Src251-GFP and 
SrcY527F, SrcMF was targeted to focal adhesions in the presence of serum (Figure 39a). 
Subsequent stimulation of these cells with PDGF resulted in the relocalisation of SrcMF to 
discrete patches around the edge of the forming lamellipodia (Figure 39b) rather than to 
continuous lamellipodia as seen in cells expressing the activated Src protein (Figure 38c). 
These discrete structures along the lamellipodia were similar to those found in cells treated 
with the kinase inhibitor PP2 or in cells expressing the Src251-GFP protein which lacks the 
kinase domain (Figure 38f and Figure 34c respectively). Magnification of the edge of the 
lamellipodia in SrcMF and activated Src expressing cells (Figure 39c) shows more clearly 
the impaired lamellipodia formation in cells expressing kinase detecti\e SrcMF. This data
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implies that, like the presence of kinase null Src251-GFP in focal adhesions, it is the 
presence of kinase defective Src at focal adhesions prior to PDGF-induced lamellipodia 
formation that interferes with the efficient formation of uniform lamellipodia.
5.2.4 c-Src kinase activity is required for remodelling of focal adhesions 
during lamellipodia formation.
To demonstrate that the discontinuous lamellipodia found in Src251-GFP expressing cells 
was associated with impaired focal adhesion re-modelling into focal complexes we 
compared Racl-induced peripheral adhesion re-modelling in cells expressing Src251-GFP 
with cells expressing the activated c-Src mutant, SrcY527F, monitoring adhesion 
complexes by staining with anti-vinculin or anti-paxillin, where appropriate (see Section
5.2.2). Anti-vinculin and anti-paxillin staining were indistinguishable, and in cells treated 
with PDGF we observed small vinculin- and paxillin-containing complexes around the 
base of lamellipodia (Figure 40a and d respectively). In cells expressing Src251-GFP, 
treatment with PDGF induced the co-localisation of Src251-GFP with vinculin at the cell 
periphery but was located in large discrete structures along the length of the lamellipodia 
(Figure 40b,c). In contrast, in activated SrcY527F-expressing cells, c-Src co-localised 
with paxillin along the base of uniform lamellipodia following lamellipodia stimulation 
(Figure 40e,f).
Figure 38
Src kinase activity is required for remodelling of the actin cytoskeleton durinsl
lamellipodia formation. Cells were transfected with SrcY527F and maintained in 10% serum I 
containing medium (a). Cells were then placed in serum-free medium overnight and treated I 
with the protein synthesis inhibitor emetine (55 pg ml'1) for 30 min prior to stimulation wit" I 
PDGF (25 ng m l'1) for 30 min (b,c). This protocol allowed us to reduce the heterogeneity in 
the population following PDGF stimulation by removing the serum, while m a i n t a i n i n g !  
SrcY527F in the peripheral focal adhesions due to the incomplete loss of stress fibres after this■ 
short time in serum-free conditions. Cells expressing SrcY527F were pre-treated with the Sal 
kinase inhibitor PP2 (5 pM) for 3 h prior to stimulation with PDGF using the same protocol a* 
outlined above (e,f). Anti- phospho-Src-Y416 western blot of cell extracts from SrcY52-F 
expressing cells in the absence (lane 1) or presence (lane 2) of PP2 (5 pM) for 3 h (top pa^ 
The same blot was re-probed with anti-Src antibody (bottom panel) (g). High resolution ima?11 
of cells expressing Src251-GFP, SrcY527F and SrcY527F + PP2 following stimulation 
PDGF (h). Actin was visualised with rhodamine-phalloidin (a,b,d,e) and SrcY527F using J 
anti-Src antibody (a,c,d,f). Scale bars 25 pm. !
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Figure 39
SrcMF expression in focal adhesion prior to PDGF stimulation inhibits actin c y to s k e le ta l  
remodelling during lamellipodia formation. Cells were transfected with SrcMF and 
maintained in 10% serum containing medium (a). Cells were then or placed in s e r u m - f r e e  
medium overnight and treated with the protein synthesis inhibitor emetine (55 pg ml’1) for 31) 
min prior to stimulation with PDGF (25 ng m l'1) for 30 min (b). High resolution image o f  the 
edge of the lamellipodia in cells expressing SrcMF and SrcY527F (c). SrcMF was v i s u a l i s e d  
using an anti-Src antibody (a,b). Arows indicate SrcMF or SrcY527F localisation. Actin was 
visualised with rhodamine-phalloidin (a,c). Scale bars 25 pm.
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Figure 40
Src kinase activity is required for the disassembly of focal adhesions during lamellipodia 
formation. Cells were grown in serum-free conditions overnight prior to stimulation with 
PDGF (25 ng ml ') for 30 min and stained with anti-vinculin (a) or rhodamine conjugated anti- 
paxillin antibodies (d). Cells transfected with Src251-GFP (b,c), or SrcY527F (e,f) were 
placed in serum-free medium overnight and then treated with the protein synthesis inh ib i to r  
emetine (55 jag m l1) for 30 min prior to stimulation with PDGF (25 ng m l'1) for 3 0  min 
(b,c,e,f). This protocol allowed us to reduce the heterogeneity in the cells following grow th 
factor stimulation while maintaining the Src proteins in the focal adhesions p r i o r  to 
stimulation. SrcY527F and vinculin were visualised by anti-Src (f) and anti-vinculin (b) 
antibodies respectively. Paxillin was visualised with rhodamine-conjugated anti-paxillin O' 
and Src251-GFP by direct immunofluoresence (c). Scale bars 25 i^m.
Figure 40
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5.2.5 c-Src kinase activity is also required for complete remodelling of the 
actin cytoskeleton and focal adhesions during filopodia formation.
Similar to the observations with PDGF, we found that bradykinin-induced focal adhesion 
remodelling to produce filopodia was impaired in Src251-GFP-expressing cells. If cells 
expressing SrcY527F or Src251-GFP were grown in serum, thus allowing their localisation 
to focal adhesions and subsequently treated with bradykinin, SrcY527F localised to small 
actin containing filopodia that were uniformly distributed around the cell body (Figure 
41a-c, soild arrows). In contrast, in Src251-GFP expressing cells, Src251-GFP was found 
in large discrete complexes (Figure 41d-f, broken arrows) at the base of filopodia (Figure 
41d-f, solid arrows). At high resolution (Figure 41g) the edge of filopodia in cells 
expressing kinase-null Src251-GFP and kinase active SrcY527F emphasises the 
requirement of Src kinase activity for efficient filopodia formation and Src targeting to 
these structures. This effect of Src251-GFP supports the interpretation, as previously 
discussed for lamellipodia, that the kinase activity of Src is required for the complete 
remodelling of the actin cytoskeleton and focal adhesions to efficiently produce filopodia.
By monitoring adhesion complexes during this process we found that as described for 
PDGF, bradykinin-induced focal adhesion remodelling to produce focal complexes at 
filopodia was impaired in Src251-GFP expressing cells. Anti-vinculin and anti-paxillin 
staining was indistinguishable in cell treated with bradykinin, in which we observed small 
vinculin and paxillin-containing complexes at the ends of filopodia (Figure 42a,d). As 
described above, SrcY527F and Src251-GFP were located to focal adhesions in the 
presence of serum and upon treatment with bradykinin, SrcY527F and paxillin co-localised 
to small structures at the ends of filopodia (Figure 42b,c), while Src251-GFP and vinculin 
co-localised mainly to large discrete complexes at the cell periphery from which filopodia 
were emanating (Figure 42e,f).
Consistent with the effect of Src251-GFP on filopodia formation, expression of SrcMF and 
subsequent stimulation of these cells with bradykinin led to the remodelling of the actin 
cytoskeleton to form discrete patches of SrcMF at the base of forming filopodia (Figure 
43a,b broken arrows), rather than the continuous and more uniformed distribution of 
filopodia in cells expressing SrcY527F (Figure 41b,c). Although cells expressing SrcMF 
were able to assemble actin containing microspikes (Figure 43b, solid arrows), these were 
not uniformly spread around the cell body and the filopodia appeared to originate from
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large clusters of paxillin containing complexes (Figure 43c,d broken arrows) in contrast to 
the more diffuse and smaller complexes in SrcY527F expressing cells (Figure 42b,c).
Thus, our data supports a critical role for the catalytic activity of c-Src in the Racl- and 
Cdc42-induced peripheral adhesion re-modelling that results in the breakdown of larger 
focal adhesions and the generation of smaller focal complex adhesion structures at 
lamellipodia and filopodia, respectively.
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Figure 41
Src kinase activity is required for re-modelling of the actin cytoskeleton during filopodia 
formation. Cells transfected with SrcY527F (a-c), or Src251-GFP (d-f) were p l a c e d !  
serum-free medium overnight and then treated with the protein synthesis inhibitor emetine (.! 
pig m l'1) for 30 min prior to stimulation with bradykinin (100 nM) for 5 min (a-f). Thil 
protocol allowed us to reduce the heterogeneity in the cells following growth factor s t i m u l a t i o n  
while maintaining the Src proteins in the focal adhesions prior to stimulation. Actin wai 
visualised with rhodamine-phalloidin (b,c,e,f). SrcY527F was visualised using an anti-SrJ 
antibody (a,c) and Src251-GFP was detected by direct fluorescence (d,f). Solid arrows indicatl 
Src in filopodia, while broken arrows indicate Src at the base of filopdia. High resolutioa 
image of filopodia in cells expressing Src251-GFP (upper panel) and SrcY527F (lower panel! 
(g). Scale bars 25 pm.
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Figure 42
Src kinase activity is required for the disassembly of focal adhesions during filopodia I 
formation. Cells were grown in serum-free conditions overnight prior to stimulation with  I  
bradykinin (100 nM) for 5 min and stained with anti-vinculin (a) or anti-paxillin antibodies
I
Cells transfected with SrcY527F (b,c), or Src251-GFP (e,f) were placed in serum-free m e d i u m  ■  
overnight and treated with the protein synthesis inhibitor emetine (55 jig ml’1) for 30 min priori 
to stimulation with bradykinin (100 nM) for 5 min (b,c,e,f). This protocol allowed us to r e d u c e ■  
the heterogeneity in the cells following growth factor stimulation while maintaining the Src I  
proteins in the focal adhesions prior to stimulation. SrcY527F (c) and vinculin (e) w e r e !  
visualised by anti-Src and anti-vinculin antibodies respectively. Paxillin was visualised with  9  
rhodamine-conjugated anti-paxillin (b) and Src251-GFP by direct immunofluoresence (0-i
Figure 42
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Figure 43
SrcMF expression in focal adhesions prior to bradykinin stimulation inhibits actin and 
focal adhesion remodelling during filopodia formation. Cells were transfected with SrcM F 
and placed in serum-free medium overnight. Cells were then treated with the protein sy n th es is  
inhibitor emetine (55 pg ml"1) for 30 min prior to stimulation with bradykinin (100 nM) for 5 
min. This protocol allowed us to reduce the heterogeneity in the cells following growth factor 
stimulation while maintaining the Src proteins in the focal adhesions prior to s t im u la t io n .  
SrcMF was visualised using an anti-Src antibody (a,c) and actin was visualised with 
rhodamine-phalloidin (b). Paxillin was visualised with rhodamine-conjugated anti-paxillin (d). 
Scale bars 25 pm.
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5.2.6 Expression of Src251-GFP or SrcMF in focal adhesions prevents Y- 
27632 induced focal adhesion disassembly.
Further evidence that Src251-GFP was acting to prevent the turnover of peripheral 
adhesion structures during lamellipodia or filopodia formation was provided by treating 
cells with Y-27632 following expression of Src251-GFP. Src251-GFP is found in focal 
adhesions in cells grown in serum and treatment of these cells with Y-27632 resulted in the 
loss of actin stress fibres (Figure 44b). Flowever, Src251-GFP remained at the cell 
periphery under these conditions (Figure 44a,c, broken arrows). Treatment with Y-27632 
also resulted in the breakdown and loss of focal adhesion structures, with few vinculin- 
containing adhesion structures evident (Figure 44e, solid arrows). In contrast, in cells 
expressing Src251-GFP, large focal adhesion-like structures remained (Figure 44d,e, 
broken arrows) although no stress fibres were present under these conditions. As a result 
of the loss of stress fibres and the majority of their focal adhesions, the surrounding cells 
appeared to have retracted and are therefore much smaller than the Src251-GFP expressing 
cell. Similarly cells expressing SrcMF prevented focal adhesion breakdown induced by Y- 
27632. The Rho-kinase inhibitor caused the loss of actin stress fibres (Figure 45b) in cells 
expressing SrcMF which remained in focal adhesions in the presence of Y-27632. 
However, Y-27632 did not induce loss of focal adhesions in cells expressing SrcMF 
(Figure 45d,e). Compare cells expressing SrcMF (broken arrows) to non-expressing cells 
(solid arrows), which have a marked reduction in paxillin staining compared to cells 
expressing SrcMF. Thus, expression of the kinase-deficient Src251-GFP or SrcMF 
proteins stabilised focal adhesion structures that normally disassemble when the RhoA 
effector pathway is inhibited. This finding is consistent with the requirement for c-Src’s 
catalytic activity during focal adhesion breakdown and turnover (Fincham & Frame, 1998), 
where kinase defective Src expressing cells have been shown to have enlarged focal 
adhesions. This may provide a potential insight into the inefficient Racl- and Cdc42- 
mediated peripheral adhesion remodelling observed in cells expressing Src251-GFP or 
SrcMF.
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Figure 44
Stabilisation of focal adhesions in cells expressing Src251-GFP. Cells were transfected with 
Src251-GFP and upon expression, treated with Y-27632 (10 pM) for 1 h. Broken arrows 
indicate cells expressing Src251-GFP, while solid arrows indicate vinculin staining in non 
expressing cells. Actin was visualised with rhodamine-phalloidin (b,c). Vinculin wa: 
visualised using an anti-vinculin antibody (e) and Src251-GFP by direct fluorescence (a,c,d). 
Scale bars 25 pm.
Src251-GFP
+ Y-27632
Vinculin
Figure 45
Stabilisation of focal adhesions in cells expressing SrcMF. Cells were transfected with 
SrcMF and following its expression, treated with Y-27632 (10 pM) for 1 h. Broken arrows 
indicate cells expressing SrcMF, while solid arrows indicate vinculin staining in non­
expressing cells. Actin was visualised with rhodamine-phalloidin (b,c). Paxillin was 
visualised with rhodamine-conjugated anti-paxillin (e) and SrcMF was visualised using a anti- 
Src antibody (a,c,d). Scale bars 25 pm.
Figure 45
+ Y-27632
SrcMF Actin Merge
+ Y-27632
SrcMF Paxillin
►
.....►
chapter 5
5.2.7 c-Src kinase activity is required for cell motility and polarity
As the formation of lamellipodia and filopodia have been associated with the regulation of 
cell motility and chemotaxis (Allen et al., 1997; Nobes & Hall, 1999) we examined 
whether the impaired focal adhesion remodelling in the cells lacking kinase activity, was 
associated with an inhibition of cell movement or the ability of cells to polarise in response 
to a chemotactic agent. Using time-lapse video microscopy we found that the random 
migration of cells expressing Src251-GFP and SrcMF was inhibited by around 70-75%, 
compared to non-transfected cells, while expression of GFP alone had no effect on cell 
motility (Figure 46). Cells were co-transfected with the respective Src mutants and GFP 
for visualisation. Expression of activated Src (SrcY527F) had no significant effect on the 
migration of the cells suggesting that the level of endogenous Src within the cells is not 
limiting for migration.
To examine the capacity of cells to respond to a chemotactic gradient, we measured the 
ability of cells to polarise towards PDGF using a Dunn chamber (see Materials and 
Methods Section 2.9.11) (Allen et al., 1997). Less than 10% of cells expressing Src251- 
GFP or SrcMF were able to polarise along the PDGF gradient, while around 80% of the 
non-transfected cells exhibited polarity (Figure 47). Expression of GFP or SrcY527F had 
no effect on the ability of cells to polarise in response to PDGF (Figure 47). Thus, both 
cell migration and cell polarisation in response to a chemotactic stimuli, biological 
responses that require the co-ordinated activities of Rho GTPases, are impaired in cells 
expressing either the Src251-GFP or SrcMF kinase-deficient mutants of c-Src. Our 
findings indicate that RhoA, Racl and Cdc42 not only control the precise sub-cellular 
localisation of c-Src, but co-operate with the catalytic activity of c-Src to mediate the 
adhesion remodelling that is required for polarisation and cell migration.
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Figure 46
Src251-GFP and SrcMF inhibit random cell migration. Random cell migration of cells I
expressing Src251-GFP, GFP, SrcY527F (+ GFP) or SrcMF (+ GFP) in 10% serum. Values I  
are mean + S.E.M. taken from at least 5 independent experiments and represent data from I  
between 30 and 60 cells in each case.
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Figure 47
Src251-GFP and SrcMF inhibit cell polarisation. Polarity of cells expressing Src251-GFPll
GFP, SrcY527F (+GFP) or SrcMF (+GFP) in response to a PGDF gradient (lOng ml1)! I 
Values are expressed as the percentage of cells in a population able to polarise towards PDGFll 
using the criteria described in the Methods Section 2.10.11, generated from at least ill 
independent experiments.
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5.3 Discussion.
The involvement of RhoA, Racl and Cdc42 in cell motility is undoubtedly linked to their 
ability to rearrange the actin cytoskeleton. However, a secondary consequence of this actin 
remodelling is apparently to target other cellular proteins, such as c-Src, to these peripheral 
sites. We show here that once located at the cell periphery, in focal adhesions, c-Src acts 
in concert with the Rho GTPases to regulate directed cell motility. Our data supports a 
critical role for the catalytic activity of c-Src in the Racl- and Cdc42-induced peripheral 
adhesion remodelling that results in the breakdown of larger focal adhesions and the 
generation of smaller focal complexes to allow lamellipodia or filopodia formation 
respectively (see Figure 48).
In this study we introduced constitutively active and inactive-Src mutants into the cells and 
used them as tools to establish the importance of Src kinase activity during adhesion 
remodelling. In addition, we also used a pharmacological agent to inhibit Src kinase 
activity during focal adhesions remodelling.
The Src kinase inhibitor specificity however is not confined to Src kinase, as it has also 
been reported to have weak inhibitory effects on other kinases such as ZAP-70 and Jak2 
(Hanke et al., 1996; Yoshizumi et al., 2000). In the context of these experiments however, 
PP2 was used at concentrations below the threshold reported to block these kinases, 
therefore ruling out their involvement in the impaired focal adhesions remodelling and Src 
localisation observed. More significant however, is the reported inhibitory effect PP2 has 
on the PDGF and EGF receptors (Hanke et al., 1996; Yoshizumi et al., 2000). As PDGF 
was used here to cause Racl-induced lamellipodia it is possible that the fragmented 
lamellipodia and Src localisation observed in the presence of PP2 occurs as a result of 
partial inhibition of the PDGF receptor. This however is not the only explanation, as the 
kinase deficient Src mutant SrcMF, like Src251-GFP, caused the same impairment in Src 
localisation and lamellipodia formation as seen in cells treated with the Src kinase 
inhibitor. Moreover, PP2 has been reported to block phosphorylation of tyrosine-577 on 
FAK, which is required for FAK kinase activity (Hanke et al., 1996) (Salazar & Rozengurt, 
1999). FAK is thought to play and important role in focal adhesion turnover (Parsons et 
al., 2000) and therefore inhibition of FAK activity may also explain the impaired focal 
adhesion remodelling observed in cells treated with PP2. It should be noted that this 
impairment in tyrosine-577 phosphorylation maybe an indirect result of Src kinase 
inactivation as Src has been reported to phosphorylate FAK on this site (Calalb et al.,
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1995). The potential involvement of Src-induced phosphorylation on various residues of 
FAK, including tyrosine-577, in focal adhesion remodelling will be discussed later in 
Chapter 7. Finally, it has been previously demonstrated that PP2 blocks Src kinase activity 
as well as the activity of other ubiquitously expressed Src family kinase such as c-Fyn and 
Yes (Hanke et al., 1996; Yoshizumi et al., 2000). This suggests that we cannot rule out the 
inhibition of other family members in this impaired focal adhesion to focal complexes 
remodelling observed in PP2 treated cells. In these experiments, expression of truncated or 
kinase defective Src has a similar effect as PP2 treatment, verifying the use of this inhibitor 
in assessing the role of Src kinase activity in this process. In keeping with this however, 
Src251-GFP and SrcMF expression may also be inhibiting other Src family members.
The kinase defective Src mutant, SrcMF has regularly been used to assess the role Src 
kinase activity plays in various cellular processes (Snyder et al., 1985). A potential pitfall 
however in using this dominant negative mutant is that the impairment of focal adhesion to 
focal complex remodelling observed during lamellipodia formation in cells expressing this 
mutant may be caused by the over-expression of available SH2/SH3 domains and could 
therefore be acting as a non-regulated adaptor molecule sequestering and maintaining 
various proteins in focal adhesions. It is therefore possible that Src plays an adaptor 
function in focal adhesion formation via the SH2/SH3 domains but ultimately its kinase 
activity is required for the turnover of these sites. This would explain why the absence of 
Src kinase activity in Src251-GFP and SrcMF expressing cells have enlarged focal 
adhesions and inefficiently remodel focal adhesions during lamellipodia or filopodia 
formation.
In this study we also used the constitutively active Src mutant (SrcY527F), to assess the 
role Src kinase activity has on focal adhesions remodelling. Previous reports using v-Src 
have demonstrated that unrestrained kinase activity of v-Src leads to enhanced cytoskeletal 
disruption and adhesion turnover (Fincham et al., 1999), where there is a breakdown and 
loss of stress fibres resulting in cell rounding and detachment associated with a 
morphologically transformed phenotype. Although SrcY527F, has unrestrained kinase 
activity and is a transforming mutant of c-Src, in the time scale of these experiments the 
cells do not undergo morphological transformation and therefore transformation-associated 
actin rearrangements or focal adhesion disruption does not interfere with the formation ol 
lamellipodia or filopodia. Therefore SrcY527F was used in these experiments to monitor 
the involvement of Src kinase activity in focal adhesion to focal complex remodelling.
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Figure 48
Schematic representation of Src’s targeting from the perinuclear region of the cell to 
lamellipodia or filopodia. Src kinase activity is not required for Src’s translocation from the 
perinuclear region of the cell to the cell periphery at focal adhesion but its kinase activity is 
required for the efficient remodelling of focal adhesion to focal complexes during la m e l l ip o d ia  
or filopodia formation respectively.
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The use of the protein synthesis inhibitor emetine in these experiments excluded the 
possibility ot any newly synthesised Src being involved in the focal adhesions remodelling 
during lamellipodia or filopodia formation. This therefore implies that Racl or Cdc42 
activation led to the re-location of c-Src that pre-existed in focal adhesions into complexes 
along lamellipodia or filopodia respectively. However, in these experiments we cannot 
rule out the possibility that some c-Src pre-existing in the perinuclear region after emetine 
treatment could move out into the newly formed lamellipodia or filopodia. In the case of 
bradykinin-stimulated filopodia however, the time scale of these experiments would not be 
sufficient to allow Src to translocate from the perinuclear region of the cell to the cell 
periphery, which has been reported to take between 15-30 min (V. Fincham, unpublished 
observation). In this study filopodia formation was observed within 5 min of stimulation 
with bradykinin. Data presented in this chapter on Src targeting to lamellipodia or 
filopodia, suggests that it is the presence of kinase-defective c-Src at focal adhesions prior 
to PDGF or bradykinin stimulation that interferes with the efficient formation of these 
structures rather than Src from the perinuclear region of the cell.
A key component of the co-ordinated movement of cells is their ability to polarise towards 
different migratory signals and in this study we have addressed the role of c-Src in this 
process. The formation of Racl dependent lamellipodia at the leading edge of cells is 
required for cell motility (Allen et al., 1998; Nobes & Hall, 1999; Ridley et al., 1995). In 
addition, while Cdc42 is not essential for cell movement per se, it is required for 
directionality and the maintenance of cell polarity (Allen et al., 1998; Nobes & Hall, 1999; 
Stowers et al., 1995). Swiss 3T3 cells have frequently been reported to have a low 
migration rate and in our system the Swiss 3T3 fibroblast migration rate was relatively low 
compared to other cell types such as macrophages (Allen et al., 1997). Moreover, the 
migration rate was significantly reduced upon expression of kinase defective Src mutants 
in these cells. It should be noted that a reduction in cell migration does not automatically 
confer a loss in the cells chemotactic capacity. Cell chemotaxis can be defined as the 
ability of cells to polarise and move towards a chemical gradient in a persistent manner. 
Using the Dunn chamber assay we can visualise cells under the influence of a constant 
chemical gradient, which can be generated rapidly and can persist for 5-20 h depending on 
the chemoattractant used. This assay allows the option of determining the persistence and 
directionality of cells during chemotaxis separately from migration rates. Other methods 
of measuring chemotaxis such as the Boyden chamber assay do not take this into account 
and can therefore potentially lead to false negative or positive results. For example, a 
reduction in cell migration (as observed in this study) could be misinterpreted as a failure 
to undergo chemotaxis, as cells that do not migrate fast enough may not reach the other
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side of the filter during the course of the experiment thereby resulting in a false negative. 
On the other, hand cells with a significantly enhanced random migration rate may give rise 
to false positive results. Inhibition of Cdc42 in macrophages for example has been 
reported to signilicantly increase cell migration rates due to the loss of directional control 
normally enforced by Cdc42 (see Introduction Section 1.5.2 (Allen et al., 1997)). Using 
the Boyden chamber assay, it can be envisaged that this impairment of Cdc42, which is 
known to be necessary for macrophage chemotaxis (Allen et al., 1998), could lead to false 
positives regarding cell chemotaxis due to the enhanced random migration leading to an 
increased number of cells reaching the other side of the filter. As Swiss 3T3 cells 
expressing Src251-GFP or SrcMF have a marked reduction in cell migration, the Dunn 
chamber assay allowed us to examine cell polarity separately form cell migration and 
eliminate these potential problems. Other methods of examining directed cell migration or 
chemotaxis include visualising golgi orientation during a wound healing assay (Nobes & 
Hall, 1999). Cell migration in a wound healing assay however is not chemotactic cell 
migration, as cells are randomly moving into an open space as opposed to reacting to a 
chemical gradient. We have shown here, using the Dunn chamber assay, that c-Src kinase 
activity is required for cells to polarise and form a leading edge.
We propose that the ability of the RhoGTPases to direct the localisation of Src to these 
peripheral sites is required for the remodelling of the more static focal adhesions into 
smaller more dynamic focal complexes found at the leading edge of motile cells. c-Src 
activity is not required downstream of migratory signals to initiate cell shape changes 
associated with lamellipodia and filopodia formation, but is required for the remodelling of 
focal adhesions to smaller focal complexes associated with these structures. This is 
consistent with studies in which cells lacking all three ubiquitously expressed Src family 
members (Src, Fyn and Yes), are able to assemble focal adhesions (Klinghoffer et al., 
1999), indicating that Src is not required for their formation. However, cells in which 
kinase defective mutants of Src are expressed have enlarged focal adhesions (Fincham & 
Frame, 1998; Kaplan et al., 1994), consistent with our observation with Src251-GFP and 
SrcMF expressing cells, suggesting a role for Src kinase activity in the turnover of these 
structures that is needed for cells to move (Fincham & Frame, 1998).
As discussed in Chapter 1 (see Section 1.6.1) a number of studies have also demonstrated a 
key role for Src family kinases in cell migration other than its role in focal adhesions 
turnover. For example, Src has been shown to be required for growth factor-induced cell 
migration which has also been attributed to Src’s role in growth factor induced signalling 
pathways (Liu et al., 1999; Rahimi et al., 1998; Rodier et al., 1995). It is therefore possible
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that in cells expressing kinase defective Src mutants that the impaired cell migration could 
be caused by an impairment in signalling pathways involving Src kinase activity.
As described earlier v-Src leads to the disruption of cellular adhesions and loss of actin 
organisation, resulting in cell rounding and detachment (Fincham et al., 1999; Fincham et 
al., 1995). This disruption of cellular adhesions and loss of actin organisation induced by 
v-Src may be an extreme version of a normal, spatial and temporally controlled process 
that allows adhesion remodelling to occur during cell migration. In cells expressing 
constitutively active SrcY527F, paxillin locates to uniform focal complexes along the 
lamellipodia, which were difficult to visualise as discrete structures, suggesting that 
costitutive Src’s activity may be further disrupting the focal complexes. Interestingly, 
expression of activated SrcY527F did not enhance the migration of cells, indicating that 
the level of endogenous Src within the cell is not limiting for cell migration. This has also 
been seen upon re-introduction of activated Src into Src -/- cells where activated Src 
restored migration to a similar level as re-introduction of the wild type protein (Hall et al.,
1996). Similarly, in this study SrcY527F did not enhance the ability of cells to form 
filopodia and polarise. Together, this indicates that adhesion dynamics must be strictly 
regulated during cell migration and polarisation, where there is sufficient adhesion 
turnover to allow focal adhesions remodelling and retraction, while maintaining enough 
adhesion for cell traction during cell polarisation and locomotion.
The presence of functional SH2 and SH3 domains in Src suggests that, in addition to Src’s 
kinase activity, Src may be acting as an adaptor protein allowing its recruitment into focal 
adhesion structures and/or the recruitment of cellular partners to these sites. In line with 
this, kinase-deficient Src mutants can rescue both defects in cell spreading and cytoskeletal 
organisation in Src -/- fibroblasts and osteoclasts respectively (Kaplan et al., 1995; 
Schwartzberg et al., 1997). Moreover, cells expressing kinase defective Src have been 
shown to enhance the adhesive strength of cells by re-enforcing the linkage between the 
actin cytoskeleton and the vitronectin receptor (Felsenfeld et al., 1999). These studies 
imply that at least some effects of Src on cell adhesions and the cytoskeleton are kinase- 
independent and may rely on the adaptor function of Src. Spatial and temporal regulation 
of this adaptor function by RhoGTPases could potentially serve to transiently strengthen 
adhesions during cell traction possibly by recruiting various scaffolding proteins to these 
sites and increasing interactions between the ECM and the actin cytoskeleton.
One interesting aspect of Src’s functional interactions with cytoskeletal regulators is the 
apparently paradoxical requirement for RhoA to mediates Src’s peripheral targeting (see
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Chapter 3 (Fincham et al., 1996)), and the Src-induced antagonism of RhoA via activation 
of pl90RhoGAP (Fincham et al., 1999). pl90RhoGAP is phosphorylated in a Src-kinase 
dependent manner (Ellis et al., 1990), leading to its association with pl20RasGAP (Chang 
et al., 1995, McGlade et al., 1993). This association, in turn, results in increased RhoA- 
GTPase activity of pl90RhoGAP, and the disruption and remodelling of the actin 
cytoskeleton (Chang et al., 1995). The antagonism of RhoA as a key event in Src’s de­
regulation ol the actin cytoskeleton was highlighted by the RhoA-induced reversion of the 
Src-mediated actin changes in rat fibroblasts (Mayer et al., 1999). In keeping with this, the 
complex between pl90RhoGAP and pl20RasGAP is required for stress fibre turnover and 
efficient cell migration (Kulkarni et al., 2000). Thus it seems that Src is recruited to 
peripheral adhesions in a RhoA and actin dependent manner where the kinase activity of 
Src leads to cytoskeletal disruption and adhesion turnover necessary for cell migration 
(Fincham & Frame, 1998). In line with this, Src selectively modulates integrin-dependent 
traction forces that are important for cell migration. In particular, linkages between 
integrin vitronectin receptors and the actin cytoskeleton are strengthened in Src-deficient 
fibroblasts (Felsenfeld et al., 1999), indicating that Src activity is required to weaken, or 
disrupt, links at the integrin-cytoskeleton interface thus modulating cell motility. 
Interestingly, integrin signalling induces early Src-dependent tyrosine phosphorylation and 
activation of pl90RhoGAP that is thought to relieve RhoA-mediated contractile forces 
thus allowing protrusions to form at the leading edge of motile cells (see section 1.6.2) 
(Arthur et al., 2000).
In our experiments, the presence of Src251-GFP or SrcMF in focal adhesions stabilised 
these adhesion sites that normally disassemble when the RhoA effector pathway is 
inhibited. The failure to relieve RhoA-induced contractile forces may partially explain the 
inefficient formation of protrusive structures such as lamellipodia or filopodia in these 
cells. Moreover failure to inhibit this contraction at focal adhesions may also explain the 
impaired focal adhesion to focal complex remodelling observed in these cells. In keeping 
with this, further studies have demonstrated that inhibition by pl90RhoGAP enhances cell 
spreading and migration by promoting cell protrusion and polarity (Arthur & Burridge, 
2001). This may provide an insight as to why Src kinase activity is required in cell 
migration and more specifically why cells expressing Src251-GFP or SrcMF cannot 
efficiently co-ordinate cell polarisation or migration in the absence of Src kinase activity 
(Klinghoffer et al., 1999). Therefore although RhoA is required for Src targeting to focal 
adhesions and the generation of contractile forces during cell motility, Src-induced 
antagonism of RhoA-induced contractility is probably also required at specific times and 
places within migrating cells. c-Src therefore seems to have both positive and negative
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effects on cellular adhesions and may act as a switch between their assembly and 
disassembly placing it in a central position from which to co-ordinate the multi-faceted 
process of cell motility.
Src induces tyrosine phosphorylation of a number of adhesion substrates, including both 
structural and regulatory proteins such as, ERM proteins, cortactin, FAK, paxillin 
(Burridge et al., 1992; Huang et al., 1997; Ilic et al., 1995; Krieg & Hunter, 1992; Martin et 
al., 1995b; Wu et al., 1991). The exact function of each individual phosphorylation event 
is not fully understood, however, alterations, in the tyrosine phosphorylation of a number 
of these proteins could potentially contribute to focal adhesion disruption and the 
regulation of cell motility (see Introduction Section 1.5.2). It should be noted that tyrosine 
phosphorylation of various proteins have also been observed in cells expressing kinase 
defective Src mutants (Kaplan et al., 1994) (E Avizienyte unpublished). This tyrosine 
phosphorylation could potentially be attributed to the adaptor function of Src’s SH2/SH3 
domains serving to localise various proteins in focal adhesions within the vicinity of 
potential binding partners/kinases thereby inducing their phosphorylation. The enhanced 
tyrosine phosphorylation observed in cells expressing constitutively active Src or v-Src 
may be involved in focal adhesion turnover and therefore some potential candidates linked 
to Src-induced focal adhesions turnover and remodelling are examined in more detail in 
the next chapter.
5.4 Summary
We have demonstrated that co-ordinated regulation of RhoGTPases not only serves to 
control cell contraction or protrusion during cell migration but also has a secondary role in 
determining the localisation of Src kinase to functionally distinct structures involved in 
directed cell migration. Moreover, we have shown that Src does not play a passive role in 
this process and demonstrate that Src kinase activity participates in the efficient 
remodelling of focal adhesions to allow the formation of lamellipodia and filopodia which 
are both necessary for polarised cell migration. In the next chapter we begin to address 
why Src kinase activity is required during this process and examine the involvement of 
some potential binding partners/substrates of Src in this process.
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6 identification of potential binding 
partners/substrates of Src specifically linked to  
focal adhesion remodelling.
6.1 Purpose
The different abilities of active and kinase defective Src to re-model Src-containing focal 
adhesions into lamellipodia- or filopodia- associated complexes is most likely due to the 
fact that kinase-null or defective forms of Src inhibit the normal function of endogenous 
Src family kinases. This is consistent with previous findings that kinase-defective v-Src 
can inhibit focal adhesion turnover (Fincham & Frame, 1998), and suggests that the 
mechanism of focal adhesion turnover during v-Src transformation and during peripheral 
re-modelling in response to Rac and Cdc42 may be similar, in that they both require kinase 
activity. In this chapter we aim to identify binding partners/substrates that are specifically 
linked to the impaired focal adhesion remodelling observed in Src251-GFP and SrcMF 
expressing cells, thereby, providing an insight as to why the kinase domain or activity of 
Src is required for efficient lamellipodia or filopodia formation and ultimately for 
biological processes such as cell migration and chemotaxis. Since there are many proteins 
reported to bind to Src, we gave priority to candidates which are of interest to our research 
and whose likely cellular functions are consistent with our current model of the role Src 
kinase activity plays in adhesion turnover and remodelling (see Chapter 5). Each potential 
candidate has been selected on the basis of their reported binding to Src and links to the 
actin cytoskeleton or focal adhesions.
6.1.1 Scar family proteins as potential candidates involved in focal 
adhesion remodelling.
Scar proteins are related to the WASP family proteins and like WASP they control actin 
dynamics by both binding to actin and inducing actin nucleation and polymerisation via the 
Arp2/3 complex (Machesky & Insall, 1998). The mammalian Scar family include at least 
four member named Scar-1 - Scar-4 (Bear et al., 1998). Recently, preliminary data 
obtained by our group indicates that Scar-1 associates with Src in immune complexes, 
which is mediated by the SH3 domain of Src (V. Brunton, unpublished). Consistent with 
this link between Src and Scar-1, there has been a great deal of evidence linking Src family 
kinases to the related protein N-WASP and the actin cytoskeleton. Vaccina virus for
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example, utilises the viral protein p 36R, which via Src kinase, recruits N-WASP to the 
cell surface and propels it through the host cell (Frischknecht et al., 1999). Furthermore, 
the Src family kinase Fyn and the Src related kinase Fgr can both bind to WASP via 
proline rich sequences in WASP (Banin et al., 1996; Finan et al., 1996; Ramesh et al., 
1999), although the consequences for actin nucleation are not known. As Scar-1 has been 
reported to play a key role in actin remodelling (Machesky & Insall, 1998), especially 
associated with the formation of PDGF/Racl-induced lamellipodia, we wanted to establish 
whether Scar was involved in Src dependent adhesion remodelling events during 
lamellipodia formation.
In this section we therefore set out to determine whether Scar localises to focal adhesions 
and focal complexes, following stimulation of RhoA and Racl. Cells stimulated with 
LPA, to activate RhoA, resulted in the formation of actin stress fibres (Figure 49b) and 
using an anti-Scar antibody, Scar was located at sites at the ends of these actin cables 
(Figure 49a,c, solid arrows). Similarly, following treatment with PDGF, to induce Racl 
activity, Scar was targeted to lamellipodia (Figure 49d, solid arrow) continuous with actin 
staining (Figure 49e,f, solid arrows). Cells were then stained with vinculin as a monitor of 
adhesion complexes and vinculin co-localised with Scar in focal adhesions following 
stimulation with LPA (Figure 50a,c, solid arrows). Moreover, PDGF stimulation resulted 
in the diffuse localisation of vinculin along the base of lamellipodia (Figure 50e, solid 
arrows) where it co-localised with Scar (Figure 50d,f). This data demonstrates that Scar 
localised to similar sub-cellular compartments, as previously described for Src in response 
to the activation of RhoA or Racl (see chapter 4). It is possible that the antibody used in 
this study could be detecting other isoforms of Scar (Bear et al., 1998; Miki et al., 1998b). 
As conformation of Scar localisation at these peripheral sites we therefore transfected cells 
with Myc-tagged Scar-1 and subsequently stimulated cells with LPA or PDGF. Cells 
stimulated with LPA, resulted in the formation of stress fibres (Figure 51b, broken arrow) 
and using an anti-myc antibody, myc-tagged Scar-1 was found at the ends of these stress 
fibres (Figure 51a,c, solid arrow). Furthermore, PDGF stimulation induced the diffuse 
localisation of myc-tagged Scar-1 along the base of lamellipodia (Figure 51d,e,f, solid 
arrows). Together, this data indicates that Scar is found at the same peripheral sites as Src 
in response to RhoA or Racl activation. It is therefore possible that Scar-1 along with Src 
may potentially play a role in the remodelling of focal adhesions to lamellipodia. As Scar 
has been shown to associate with Src (V Brunton, unpublished) we therefore set out to 
determine whether Scar co-localised with Src after the stimulation of peripheral targeting 
of Src from focal adhesions to lamellipodia. Src251-GFP was found to co-localise with 
Scar in focal adhesions following LPA treatment of cells (Figure 52a-c, solid arrows).
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Similarly, SrcY527F co-localised with Scar in focal adhesions after LPA stimulation 
(Figure 52d-e, solid arrows). Upon stimulation of focal adhesion remodelling to produce 
lamellipodia both, Src251-GFP and Scar where found at large discrete structures along the 
base of forming lamellipodia induced by PDGF (Figure 53a-c, solid arrows). In contrast in 
SrcY527F expressing cells Scar localised with SrcY527F along the base of uniform 
lamellipodia (Figure 53d-f, solid arrows). This data indicates that in cells with both, 
activated or kinase-defective forms of Src, Scar co-localised with Src even in cells that 
were unable to remodel their focal adhesions efficiently to form uniform lamellipodia. 
This suggests that the binding or co-localisation of Src and Scar does not seem to be 
determined by the kinase activity of Src and implies that more subtle differences in Scar 
function may be involved in the impaired lamellipodia formation observed in kinase 
defective Src expressing cells. One explanation for this is that Scar’s activity may be 
compromised in cells expressing the kinase defective Src mutants.
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Figure 49.
Scar localises to focal adhesion and lamellipodia induced by LPA and PDGF. Cells were
grown in serum-free conditions overnight prior to stimulation with LPA (200 ng ml" ) for 30 
min (a-c) or PDGF (25 ng ml"1) for 30 min (d-f). Solid arrows indicate Scar localisation, 
Actin was visualised with rhodamine-phalloidin (b,c,e,f). Scar was visualised using an anti- 
Scar antibody. Scale bars 25 pm.
L P A
Actin M erue
BBbb
P D G F
Scar Actin M erg e
Figure 50 I
Scar co-localises with vinculin at focal adhesions and lamellipodia induced by LPA and I 
PDGF. Cells were grown in serum-free conditions overnight prior to stimulation with LPA I 
(200 ng m l'1) for 30 min (a-c) or PDGF (25 ng m l'1) for 30 min (d-f). Solid arrows indicate I 
Scar localisation. Vinculin was visualised using an anti-vinculin antibody (b,c,e,f) and Scar I 
was visualised using an anti-Scar antibody (a,c,d,f). Scale bars 25 pm.
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Figure 51
Myc-tagged Scar-1 localises to focal adhesions and lamellipodia induced by LPA and 
PDGF. Cells were grown in serum-free conditions overnight prior to stimulation with LPA 
(200 ng m l'1) for 30 min (a-c), or PDGF (25 ng mL1) for 30 min (d-f). Actin was visualised 
with rhodamine-phalloidin (b,c,e,f). Myc-tagged Scar-1 was visualised using an anti-myc 
antibody (a,c,d,f). Scale bars 25 pm.
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Figure 52
Scar co-localises with Src251-GFP and SrcY527F at focal adhesions induced by RhoA 
activation. Cells transfected with Src251-GFP (a-c) or SrcY527F (d-f) were placed in serum- 
free medium overnight and then treated with the protein synthesis inhibitor emetine (55 pg ml 
l) for 30 min prior to stimulation with LPA (200 ng m l1) for 30 min (a-f). This protocol 
allowed us to reduce the heterogeneity in the cells prior to LPA stimulation while maintaining 
the Src proteins in the focal adhesions prior to stimulation. Scar was visualised using an anti- 
Scar antibody (b,c,e,f), Src251-GFP by direct fluorescence (a,c) and SrcY527F using anti-Src | 
antibody (d,f). Scale bars 25 pm.
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Figure 53
Scar co-localises with Src251-GFP and SrcY527F in lamellipodia induced by Rac-1 
activation. Cells transfected with Src251-GFP (a-c) or SrcY527F (d-f) were placed in serum- 
free medium overnight and then treated with the protein synthesis inhibitor emetine (55 pg ml 
*) for 30 min prior to stimulation with PDGF (25 ng ml"1) for 30 min (a-f). This protocol 
allowed us to reduce the heterogeneity in the cells prior to PDGF stimulation while 
maintaining the Src proteins in the focal adhesions prior to stimulation. Scar was visualised 
using an anti-Scar antibody (b,c,e,f), Src251-GFP by direct fluorescence (a,c) and SrcY527F 
using anti-Src antibody (d,f). Scale bars 25 pm.
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6-1-2 The effect of Src kinase activity on Scar-1 function.
As discussed earlier Scar is involved in actin cytoskeletal remodelling by binding to actin 
and the Arp2/3 complex (Machesky & Insall, 1998). We therefore examined Scar’s ability 
to regulate these processes where there was inefficient actin and focal adhesion 
remodelling during lamellipodia formation. In particular, as Scar is known to bind directly 
to the Arp2/3 complex and stimulate its ability to promote the nucleation of new actin 
filaments (Machesky & Insall, 1998), we determined whether a functional kinase domain 
of c-Src was required for Arp2/3 binding. We examined the binding of Myc-tagged Scar-1 
and Arp2/3 in cells expressing kinase-defective mutants of Src that where unable to 
remodel focal adhesions in response to PDGF and displayed impaired motility (see Chapter 
5) and compared this with cells expressing constitutively active Src. Swiss 3T3 cells 
expressing Myc-tagged Scar-1 or co-expressing Scar-1 with Src251-GFP, SrcMF or 
SrcY527F were stimulated with PDGF. (Machesky et al., 1997; Welch et al., 1997). 
Using one component of the Arp2/3 complex, Arp3, as a surrogate marker of Arp2/3 
binding, we found that the presence of either constitutively active Src or kinase defective 
Src mutants within the cell had no effect on the ability of Scar-1 to bind to Arp3 (Figure 
54). As Scar is known to bind directly to actin monomers (Machesky & Insall, 1998) and 
via the Arp2/3 complex induce actin nucleation, we assessed whether a functional kinase 
domain of Src could influence the capacityof Scar to bind to actin, which could potentially 
alter lamellipodia formation (Machesky & Insall, 1998; Miki et al., 1998b). Swiss 3T3 
cells expressing Scar-1 or co-expressed with Src251-GFP, SrcMF or SrcY527F were 
stimulated with PDGF. Myc-tagged Scar-1 was immunoprecipitated from cell lysates and 
incubated with monomeric actin for 30 min. Using an antibody to actin, we found that the 
actin binding capacity of Scar-1 was not altered in cells co-expressing the constitutively 
active or kinase defective Src mutants (Figure 55).
As Scar is known to act as an intermediate between growth factor receptors and the actin 
cytoskeleton, via adapter molecules such as Grb2 and Nek (Frischknecht et al., 1999; Miki 
et al., 1999), we investigated whether Src kinase activity effected the adapter function of 
Scar by examining its ability to bind to Grb2. Cells expressing kinase-defective mutants of 
Src that where unable to remodel focal adhesions in response to PDGF were compared to 
cells expressing constitutively active Src. Cells expressing Scar-1 or co-expressing Scar-1 
with Src251-GFP, SrcMF or SrcY527F were stimulated with PDGF. Using an antibody to 
Grb2, we discovered that the presence of a Src kinase domain had no effect on the adaptor
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function of Scar-1 (Figure 56). Thus we have no evidence to date that the Src kinase 
domain can influence the function of Scar-1 within the cell.
Figure 54
Src kinase activity does not effect Arp2/3 binding to Scar-1. Cells were placed in serum- 
free conditions overnight and then stimulated with PDGF (25 ng m l'1) for 30 min. Myc-tagged 
Scar-1 was immunoprecipitated from extracts of cells co-transfected with SrcY527F, SrcMF, 
Src251-GFP or Scar-1 alone using conjugated 9E10 anti-serum. The proteins were resolved by 
SDS-PAGE and the levels of Arp2/3 binding to Scar-1 were detected following blotting with 
an anti-Arp3 antibody, upper panel. Levels of Scar-1 immunoprecipitated from cell extracts 
was determined using an anti-Scar-1 antibody, lower panel.
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Figure 55
Src kinase activity does not effect actin monomer binding to Scar-1. Cells were placed in 
serum-free conditions overnight and then stimulated with PDGF (25 ng m l'1) for 30 min. Myc- 
tagged Scar-1 was immunoprecipitated from extracts of cells co-transfected with SrcY527F, 
SrcMF, Src251-GFP or Scar-1 alone using conjugated 9E10 anti-serum and incubated with 
monomeric actin for 30 min at 4°C. The proteins were resolved by SDS-PAGE and the levels 
of actin binding to Scar-1 detected following blotting with an anti-actin antibody, upper panel. 
Levels of Scar-1 immunoprecipitated from cell extracts was determined using an anti-Scar-1 
antibody, lower panel.
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Figure 56
Src kinase activity does not effect Grb2 binding to Scar-1. Cells were placed in serum-free 
conditions overnight and then stimulated with PDGF (25 ng m l'1) for 30 min. Myc-tagged 
Scar-1 was immunoprecipitated from extracts of cells co-transfected with SrcY527F, SrcMF, 
Src251-GFP or Scar-1 alone using conjugated 9E10 anti-serum. The proteins were resolved by I 
SDS-PAGE and the levels of Grb2 binding to Scar-1 detected following blotting with an anti- 
Grb2 antibody, upper panel. Levels of Scar-1 immunoprecipitated from cell extracts was 
determined using an anti-Scar-1 antibody, lower panel.
Figure 56
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6.1.3 FA K as a candidate in Src induced focal adhesions remodelling.
Src phosphorylates and associates with a number of proteins involved in the regulation of 
focal adhesion dynamics. FAK for example, is a known Src substrate at adhesion sites and 
there is considerable evidence that FAK plays a central role in the regulation of focal 
adhesion disassembly and cell motility (see Section 1.6.2). We therefore, initially set out 
to determine whether phosphorylation of FAK was altered during PDGF-induced focal 
adhesion remodelling and lamellipodia formation. Swiss 3T3 cells were stimulated with 
PDGF, and FAK was immunoprecipitated from cell lysates with an anti-FAK antibody. 
Using an phosphotyrosine antibody we found that there was an increase in the tyrosine 
phosphorylation of FAK in PDGF stimulated cells, compared to non-stimulated cells 
(Figure 57), indicating that the PDGF-induced focal adhesion remodelling seen in Swiss 
3T3 cells is accompanied by FAK phosphorylation events. We therefore, tested whether 
phosphorylation of FAK was regulated by Src kinase activity, by examining FAK 
phosphorylation in cells expressing Src kinase defective mutants that were unable to 
remodel focal adhesions in response to PDGF and compared this to cells expressing 
constitutively active Src. Cells expressing Src251-GFP, SrcMF or SrcY527F, in which the 
Src mutants localised to focal adhesions in the presence of serum, were subsequently 
stimulated with PDGF to induce focal adhesion remodelling and lamellipodia formation. 
Under these conditions the tyrosine phosphorylation of FAK in response to PDGF 
stimulation, was compromised in cells expressing Src251-GFP and SrcMF, compared to 
cells expressing SrcY527F and was reduced to similar levels as non-transfected cells 
(Figure 58). This indicates that the presence of kinase defective Src in focal adhesions is 
inhibiting the normal phosphorylation of FAK during focal adhesion remodelling induced 
by PDGF.
FAK has been reported to be phosphorylated on a number of different sites that are 
potentially involved in mediating various properties of FAK (Calalb et al., 1995, Owen et 
al., 1999). Src for example, has been shown to phosphorylate FAK on many sites 
including tyrosine-925 (Schlaepfer & Hunter, 1996). Recent data obtained by our group 
however demonstrates that in a colorectal cancer cell line expressing Src251-GFP, FAK is 
phosphorylated on all tyrosine phosphorylation sites except for tyrosine-925 (E Avizienyte, 
unpublished). It is therefore possible that this site is a potential phosphorylation site 
linking the activities of Src and FAK to the impaired focal adhesions turnover and 
remodelling observed in this study. We therefore tested whether FAK phosphorylated on 
tyrosine-925 was located at peripheral focal adhesions or focal complexes described
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earlier, following stimulation of RhoA or Racl. In cells stimulated with LPA, FAK 
phosphorylation on tyrosine-925 (visualised using a phospho-Y925 FAK antibody) could 
be seen to localise to focal adhesions (Figure 59a, solid arrows), while FAK 
phosphorylated on tyrosine-925 was evenly distributed at the base of lamellipodia in cells 
stimulated with PDGF (Figure 59b, solid arrows). Total (non-phosphorylated and 
phosphorylated) FAK localisation was also examined under these conditions and was 
found in focal adhesions or focal complexes along the base of lamellipodia in response to 
LPA or PDGF respectively (Figure 59c,d). This data, indicates that phosphorylation of 
tyrosine-925 of FAK occurs at these peripheral adhesion sites and we therefore used 
tyrosine-925 phosphorylation as a marker of Src-induced, phosphorylation events during 
the remodelling process. We wished to establish whether, in the context of this 
remodelling, the phosphorylation of FAK on tyrosine-925 was differentially regulated in 
cells expressing constitutively active or kinase defective Src. Cells expressing Src251- 
GFP or SrcY527F, in which the Src mutants localised to focal adhesions in the presence of 
serum, were subsequently stimulated with PDGF to induce focal adhesion remodelling and 
lamellipodia formation. Under these conditions FAK phosphorylation on tyrosine-925 
could be seen to localise to discrete patches around the edge of the lamellipodia in Src251- 
GFP expressing cells (Figure 60a), while in SrcY527F expressing cells FAK 
phosphorylation on tyrosine-925 was found to be continuous along the lamellipodia 
(Figure 60b). Thus a different spatial regulation in FAK phosphorylation on tyrosine-925 
can be seen between cells expressing kinase active or defective Src however differences in 
FAK phosphorylation levels were difficult to establish. Subsequent experiments 
employing a retroviral transfection system allowed us to examine differences between 
kinase defective and active Src expressing cells (see Disccusion Section 6.2.2).
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1Figure 57
PDGF stimulation increases FAK phosphorylation. Cells were placed in serum-free 
conditions overnight and then stimulated with PDGF (25 ng m l1) for 30 min. Control cells 
were not stimulated with PDGF. FAK was immunoprecipitated from whole cell extracts using 
an anti-FAK antibody. The proteins resolved by SDS-PAGE and the levels of tyrosine 
phosphorylation were detected following blotting with an anti-phosphotyrosine antibody, upper 
panel. Levels of FAK immunoprecipitated from cell extracts was determined using an anti- 
FAK antibody, lower panel.
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Figure 58
Phosphorylation of FAK is inhibited in cells expressing kinase defective Src. Cells were 
placed in serum-free conditions overnight and then stimulated with PDGF (25 ng m l1) for 30 
min (lane 2-4). FAK was immunoprecipitated from extracts of cells transfected with 
SrcY527F, SrcMF, or Src251-GFP or non-transfected cells using an anti-FAK antibody. The 
proteins were resolved by SDS-PAGE and the levels of tyrosine phosphorylation detected 
following blotting with an anti-phosphotyrosine antibody, upper panel. Levels of FAK 
immunoprecipitated from cell extracts was determined using an anti-FAK antibody, lower 
panel.
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Figure 59
FAK phosphorylated on tyrosine-925 is found in focal adhesions and lamellipodia. Cells
were grown in serum-free conditions overnight prior to stimulation with LPA (200 ng ml "') for 
30 min (a,c) or PDGF (25 ng ml"1) for 30 min (b,d). FAK phosphorylated on tyrosine-925 was 
visualised using a phospho-FAK-Y925 specific antibody (a,b), while FAK was visualised 
using an anti-FAK antibody (c,d). Arrows indicate FAK localisation. Scale bars 25 pm.
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Figure 60
FAK phosphorylation on tyrosine-925 localises to discrete patches around the edge of the 
lamellipodia in Src251-GFP expressing cells and is found to be continuous along the
lamellipodia in SrcY527F expressing cells. Cells transfected with SrcY527F (a) or Src251- 
GFP (b) were grown in serum-free conditions overnight prior to stimulation with PDGF (25 ng 
m l'1) for 30 min. FAK phosphorylated on tyrosine-925 was visualised using a phospho-FAK- 
Y925 specific antibody (a,b). Scale bars 25 pm.
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6.2 Discussion
In this chapter we addressed whether the impaired remodelling observed in cells 
expressing kinase defective Src could be linked to two potentially important Src binding 
partners/substrates, Scar and FAK.
6.2.1 Scar as a candidate in Src induced focal adhesions remodelling.
We initially addressed whether the impaired remodelling in cells expressing kinase- 
defective Src could be related to Src-induced changes in the localisation of Scar. Scar is 
involved in Racl mediated actin polymerisation, which is a prerequisite for lamellipodia 
formation and could potentially influence the efficiency of lamellipodia formation 
(Machesky & Insall, 1998; Machesky et al., 1997; Miki et al., 1998b). Previous reports for 
example, have demonstrated that Scar plays a critical role in Racl induced lamellipodia 
formation (Machesky & Insall, 1998; Miki et al., 1998b). Scar was found at the same 
peripheral sites as Src in response to RhoA and Racl stimuli, indicating that Scar’s spatial 
regulation within the cell is consistent with a potential role in remodelling events during 
lamellipodia formation. After inducing focal adhesion remodelling to form lamellipodia, 
we found that Scar was still localised with Src even in the kinase-defective cells that were 
unable to efficiently remodel their focal adhesions to induce uniform lamellipodia. This 
suggested that Scar was at the correct sites within the cell to initiate the actin remodelling, 
required for lamellipodia formation, however efficient remodelling of the actin 
cytoskeleton did not occur. One explanation for this is that Scar activity may be 
compromised in cells expressing the kinase defective Src mutants. We therefore examined 
whether the function of Scar within the cell was altered in cells expressing constitutively 
active or kinase defective mutants of Src. The ability of Scar to bind to the Arp2/3 
complex and thereby control actin polymerisation during lamellipodia formation however 
was not altered in cells expressing kinase defective Src mutants. Consistent with this, Src 
kinase activity had no effect on the ability of Scar to bind to actin monomers in vitro. We 
can therefore conclude from this that the inhibition of focal adhesion remodelling observed 
in kinase defective Src expressing cells may not be mediated by alterations in Scar-1- 
induced actin binding events.
Other factors involving Scar-1 however could also influence the remodelling events during 
lamellipodia formation. Grb2 for example, has recently been shown to bind to Scar (Miki 
et al 1999) and has been shown to be required for lamellipodia formation, as inhibitory
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antibodies to Grb2 block PDGF-induced lamellipodia formation (Matuoka et al., 1993). 
Moreover, Grb2 has also been shown to bind and sequester proteins to the plasma 
membrane (Li et al., 1993; Miki et al., 1999; Rozakis-Adcock et al., 1993; She et al., 
1997). The binding therefore of Grb2 to Scar could potentially be involved in the 
peripheral targeting of Scar and the Arp2/3 complex to the cell membrane during 
lamellipodia formation. Alterations in the binding of Grb2 to Scar in cells expressing 
active or kinase defective Src could therefore effect the efficient formation of lamellipodia 
(Miki et al., 1999). In this study however we demonstrate that expression of kinase active 
or deficient Src mutants in cells has no effect on Grb2 binding to Scar thereby ruling out 
this possibility in our model. Tyrosine phosphorylation of the related protein WASP has 
been reported in various cell systems to alter its function and thereby the actin dynamics 
within the cell during a number of processes and this phosphorylation-induced alteration in 
WASP function could therefore act as a precedent for Scar regulation during lamellipodia 
formation (Oda et al., 1998; She et al., 1997; Wu et al., 1998). Under the conditions of our 
study however we have not detected any alteration in the tyrosine phosphorylation status of 
Scar within the cells expressing kinase active or defective Src mutants. Scar was thought 
to be a potential candidate involved in linking Src to the actin cytoskeleton during 
lamellipodia formation. To date however we have no evidence that Scar function is altered 
in cells expressing constitutively active or kinase defective Src mutants, suggesting that 
alterations in Scar localisation or activity are not responsible for the impaired remodelling 
observed in cells expressing kinase defective Src. We cannot however completely rule out 
the possibility that Scar may be involved in this process by mechanisms that we have not 
addressed.
6.2.2 FAK as a candidate in Src induced focal adhesions remodelling.
Src binds to and phosphorylates a number of other cytoskeletal associated proteins and 
here we have addressed the involvement of FAK in focal adhesion remodelling. There is 
convincing evidence that the linked activity of Src and FAK, controls adhesion turnover 
and cell migration (see Section 1.6.2). Direct evidence for a link between Src and FAK in 
adhesion turnover comes from studies where over-expression of exogenous FAK in CHO 
cells stimulates cell migration, which is dependent on its ability to associate with Src 
family members (Cary et al., 1996). Furthermore, expression of FAK mutants unable to 
bind Src, hinders focal adhesion turnover and cell migration (Cary et al., 1996). Finally, 
evidence that dominant-inhibitory Src proteins and the absence of FAK both give rise to 
enlarged cellular adhesions and impaired migration (see Section 1.6.1), strongly suggests 
that the critical role of their activity is to induce adhesion turnover and remodelling. In this
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regard, mutants of Src that suppress cell motility, including kinase defective Src (see 
Chapter 3) have previously been shown to impair FAK proteolysis and adhesion turnover 
(Fincham & Frame, 1998). In this study we have shown that tyrosine phosphorylation of 
FAK is suppressed in cells expressing kinase defective Src. Recently, regulatory events 
that lead to Src-mediated adhesion disassembly via FAK have come from studies on v-Src- 
induced focal adhesion disruption, in which v-Src induced tyrosine phosphorylation of 
FAK precedes its calpain-mediated proteolytic cleavage. This results in FAK cleavage, 
adhesion disassembly and cell detachment (Carragher et al., 2001; Carragher et al., 1999; 
Fincham et al., 1995). In keeping with this, calpain is present at focal adhesions and is 
required for migratory responses downstream of EGFR (Beckerle et al., 1987; Glading et 
al., 2000). Moreover, recent work by our group has also demonstrated that inhibition of 
calpain blocks cell migration (Carragher et al., 2001). It is therefore possible that FAK 
phosphorylation and the calpain-mediated proteolysis of FAK is a tightly controlled 
process that triggers adhesion turnover and remodelling when cell/matrix adhesions are 
being dynamically regulated during Src dependent cell migration. In this regard, the 
reduced phosphorylation of FAK in kinase defective cells may explain why cells 
expressing kinase defective Src have reduced focal adhesion turnover and remodelling and 
as a result cell migration and polarisation is impaired. In line with this, previous work by 
our group has shown that un-phosphorylated FAK, in the presence of kinase defective v- 
Src, forms a more stable complex with Src and remains un-degraded in stabilised focal 
adhesions (Fincham & Frame, 1998).
FAK has been documented to be phosphorylated on a number of different sites (Calalb et 
al., 1995; Owen et al., 1999). We chose to study the phosphorylation of FAK on tyrosine- 
925 as it has previously been shown to be the only site on FAK that is not phosphorylated 
in Src251-GFP expressing colorectal cancer cells (E Avizienyte, unpublished) and is 
therefore a potential link between the impaired focal adhesion turnover and remodelling 
observed in cells expressing kinase defective Src and the activities of Src and FAK in this 
process. In the context of focal adhesion remodelling to lamellipodia, we examined 
whether the phosphorylation of FAK on tyrosine-925 is differentially regulated in cells 
expressing SrcY527F or SrcMF. We found a different spatial regulation in FAK 
phosphorylation on tyrosine-925 between cells expressing kinase active or defective Src 
however differences in FAK phosphorylation levels by immunofluorescence were difficult 
to visualise. Subsequently, experiments employing a retroviral transfection system to 
increase the percentage of cell expressing the respective Src constructs allowed us to see 
more subtle differences between cells expressing kinase defective and active Src mutants. 
Cells expressing the empty vector or SrcMF in which SrcMF was localised to focal
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adhesions, were stimulated with PDGF. Using an antibody against phosphorylated 
tyrosine-925 in FAK, we found that PDGF stimulated the phosphorylation of tyrosine-925, 
while in cells expressing SrcMF there was very little phosphorylation on this site (Figure 7, 
(Timpson et al., 2001). Therefore, using FAK tyrosine 925 phosphorylation as a marker of 
Src-dependent phosphorylation events at peripheral adhesions, we have shown that kinase 
defective Src expression suppresses both peripheral phosphorylation events and adhesion 
re-modelling. The potential link between FAK-925 phosphorylation and focal adhesion 
remodelling and turnover will be discussed in more detail in chapter 7 (see section 7.1.4, 
future studies). Reduced FAK phosphorylation on tyrosine-925, like the general reduction 
in phosphorylation of FAK in kinase defective cells, in response to PDGF stimulation, may 
effect its susceptibility to calpain cleavage and explain the impaired remodelling and 
directed cell migration observed in these cells. The potential involvement of FAK-specific 
phospho-acceptor sites and their involvement in FAK degradation, focal adhesion 
disruption and remodelling could be examined in the future. For this, we currently have 
constructs encoding epitope tagged mutant FAK proteins with each of FAK’s tyrosine 
phosphorylation sites mutated to phenylalanine, both individually and in combinations, 
thereby inhibiting possible tyrosine phosphorylation on these sites. Over-expression of 
these proteins would allow us to determine for example, whether Src-induced 
phosphorylation of FAK on tyrosine-925 observed here, regulates focal adhesion turnover 
and remodelling, as well as allowing us to assess the role other phosphorylation sites play 
in this process. It is possible that phosphorylation on one or more of these sites could be 
involved in focal adhesion turnover during cell migration. On the other hand 
phosphorylation has been shown to stabilise FAK, for example, integrin-induced 
phosphorylation of FAK on tyrosine-397 is associated with focal adhesions assembly, 
which interestingly has recently been shown to protect FAK and focal adhesions from 
degradation induced by v-Src (N Carragher, unpublished). The potential for site specific 
phosphorylation events in controlling focal adhesions disassembly or assembly, makes 
FAK an exciting candidate to examine further as a key player in adhesion dynamics 
induced by Src during cell migration.
Phosphorylation of FAK on tyrosine-925 also recruits the SH2 domain of the adaptor 
protein Grb2 (Schlaepfer & Hunter, 1996) which in turn can result in activation of the Ras- 
extracellular signal regulated kinase (ERK) pathway. Several lines of evidence suggest a 
role for this pathway in the control of cell motility and polarity. Firstly, as described 
earlier inhibitory antibodies to Grb2 block PDGF-induced lamellipodia (Matuoka et al.,
1993). Secondly, activated ERK has been found in newly forming focal adhesions where it 
is thought to play a role in their assembly (Fincham et al., 2000). Thirdly, inhibition of
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ERK activation blocks cell migration in different cell types (Klemke et al., 1997; Nguyen 
et al., 1999) which has been attributed to the ability of ERK to phosphorylate and activate 
MLCK (Nguyen et al., 1999). Moreover, we have recently shown that inhibition of MEK 
blocks Src-induced focal adhesion turnover (V. Fincham unpublished). MLCK is 
important for the formation of peripheral adhesions and the generation of tension during 
cell motility (Schoenwaelder & Burridge, 1999). Therefore, the reduced phosphorylation 
on tyrosine-925 could potentially explain the impaired lamellipodia and cell migration 
observed in cells expressing kinase defective Src by a mechanism which involves an 
impaired FAK-Grb2-ERK signalling pathway.
6.3 Summary
In this chapter we have initiated studies to address the involvement of two potentially 
interesting binding partners/substrates of Src in focal adhesion to focal complex 
remodelling during lamellipodia formation. Src however, also phosphorylates and binds to 
a number of other cytoskeletal and focal adhesion associated proteins and these events 
along with Src’s potential link to yet unidentified proteins may also be involved in 
adhesion turnover, remodelling and directed cell motility (Arthur & Burridge, 2001; Arthur 
et al., 2000; Thomas et al., 1995). The impaired FAK phosphorylation reported in this 
study are therefore likely to represent only part of a number of Src mediated 
phosphorylation events regulating focal adhesion remodelling and directed cell motility.
In these experiments we have focused on focal adhesion remodelling events during 
lamellipodia formation. It should be noted that time permitting we would also like to 
address the involvement of potential candidates in the focal adhesion remodelling during 
bradykinin (Cdc42)-induced filopodia formation. It is possible that different candidates 
may play a role in focal adhesion remodelling depending on the structure being formed and 
therefore some candidates may be specifically involved in lamellipodia formation while 
others could be involved in filopodia formation or both.
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7 C onclusion
7.1 Summary and future work.
7.1.1 Summary
The ability of a cell to move depends on a cycle of adhesion, loss of attachment and re­
adhesion, which is governed by, and co-ordinated with, changes in the actin cytoskeleton 
arrangement (Schoenwaelder & Burridge, 1999; Small et al., 1999). The actin structures, 
lamellipodia and filopodia assemble and disassemble at the leading edge of cells under the 
control of Racl and Cdc42, providing a means of polarised cell movement. Small focal 
complexes form at lamellipodia and filopodia, which are rapidly turned over as the cell 
moves forward, while the RhoA-dependent assembly of stress fibres provide contractility 
and propulsion required for forward cell movement. Since it is the balance between 
contractility and adhesion that governs the rate of cell motility, relative activities of RhoA, 
Racl and Cdc42 are critical in determining whether and how a cell moves. Moreover, 
alterations in adhesive interactions between the cell and the substratum by protein-protein 
interactions, via proteins such as Src, during this process also influence cell migration. In 
the current study we have examined both the role of the RhoGTPases in directing the 
intracellular localisation of the tyrosine kinase c-Src, that is known to be required for 
adhesion turnover and cell motility (Fincham & Frame, 1998), and secondly examined the 
role of Src kinase activity in controlling cell movement.
The current data presented here and in previous studies with v-Src (Fincham et al., 2000; 
Fincham & Frame, 1998; Fincham et al., 1996) has helped us define a number of stages in 
Src’s peripheral targeting. Firstly, Src is transferred from the microtubule-dependent 
perinuclear region of the cell into multi-protein complexes, yet to be fully identified, which 
associate with the actin cytoskeleton (Fincham & Frame, 1998; Fincham et al., 1996). 
Subsequently Src translocates to the cell periphery to focal adhesions in a RhoA and actin- 
dependent manner (see Figure 61) (See Chapter 4, Section 4.1.1 (Fincham et al., 1996). 
Moreover, we have illustrated here, that the co-ordination of RhoGTPases is required to 
specifically relocate Src from RhoA-induced focal adhesions to lamellipodia or filopodia 
following Racl or Cdc42 activation, respectively (see Chapter 4, section 4.1.1). 
Furthermore, the kinase activity of Src has previously been shown to be dispensable for 
Src’s peripheral targeting to focal adhesions (Fincham & Frame, 1998; Kaplan et al.,
1994).
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We show in this study that Src kinase activity is required for focal adhesion turnover and 
remodelling to induce the disassembly of large focal adhesions to smaller focal complexes 
needed for efficient lamellipodia or filopodia formation and directed cell migration 
(Chapter 5). Finally, we have identified FAK as a potential binding partner/substrate 
involved in Src-induced focal adhesion remodelling during lamellipodia formation 
(Chapter 6).
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Figure 61
Schematic representation of Src’s intracellular targeting from the perinuclear region of 
the cell to lamellipodia or filopodia. Illustrating some questions yet to be addressed 
including which potential chaperon proteins are involved in the peripheral targeting of Src and 
which potential candidates are involved in Src’s focal adhesion remodelling during 
lamellipodia or filopodia formation.
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7.1.2 Future studies.
The two main areas for future investigations are (a) the role of various proteins in the 
initial peripheral targeting of Src from a perinuclear location to the cell periphery (see 
Figure 61) and (b) examination of proteins potentially involved in Src-induced focal 
adhesion turnover and remodelling during lamellipodia and filopodia formation (See 
Figure 61).
7.1.3 Potential candidates involved in Src’s perinuclear to peripheral 
targeting
As discussed in the introduction (see Section 1.1.1), Src contains both SH2 and SH3 
protein-protein interacting domains, which can associate with a variety of different 
chaperon proteins. It has been postulated that sequential binding of a sub-set of proteins 
may mediate the translocation of Src between sub-cellular compartments within the cell 
and it is therefore likely that different proteins will be specifically involved in different 
stages of Src’s intracellular targeting. To date, we ha^e ruled out a number of key 
components in Src’s peripheral targeting including AFAP, HSP90 and FAK (see 
Introduction Section 1.2.2) (Fincham et al., 2000). We have however, identified PI3- 
kinase as an SH3 binding protein required for Src’s peripheral targeting to focal adhesions, 
most likely mediated by its ability to maintain actin stress fibre integrity (Fincham et al., 
2000). In addition to this, there are many proteins that bind to Src, whose likely cellular 
functions are consistent with a role in Src’s peripheral targeting. The Scar family of 
proteins that control actin polymerisation for example, were assessed in Chapter 6 (see 
Section 6.1.1) as potential candidates involved in focal adhesions remodelling and actin 
reorganisation during lamellipodia formation. Interestingly, Machesky and Hall have 
previously demonstrated that long-term expression of inhibitory Scar-1 mutants result in a 
loss of actin stress fibres, indicating that there is a need for actin nucleation and new 
polymerisation, induced by Scar-1, for long-term maintenance of stress fibres (Machesky 
& Hall, 1997). This requirement for actin polymerisation to maintain stress fibres has been 
demonstrated by the incorporation of new polymerised actin into stress fibres (Machesky 
& Hall, 1997). It is therefore possible that Scar-ls ability to control actin polymerisation 
may be involved in Src’s peripheral targeting by maintaining actin stress fibre integrity 
during RhoA and actin dependent targeting of Src to focal adhesions.
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To address the role of actin polymerisation in Src targeting to the cell periphery, we could 
inhibit actin polymerisation and examine Src translocation and new actin assembly in real 
time using time lapse microscopy. Cells could be microinjected with rhodamine-labelled 
actin (Chan et al., 1998; Small et ah, 2002), to allow us to monitor actin dynamics in real 
time. This will allow us to visualise both, Src251-GFP translocation to focal adhesions and 
the incorporation and remodelling of new actin in real time. From this we could determine 
whether Src translocation occurs along with new actin polymerisation or whether Src is 
targeting to the cell periphery along pre-formed actin stress fibres.
With regards to RhoA-induced peripheral targeting of Src to focal adhesions we have also 
demonstrated that inhibition of the Rho-effector ROCK (see Section 1.4.1), blocks this 
peripheral targeting process (see Chapter 4). ROCK is thought to co-operate with various 
other RhoA effector to induce stress fibres (see Section 1.4.1). Recently the diaphanous 
related formin proteins, mDia 1/2 have attracted attention as important effectors co­
operating with ROCK to induce actin stress fibres (see Section 1.4.1). Interestingly, a 
direct association between c-Src and mDial/2, most likely mediated by the SH3 domain of 
Src and the proline-rich sequences of the Dia protein FH domains has been reported 
(Tominaga et al., 2000). Moreover, the expression of a dominant inhibitory Src protein, or 
deletion of the FH1 domain of mDia2 has been reported to abolish the co-operative effects 
of the Dia proteins with ROCK in mediating RhoA-induced stress fibre formation 
(Tominaga et al., 2000). These properties of mDial/2 make them exiting candidates that 
potentially play a role in Src’s peripheral targeting. It has therefore been proposed that 
RhoA may localise Src to focal adhesions via mDial/2 (Tominaga et al., 2000). A number 
of DRF proteins and mutants are currently available to address the involvement of 
diaphanous proteins in Src’s peripheral targeting (provided by Art Albert’s group at the 
Van Andel Institute, Michigan). Furthermore, mouse cells that are functionally -/- for 
mDial or mDia2 are being generated by Art Alberts group, which will help establish the 
involvement of Dia in Src’s peripheral transport to focal adhesions.
There are almost certainly more Src binding partners and methods of Src transport to the 
cell periphery to be identified. For example, recent work by our group has suggested that, 
like its binding partner paxillin, there may be a vesicle-mediated delivery component to the 
intracellular targeting of Src. Mutants of v-Src which do not target to the cell periphery 
can be observed located in the perinulcear region of the cell in structures that resemble 
large vesicles (V Fincham, unpublished observation), suggesting that these non-targeting 
mutants are unable to be released from this mode of transport to the actin cytoskeletal 
transport mechanisms described in this study. The ARF-GTP-binding proteins could be
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potential candidates involved in this process, as they are well known regulators of 
intracellular membrane traffic (Serafini et al., 1991) and have previously been identified as 
Src binding partners (Brown et al., 1998). Moreover, ARF proteins have been shown to be 
involved in the vesicular transport of various proteins to the cell periphery, such as paxillin 
(Norman et al., 1998), as well as being implicated in regulation of the actin cytoskeleton 
(Randazzo et al., 2000). Furthermore, ARF proteins have been documented to localise in 
the perinuclear region of the cell and to focal adhesions, or to peripheral lamellipodia 
during cell migration (Brown et al., 1998; Randazzo et al., 2000). These properties of ARF 
proteins make them exciting candidates that may potentially play a role in Src’s 
intracellular targeting, both as a link between the potential vesicle-mediated targeting of 
Src and the known actin-dependent targeting of Src described in this study. As discussed 
earlier, it is likely that the sequential binding of a sub-set of proteins may mediate the 
transport of Src between sub-cellular compartments. Our ability to regulate the 
intracellular localisation of Src by modulating the actin cytoskeleton (described in this 
study) or by utilising the versatile properties of the temperature sensitive (ts) v-Src system, 
which incorporates both targeting and non-targeting mutants of Src (Fincham et al., 2000; 
Westphal et al., 1997), provides us with excellent tools to address the involvement of 
various proteins at different stages of Src’s intracellular targeting and may reveal more 
about the interactions between Src, the actin cytoskeleton and other potentially modes of 
transport, including vesicle based targeting within the cell. A greater understanding of the 
nature and mechanisms involved in the defined stages of Src’s intracellular transport may 
lead to the identificatio of new key players in this process in the future.
7.1.4 Potential candidates involved in Src’s focal adhesion remodelling 
during lamellipodia or filopodia formation.
In this study we have demonstrated a further stage in Src’s intracellular targeting, by 
illustrating the remodelling of Src containing focal adhesions to lamellipodia or filopodia 
in response to the respective RhoGTPase (see Figure 61) (see chapter 4 section 4.1.4 and 
4.1.5). Similar to the strategy discussed above, we have employed a candidate approach 
here to address the involvement of potential proteins involved in this specific remodelling 
and our preliminary results suggest that FAK might be involved in the regulation and 
partial disassembly of large focal adhesions to smaller focal complexes necessary for 
lamellipodia formation (see chapter 5 section 5.1.4 and 5.1.5 and chapter 6 section 6.1.3).
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FAK is unlikely to be the sole substrate of Src involved in focal adhesion turnover. 
Cortactin, paxillin and ERM proteins are amongst some of the other potential candidates 
involved in Src induced focal adhesion remodelling. The effects on FAK phosphorylation 
reported in this study are therefore likely to represent only part of a number of Src 
mediated phosphorylation and binding events regulating adhesion remodelling in response 
to biological stimuli that induce directed cell migration. The list of potential candidates 
involved in Src’s perinuclear to peripheral targeting or in Src-induced phosphorylation 
events during adhesion remodelling, is not exhaustive, and on a long term basis we plan to 
screen for other potential candidates involved in these processes. Standard procedures will 
be used, including co-immunoprecipitation, metabolic labelling and 2D gel electrophoresis 
to identify binding partners/substrates that are specifically linked to the impaired focal 
adhesion remodelling observed in cells expressing kinase defective Src. Cells expressing 
activated or kinase deficient Src, treated with the respective stimuli (PDGF or bradykinin), 
will be used to examine the differential Src protein binding partners/substrates involved in 
Src’s intracellular targeting at different stages within the targeting process. This will allow 
us to specifically link known and potentially unknown binding proteins to the impaired 
focal adhesions remodelling observed in this study during lamellipodia of filopodia 
formation respectively. Unidentified proteins that are differentially expressed will then be 
subjected to further examination and identification by mass spectroscopy.
A great deal of structural and functional studies with members of the Src family kinases 
has led to a detailed understanding of Src activation and inactivation at the molecular level 
(see Introduction Section 1.1.3). Conformational activation, usually induced by de­
phosphorylation of Src tyrosine-527, or displacement of Src’s intramolecular interactions, 
simultaneously stimulates catalytic activity and frees the protein binding domains for 
protein-protein interactions, which could potentially control Src’s targeting within the cell. 
The co-ordinated regulation of Src targeting by RhoGTPases and the simultaneous kinase 
activation ensures that inadvertant relocalisation of active Src is avoided. This allows Src 
to respond for example, to migratory stimuli such as PDGF, and specifically incorporate 
into adhesions as they form. Src activity at these sites however, ultimately induces the 
disassembly and remodelling of adhesions (see Introduction Section 1.6.1) which is 
necessary for example, to produce protrusive structures such as lamellipodia and filopodia. 
Since the formation of these structures is intimately involved in controlling cell migration 
and chemotaxis, the major challenge now is to establish how motile cells spatially and 
temporally integrate the activity of RhoA, Racl and Cdc42, which in turn spatially 
regulates c-Src during cell migration. In future work, monitoring Src by direct 
fluorescence may allow us to begin to address how the integrated effects of RhoGTPases
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relates to the spatial and temporal regulation of Src at different stages during the process of 
directed cell migration. Recently, we have intitiated studies to address this by visualising 
Src’s intracellular targeting in real time using a C-terminal linker sequence to tag full 
length Src with GFP (a kind gift from G. Superti Furga). Furthermore, understanding 
which proteins are key regulators in this process and determining how Src-kinase 
dependent events at focal adhesions regulate remodelling in response to biological stimuli 
that induce directed cell migration will be of great interest in the future. It should be noted 
that RhoA, Racl and Cdc42 may also regulate the localisation of other proteins within the 
cell that, like Src, play an important role in adhesion dynamics during cell migration.
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Background: The ability of a cell to polarize and move is governed by 
remodeling of the cellular adhesion/cytoskeletal network that is in turn 
controlled by the Rho family of small GTPases. However, it is not known 
what signals lie downstream of Racl and Cdc42 during peripheral actin and 
adhesion remodeling that is required for directional migration.
Results: W e show here that individual members of the Rho family, RhoA, 
R a c l, and Cdc42, direct the specific intracellular targeting of c-Src 
tyrosine kinase to focal adhesions, lamellipodia, or filopodia, respectively, 
and that the adaptor function of c-Src (the combined SH3/SH2 domains 
coupled to green fluorescent protein) is sufficient for targeting. Furthermore, 
S rc ’s catalytic activity is absolutely required at these peripheral cell-matrix 
attachment sites for remodeling that converts RhoA-dependent focal 
adhesions into smaller focal complexes along R ad-induced lamellipodia 
(or Cdc42-induced filopodia). Consequently, cells in which kinase-deficient 
c-Src occupies peripheral adhesion sites exhibit impaired polarization toward 
migratory stimuli and reduced motility. Furthermore, phosphorylation of FAK, 
an Src adhesion substrate, is suppressed under these conditions.
Conclusions: Our findings demonstrate that individual Rho GTPases 
specify S rc ’s exact peripheral localization and that R a d  - and Cdc42- 
induced adhesion remodeling and directed cell migration require Src activity 
at peripheral adhesion sites.
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Background
Adhesive interactions between cells and the extracellular 
environment, together with regulation of the intracellular 
cytoskeleton, control a number of key biological functions, 
including cell motility and invasion. Focal adhesions con­
sist of clustered integrins and proteins that link the extra­
cellular matrix (EGM), through the integrins, to the actin 
cytoskeleton and to proteins involved in adhesion-depen­
dent signal transduction [1]. One such protein is the non­
receptor tyrosine kinase c-Src that can also associate with 
endosomal membranes in the perinuclear region of the 
cell [2, 3]. Mutation of tyrosine-527 to phenylalanine in 
c-Src, which results in catalytic activation, as well as re­
lease of constraints on the SH3 and SH2 domains, leads 
to c-Src being constitutively associated with focal adhe­
sions 14], Similarly, temperature-sensitive variants of the 
viral oncoprotein v-Src localize to focal adhesions when 
activated by switch to permissive temperature [5]. 1 he 
kinase activity of v-Src or c-Src is not required foi focal 
adhesion localization, but mutational analy sis has i c\ ealed 
a critical role for the SH3 domain of both proteins in their 
intracellular targeting f4, 6, 7]. Although the localization 
of Src to focal adhesions does not require Src’s catalytic 
activity, kinase activity is required foi v-Src-induced focal 
adhesion turnover during transformation and motility [6,
8]. Thus, in order for v-Src to induce its biological effects, 
it must first be translocated from its site of synthesis to 
its site of action at peripheral cell-matrix adhesions.
T h e  localization of v-Src to focal adhesions requires the 
integrity of the actin cytoskeleton and is under the control 
of RhoA G TPase  [5]. In fibroblasts, activation of Rho 
GTPases, RhoA, Racl, and Gdc42 by different transmem­
brane receptors leads to distinct rearrangements of the 
actin cytoskeleton. Activation of RhoA stimulates actomy- 
osin-based contractility, which leads to the assembly of 
actin stress fibers and focal adhesions found at the end 
of stress fibers [9, 10]. Racl activation leads to localized 
actin polymerization at the cell periphery, resulting in 
the formation of lamellipodia, while activation of Cdc42 
results in the formation of fine actin-rich protrusions, 
known as filopodia [11-13]. Racl and Cdc42 stimulate 
the assembly of focal complexes that are associated w ith 
lamellipodia and filopodia, respectively. They  contain a 
number of the same proteins found in Rho-induced focal 
adhesions, including vinculin, paxillin, and focal adhesion 
kinase (FAK) [13].
Here, we addressed how RhoA-, Racl-, or Cdc42-induced 
changes in the actin cytoskeleton influence the intracellu-
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lar localization of c-Src and Src’s biological effects at these 
peripheral sites. As the first 251 amino acids of c-Src, 
comprising the site of myristylation, unique region, and 
SH3 and SH2 domains, are sufficient to localize c-Src to 
ocal adhesions, we used green fluorescent protein (OFF) 
used to the first 251 amino acids of c-Src (Src251-GFP) 
o monitor subcellular localization following stimulation 
of the Rho GTPases. Upon stimulation of RhoA, Racl, 
or Gdc42, actin reorganization is accompanied bv recruit­
ment of c-Src to peripheral adhesion sites at stress fiber 
lermini, lamellipodia, or filopodia, respectively. Further­
more, modulation of the actin cytoskeleton showed that 
ThoA activity and actin stress fibers are needed for Src’s 
ranslocation from the cell interior to the membrane, with 
he precise peripheral localization being determined by 
local actin organization that is in turn controlled by RhoA, 
OcT, and Cdc42 activities. In addition, Src’s catalytic 
ictivity is required for the Racl- and Cdc42-induced adhe- 
ion remodeling that is required for cell polarization and 
nigration. We also show that impaired adhesion remodel­
ing in the presence of Src proteins that lack kinase activity 
s accompanied by reduced peripheral phosphorylation 
events, as shown by suppression of FAK phosphorylation 
it tyrosine 925.
Results
The regulation of the actin cytoskeleton by the Rho family 
>f G T P ases  is well docum ented and readily manipulated 
n Swiss 3T3 cells, making them  an ideal model system 
n which to study the role of RhoA, Racl, and Cdc42 in the 
ntracellular targeting of c-Src. We therefore determined 
w hether Src251-GFP (Figure 1) was a suitable tool for 
tudying the targeting of c-Src in these cells. We intro­
duced Rho, Rac, and Cdc42 expression plasmids and 
Src251-GFP by transient transfection or microinjection 
'further  details on the conditions used are given in the 
Supplementary methods section available with this article 
online).
ranslocation of Src251-GFP to focal adhesions 
s dependent on the actin cytoskeleton
When Src251-GFP was microinjected into serum-starved 
veils, it was located in the perinuclear region (f igu re  lb, 
;Trow). I lowever, upon addition of serum, which resulted 
in reformation of stress fibers, S rc251-G fP translocated 
to sites at the end of the actin cables (Figure lc, arrows), 
where it colocalized with the focal adhesion protein vin- 
culin (data not shown). Similar results were seen following 
treatm ent with lysophosphatidic acid (UFA) (f igure  Id), 
which initiates the reformation of actin stress fibers in 
serum-starved Swiss 3 1 3 cells in a RhoA-depcndent man­
ner [9], T re a tm e n t  with the actin-disrupting drugcytocha- 
lasin I) p revented the reformation of the actin stress fibers 
in response to serum and the translocation of Src251- 
G FF  from the perinuclear region to the peripheral focal 
adhesions (Figure le), further confirming that the translo­
cation of Src251-GFP to focal adhesions was actin d ep en ­
dent. Thus ,  the regulation of Src251-GFP in Swiss 3T3 
fibroblasts is indistinguishable from the actin-dependent 
translocation of v-Src to focal adhesions that we have 
described previously [5]. T h e se  results imply that Src251- 
G F F  is a useful tool to monitor the control of c-Src’s 
intracellular targeting by direct fluorescence.
Localization of Src251-GFP to specific peripheral sites 
is under the control of Rho family GTPases
As treatm ent with LPA, which activates RhoA, resulted 
in translocation of Src251-GFP to focal adhesions (Figure 
Id), we set out to determ ine w hether this was a RhoA- 
d ep en d en t  event. Expression of a constitutively active 
RhoA protein (V14RhoA) in the absence of serum resulted 
in the formation of stress fibers (Figure 2a, broken arrow). 
Coexpression of V14RhoA with Src251-GFP was suffi­
cient to localize Src to the cell periphery at the ends of 
stress fibers (Figure 2a, broken arrow), where it coloca­
lized with the focal adhesion protein vinculin (data not 
shown).
We then addressed how activation of Racl or Cdc42 influ­
enced the localization of c-Src within the cell. Activated 
Racl protein (L b lR a e l)  was expressed in the cells by 
transient transfection and resulted in the formation of 
lamellipodia (Figure 2b, broken arrows). Coexpression of 
Src251-GFP with L b lR a c l  showed that Src251-GFP was 
localized at an actin ring around the cell periphery (Figure 
2b, solid arrow) beyond which an actin ruffle had formed. 
Src251-GFP was also found at the tip of the ruffle that 
appeared to have folded back on itself (Figure 2b, broken 
arrows). Coexpression of a constitutively active Cdc42 
protein (V12Cdc42) with Src251-GFP resulted in the for­
mation of filopodia, and some of the expressed Src251- 
G FF  moved from the perinuclear region to mem brane 
regions at the base of filopodia (Figure 2c, broken arrow), 
and at enhanced resolution (Figure 2c, inset) it can be 
seen in distinct complexes spaced along the actin filopodia 
(broken arrows, inset).
T h e  role of the individual Rho GT Pases in the subcellular 
targeting of c-Src was further probed in experiments using 
specific inhibitors of RhoA, Racl, and Cdc42. Expression 
of a dominant-negative RhoA protein (N19RhoA) pre­
vented the reformation of  stress fibers in response to 
serum (compare Figure 3a with 3b). T h e  broken arrow 
shows a cell expressing N19RhoA, which is consequently 
devoid of actin stress fibers and in which Src251-GFP 
remained perinuclear (Figure 3b). T h is  was in contrast to 
its location at peripheral focal adhesions in cells stimulated 
with serum (Figure 3a). Y-27632 is a chemical inhibitor 
of Rho kinase (ROCK) [14], which is a downstream ef­
fector of RhoA implicated in stress fiber formation [15, 
16]. T reatm ent of cells with Y-27632 residts in the loss 
of stress fibers, and, when cells were treated with Y-27632
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Transiocation of S rc251-G FP to focal 
adhesions is dependent on the actin 
cytoskeleton. (a ) Schem atic representation of 
the structural domains of Src251-G FP, 
SrcY527F, and SrcMF constructs used, (b ) 
Cells w ere serum starved for 48 hr prior to 
microinjection of Src251-G FP. (c ,d) Serum- 
starved cells were microinjected with Src251- 
GFP and, following expression of the protein, 
were stimulated with serum (c) or LPA (d).
(e ) Serum -starved cells were microinjected 
with S rc251-G F P  and pretreated with 
cytochalasin D for 2 hr before stimulation with 
serum. Actin w as visualized with rhodamine- 
phalloidin, and Src251-G F P  was localized by 
direct fluorescence. Scale bars =  25 |xm.
(a) Src251-GFP
amini
myristylation site 
1
acid 251
M unique SH3 SH2 GFP
SrcY527F (constitutively active) 
myristylation site
Tyr 416 Tyr 527 ( Y ) - ^ P h e ( F
M unique SH3 SH2 kinase domain tail
SrcMF (kinase defective; K295M, Y527F)
myristylation site
Lys 295 ( K )—► Met (M) Tyr 527 ( Y ) —► Phe ( )
M unique SH3 SH2 kinase domain tail
Serum-free
(b)
Serum LPA Serum + cytochalasin ;
(e)
/
Src, green; phalloidin, red
prior to expression o f  Src251-GFP, the cells were devoid 
of  stress fibers even though serum was present and transio­
cation o f  Src251-GFP to peripheral focal adhesions in 
response to serum was blocked (Figure 3c). Y-27632 has 
also been  reported to inhibit o ther kinases, and we cannot 
rule ou t the possibility that Y-27632 is inhibiting kinases 
o ther than ROCK. However, in the context of  these  exper­
iments, trea tm en t with Y-27632 results in the loss o f  stress 
fibers and taken toge ther  with the ability o f  N19RhoA to 
block transiocation of Src251 -G F P  to focal adhesions we 
conclude that the  ac tin -dependen t localization of  Src251- 
G F P  to these  peripheral sites is controlled hy RhoA.
Platelet-derived growth factor (P D G F )  stimulates the for­
mation of lamellipodia at the cell periphery |17| via a 
R a c i-d ep en d en t  mechanism [11]. T o  address the rela­
tionship between RhoA and Racl signaling in the localiza­
tion of  c-Src within the cell, we stimulated cells with 
P D G F  while inhibiting the formation o f  stress fibers by 
treating the cells with Y-27632. As above, Y-27632 was 
added to the cells prior to expression of Src251-GH > 
resulting in loss of stress fibers. After stimulation with 
P D G F , Src251-GFP remained perinuclear (Figure 3d, 
broken arrow) and did not translocate to the cell periphery* 
although the shape o f  the cell did change in response to
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Pigure 2
Scrum-free + V 14RhoA
(a)
L61 Racl V12Cdc42
Src, green; phalioidin, red
Src localization is under the control of Rho family GTPases. (a) Cells 
vere serum starved for 48 hr to remove stress fibers prior to 
:omicroinjection of VMRhoA and Src251-G FP (broken arrow). Solid 
rrow indicates noninjected cell, (b) Cells were cotransfected with 
1 61R ac and Src251-GFP. (c) Cells were cotransfected with 
'12C dc42  and Src251-GFP. The broken arrow indicates Src251- 
GFP at the base of filopodia, and the broken arrows (inset) show an 
( nhanced resolution of Src251-G FP localizing along filopodia. Actin 
was visualized with rhodamine-phalloidin and Src251-G FP by direct 
I uorescence. Scale bars =  25 p,m.
’D G F  at the cell periphery (Figure 3d, solid arrows). 
However, if Y-27632 was washed out prior to stimulation 
with P D G F , Src251-GFP localized to lamellipodia (Fig­
ure 3e, solid arrows). Expression of dominant-negative 
N l7 R a c l  blocked the formation of lamellipodia in re- 
ponse to P D G F  (Figure 30 , confirming that P D G F  was 
working through activation of Racl. No lamellipodia were 
>rmed in cells expressing N17Racl (broken arrow) as 
compared to the nontransfected cells (solid arrows). Al­
though cells expressing N17Racl did not form lamelli­
podia, these cells still contained actin stress fibers, and 
Src251-GFP was consequently located at the ends of these 
stress fibers in peripheral focal adhesions (f ig u re  of, bro­
ken arrow). T h u s ,  Racl drives the targeting of c-Sre to 
lamellipodia but is not involved in the initial m ovement 
of c-Src from the cell interior to the cell periphery, which is 
mediated by R hoA -dependent formation of stress fibers.
Similar experim ents were carried out to define the rela­
tionship between RhoA signaling and Cdc42. Brads kinin 
stimulates the formation of actin microspikes, known as 
hlopodia, at the cell periphery, by a ( ,dc42-mediated path­
way [12, 13]. Addition of bradykinin to Y-27632-treated 
cells resulted in the formation of filopodia seen as small 
actin-containing microspikes protruding from the cell 
body (Figure 3g, solid arrows), although Src251-GFP re­
mained perinuclear in the  presence of Y-27632 (Figure 
3g, broken arrow). However, removal of Y-27632 prior to 
addition of bradykinin resulted in the transiocation of 
Src251-GFP to the peripheral microspikes in response to 
bradykinin (Figure 3h, solid arrows). 'The expression of 
a dominant-negative Cdc42 protein (N17Cdc42) blocked 
bradykinin-induced filopodia formation (Figure 3i, bro­
ken arrow) as compared to nonexpressing cells (solid 
arrow) that were able to induce filopodia. Coexpression 
of Src251-GFP with N17Cdc42, blocked bradykinin- 
induced transiocation of Src to filopodia; however, Src251- 
G F P  was not retained in the perinuclear region but was 
present in peripheral focal adhesions under these condi­
tions (Figure 3i, broken arrow). T hus ,  the RhoA pathway 
is also required to target c-Src from the perinuclear region 
to the cell periphery, prior to its localization to filopodia 
induced by Cdc42.
T o  eliminate the possibility that the localization ofSrc251- 
G F P  to these peripheral sites was a consequence of over­
expression of available SH3 and SH2 domains, we were 
also able to show that endogenous Src w as able to localize 
to lamellipodia in response to P D G F  (Figure 3j). It was 
difficult to visualize endogenous Src in filopodia follow ing 
stimulation with bradykinin, which is most likely due to 
problems in detection of the low levels o f  endogenous 
proteins in small structures. I However, this could be over­
come by expressing full-length wild-type Src protein 
where trea tm ent with bradykinin resulted in Src being 
readily seen in filopodia (Figure 3k, inset). T h ese  data 
imply that the control of Src25H-GFP targeting w ithin the 
cell is the same as for endogenous Src or expressed wild- 
type Src protein.
c-Src kinase activity is required for the efficient 
remodeling of cellular adhesions
It is the dynamic remodeling and interchange betw een 
focal adhesions and focal complexes associated with la­
mellipodia and filopodia that regulates cell motility, and 
we therefore addressed w hether  the activity of c-Src at 
these cellular adhesions altered their remodeling. Cells 
were grown in serum, where Src251-GFP is localized at 
focal adhesions as a consequence of RhoA activity (Fig­
ures 1 and 4c). Subsequen t  trea tm ent of these cells with 
P D G F  resulted in P D G F-induced  shape changes and 
formation of lamellipodia. Although expression of Src25H- 
G F P  did not significantly alter the num ber of cells able to 
form lamellipodia (around 80% of cells expressing Src251- 
G F P  underw ent shape changes associated with the forma­
tion of lamellipodia), we found that the Src was localized 
only to discrete patches around the forming ruffle (broken 
arrow in Figure 4d) where it colocalized with actin (data
b)
▲
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Coordinated regulation of the actin 
cytoskeleton by Rho family G T Pases is 
required for Src targeting, (a -c )  Cells were 
serum starved for 48 hr to remove stress 
fibers prior to microinjection of S rc251-G FP 
(a,c) or comicroinjection of Src251-G FP with 
N19RhoA (b). Following expression of the 
proteins, cells were stimulated with serum 
(a,b) or preincubated with Y-27632 for 1 hr 
prior to stimulation with serum (c). Broken 
arrows indicate microinjected cells, while solid 
arrows are nonexpressing cells. (d ,e ,g ,h )
Cells were transfected with S rc251-G FP and 
prior to expression of the protein were treated 
overnight with Y-27632 to abolish stress  
fibers. The cells were then stimulated with 
PDGF (d) or bradykinin (g) or were stimulated 
with PDGF or bradykinin following wash out 
of the Y-27632 (e,h). (f ,i) Cells were 
cotransfected  with S rc251-G F P  and 
N1 7Rac or N1 7C dc42  and then placed in 
serum-free medium overnight to reduce the 
heterogeneity in the population prior to PDGF 
(f) or bradykinin (i) stimulation. Solid arrows 
show nontransfected cells, while broken 
arrows show  cells expressing the constructs. 
Actin w as visualized with rhodamine-phalloidin 
and Src251-G F P  by direct fluorescence, (j)  
Cells were placed in serum-free conditions 
overnight, stimulated with PDGF and 
endogenous Src visualized using the N2-1 7 
Src antibody, (k ) Cells expressing wild-type 
Src were placed in serum-free conditions 
overnight and stimulated with bradykinin.
Inset show s enhanced resolution of wt-Src 
localizing along filopodia. Exogenously 
expressed  Src w as visualized using the 
chicken-specific Src EC1 0 antibody. Scale 
bars =  25 |xm.
Serum Serum + N 19RhoA
PDGF + Y-27632
PDGF following removal 
of  Y-27632
Serum + Y-27632
N17Rac + PDGF
Bradykinin following 
Bradvkinin + Y-27632 removal of Y-27632 N 17Cdc42 + Bradykinin
Src, green; phalloidin. red
PDGF Bradykinin
endogenous c-Src expressed wt-c-Src
not shown). T h is  is in contrast to the uniform lamellipodia 
formed w hen  Src251-GF'P is held in the perinuclear region 
o f  the cell prior to stimulation with P D G F  (Figure 3e), 
where Src251-G FP is found in small structures continuous 
along the  lamellipodia. T h is  suggests that it is the pres­
ence of  Src251-GFP at focal adhesions prior to addition
of P D G F  that interferes with the actin rearrangements 
required for efficient formation of uniform lamellipodia. 
Since Src251-GFP lacks a c-Src kinase domain (Figure 
1), we exam ined w hether  the presence of an activated 
c-Src kinase at focal adhesions facilitated the R a c l -depen­
dent formation of uniform, continuous lame!!., ha. Foi4
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Src kinase activity is required for efficient 
amellipodia formation. (a ,b ) Cells were 
ransfected with SrcY527F and maintained in 
IO°/o serum to localize SrcY527F in 
peripheral focal adhesions (a). Cells were then 
placed in serum-free medium overnight to 
educe heterogeneity in the population and 
reated with emetine for 30 min prior to PDGF 
stimulation (b). (c,d) Cells were transfected 
A/ith Src251 -GFP and maintained in 10% serum 
c) or stimulated with PDGF as described 
above (d). (e ,f) Cells were transfected with 
SrcMF and maintained in 10% serum (e) or 
stimulated with PDGF as described above 
f). (g ) Enhanced magnification of kinase- 
defective (SrcMF) (upper panel) or kinase-active 
Src (SrcY527F) (lower panel) localization in 
^DGF-induced lamellipodia. Src251-GFP 
was visualized by direct fluorescence, 
3rcY527F and SrcMF using an anti-Src 
antibody. Scale bars =  25 jam.
Serum PDGF
SrcY527F
Src251-GFP
Src-MF (kinase-defective)
(g)
kinase-defect ive
kinase-active
(e) *
this, we expressed a c-Src protein, which has an activating 
tyrosine to phenylalanine mutation at position 527 in the 
c-Src coding sequences (SrcY527F) (reviewed in [IS]) 
(Figure 1). SrcY527F localized to focal adhesions in the 
presence of serum (Figure 4a). Following treatm ent with 
P D G F , peripheral SrcY527F was located at lamellipodia 
that appeared continuous and relatively uniform (Figure 
4b, broken arrows), in contrast to the discontinuous struc­
tures formed in cells expressing Src251-GFP (Figure 4d, 
broken arrow). T h ese  data imply that the efficient reloca­
tion of  c-Src from RhoA-induced focal adhesions into 
R ad - in d u ced  structures along lamellipodia requires Src’s 
catalytic activity, although expression of kinase-deficient 
Src251-GFP did not block the initial PD G F-induced  
shape changes that accompany lamellipodia formation 
(Figure 4d). Furthermore, the protein synthesis inhibitor 
em etine  was added prior to P D G F  treatment in these 
experiments, implying that Racl activation led to relocal- 
ization of c-Src that preexisted in focal adhesions into 
complexes that arc continuous along lamellipodia. How­
ever, we cannot rule out that some c-Src preexisted in 
the perinuclear region after em etine treatment and mo\ ed 
out into the newly forming lamellipodia upon ac tuation 
of Racl.
T o  further test whether the kinase actixitx of Src was 
required for efficient remodeling, we expressed a kinasc- 
defective Src mutant, SrcMF, in the cells and examined
the ability of these cells to form lamellipodia in response 
to P D G F . SrcM F has a point mutation in the kinase 
domain (K295M) rendering it kinase inactive (Figure 1). 
SrcMF localizes to focal adhesions in cells grow n in serum 
(Figure 4e), and subsequent stimulation of these cells 
with P D G F  resulted in the relocalization of SrcMF to 
discrete patches around the edge of the forming lamelli- 
podia (Figure 4f) rather than to continuous lamellipodia 
as seen in cells expressing the activated Src protein (Fig­
ure 4b). Magnification of the edge of the lamellipodia 
in SrcMF and activated Src-expressing cells (Figure 4g) 
shows more clearly the influence of Src kinase activity 
on the formation of the lamellipodia. Src colocalizes with 
actin both in the discrete patches in the SrcMF-expressing 
eells and the continuous lamellipodia formed in cells ex ­
pressing activated Src (data not shown). T rea tm en t of 
cells with the Src kinase inhibitor PP2 also resulted in 
the formation of fragmented lamellipodia in response to 
P D G F  (results shown in Supplementary materials). T ak en  
together, these data imply a role for Src kinase activity 
in the efficient R aci-induced actin remodeling associated 
with lamellipodia formation.
T o  demonstrate that the discontinuous lamellipodia 
found in Src251-GFP-expressing cells w as associated with 
impaired focal adhesion remodeling into focal complexes, 
we compared Racl-induced peripheral adhesion rem odel­
ing in cells expressing Sre251-GF'P with cells expressing
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Src kinase activity is required for the 
remodeling of peripheral adhesions during 
lamellipodia formation. (a ,d ) Cells were grown 
in serum-free conditions overnight to reduce 
heterogeneity in the population, then treated 
with emetine for 30 min prior to stimulation 
with PDGF, and stained with anti-vinculin (a) 
or anti-paxillin antibodies (d). (b ,c ) Cells 
transfected with S rc251-G FP or (e ,f) 
SrcY 527F were placed in serum-free 
medium overnight prior to PDGF stimulation. 
SrcY 527F and vinculin were visualized by 
anti-Src and anti-vinculin antibodies, 
respectively. Paxillin w as visualized with 
rhodamine-conjugated anti-paxillin and 
Src251-G F P  by direct immunofluoresence. 
Scale bars =  25 (j.m.
Non-transfected cells 
PDGF
Src251-GFP transfected cells 
PDGF
V in c u l in
Non-transfected cells 
PDGF
Vinculin
SrcY527F transfected cells 
PDGF
Pax il l in P a x i l l in Src
the activated c-Src m u tan t  SrcY527F, monitoring adhe­
sion com plexes by staining with anti-vinculin or anti-pax­
illin. (Anti-paxillin staining was used for eolocalization 
studies with anti-SrcY527F because anti-vinculin and 
anti-Src sera used were from the same species, restricting 
eolocalization studies.) Anti-vinculin and anti-paxillin 
staining were indistinguishable, and, in growing cells 
treated with P D G F , we observed small vinculin- and pax- 
illin-containing com plexes around the base of lamelli­
podia (F igure  5a,d, respectively). In P D G F -trea ted  cells 
expressing Src251-GFP, vinculin colocalized with Src251- 
G F P  at the  cell periphery bu t was located in larger discrete 
structures along the  length of the  lamellipodia (Figure 
5b,c). In contrast, in activated SrcY527F-expressing cells, 
c-Src colocalized with paxillin along the base of uniform 
lamellipodia (F igure 5e,f). Paxillin localizes to focal com ­
plexes at the leading edge of lamellipodia as described 
by N obes  and Hall [15]; however, in cells expressing 
activated Src, these  were difficult to visualize as discrete 
structures, suggesting that Src’s overactivity may be fur­
ther breaking down the focal complexes.
Similar to these observations with P D G F , we found that 
bradykin in-induced  focal adhesion rem odeling to produce 
focal com plexes at filopodia was impaired in Src251-GFP- 
expressing cells (results shown in Supp lem entary  materi­
als). T h u s ,  our data support a critical role for the catalytic 
activity o f  c-Src in the R acl-  and G dc42-induced periph­
eral adhesion remodeling that results in the  breakdow 
of larger focal adhesions and the generation of smalle 
focal com plex adhesion structures at lamellipodia and file 
podia, respectively. Further details given in Supplemen 
tary materials.
c-Src kinase activity is required for cell motility 
and polarization
As the formation of lamellipodia and fi! r 1 ia have beei 
associated with the regulation of  cell motility and chemo 
taxis [19, 20], we exam ined w hether  the impaired foca 
adhesion remodeling in the cells lacking kinase activity 
inhibited cell m ovem ent or the ability of cells to polarize 
in response to a chemotactic agent. W e found that the 
random migration o f  cells expressing Src251-GFP oi 
SrcMF' was inhibited by around 70%, while expression of 
G F P  alone had no effect on cell motility (Figure 6a). 
Expression o f  activated Src (SrcY527F) had no effect on 
the migration of  the cells, suggesting that the level oi 
endogenous Src within the cells is not limiting for migra­
tion. T h is  has also been reported for reintroduction of 
activated Src into Src '1 cells w here activated Src restored 
migration to a similar level as reintroduction of the wild- 
tvpe protein [21]. T o  examine the capacity of cells to 
respond to a chemotactic  gradient, we measured the abil­
ity of cells to polarize toward PDGF' using a D unn  cham­
ber [19]. Approximately 10% o f  cells expressing Src25F 
G F P  or SrcM F were able to polarize along the P lX d
^
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S rc251-G FP and SrcM F im pair random  cell m igration
Non- Src251 SrcMF GFP SrcY527F
transfected -GFP
(b)
Src251-G FP and SrcM F im pair cell polarisation
N on- Src251 - SrcMF GFP SrcY527F
transfected GFP
3rc kinase activity is required for random cell migration and the ability 
of cells to remodel in response to a chemoattractant gradient, (a ) 
Random cell migration of cells in 10% serum expressing Src251-GFP, 
GFP, SrcY527F (+ GFP), or SrcMF (+  GFP). Values are mean ±  
SEM taken from at least five independent experiments and represent 
data from between 30  and 60 cells in each case, (b ) Polarity of 
cells expressing Src251-GFP, GFP, SrcY527F (+ GFP), or SrcMF 
(+ GFP) in response to a 10 ng/m T1 PGDF gradient. Values are 
expressed as the percentage of cells in a population able to polarize, 
using the criteria described in the Supplementary materials section, 
generated from at least five independent experiments.
gradient, while around 80% of the nontransfected cells 
exhibited polarity (Figure 6b). Expression of G F P  or 
SrcY527F had no effect on the polarity of the cells in 
response to P D G F  (Figure 6b). Thus, both cell migration 
md cell polarization in response to a chemotactic stimuli, 
biological responses that require the coordinated activ­
ities of Rho GTPases, are impaired in cells expressing 
e ither the Src251 -GFP or SrcMF kinase-deficient mutants 
of c-Src.
Src activity is required for phosphorylation of FAK
FAK is a known Src substrate at adhesion sites, and there 
is considerable evidence that fA K  plays a central role 
in the regulation of cell motility (reviewed in [22]). We 
therefore addressed whether phosphorylation of fAK was 
suppressed in cells expressing Src kinase-detective m u­
tants that were unable to remodel focal adhesions in re­
sponse to P D G F  and displayed impaired motility. Using 
an antibody against phosphorylated tyrosine 925 in fAK, 
which is a site specifically phosphorylated by Src ([25]
and our unpublished data), we found that P D G F  stimu­
lated the phosphory lation of tyrosine 925, while in cells 
expressing SrcMF there was very little phosphorylation 
on this site (Figure 7a). Expression of SrcM F (Figure 7b, 
lower panel) did not alter the level of FAK protein within 
the cells (Figure 7b, upper panel). Therefore, using FAK 
tyrosine 925 phosphorylation as a marker of Src-depen- 
dent phosphorylation events at adhesions, we have shown 
that kinase-defective SrcM F expression suppresses both 
peripheral phosphorylation events and adhesion rem od­
eling.
Discussion
T h e  ability of a cell to move depends on a cycle of adhe­
sion, loss of attachment, and readhesion, which is gov­
erned by and coordinated with changes in the actin cy­
toskeleton arrangement and the microtubule system [1, 
24], T h e  actin structures, lamellipodia, and filopodia as­
semble and disassemble at the leading edge of ceils under 
the control of Racl and Cdc42, providing a means of 
polarized cell movement. Small focal complexes form at 
lamellipodia and filopodia, which are rapidly turned over 
as the cell moves forward, while the RhoA-dependent 
assembly of stress fibers provide contractility and propul­
sion required for forward cell movement. Since it is the 
balance between contractility and adhesion that governs 
the rate of cell motility, relative activities of RhoA, Racl, 
and Cdc42 are critical in determ ining w hether and how 
a cell moves. In this study, we examined the role of the 
Rho G TPases in directing the intracellular localization of 
the tyrosine kinase c-Src, which is known to be required 
for cell motility, and the role of its kinase activity in 
controling cell movement.
The intracellular localization of c-Src is modulated 
by RhoA, Racl, and Cdc42 activity
T h e  localization of  v-Src and c-Src to the cell periphery 
in fibroblasts requires an intact actin cytoskeletal network 
[5], Here, we show that the peripheral localization of 
Src251-GFP, a fusion protein that contains Src’s SH5 and 
SH2 domains bu t lacks a kinase domain, is also dependen t 
on RhoA-mediated assembly of actin stress fibers. Al­
though Src251-GFP was found in lamellipodia and filo­
podia following activation of Racl or Cdc42, this was also 
d ep enden t on the  activity of RhoA, which mediates transit 
from the perinuclear region to the cell periphery. T h is  
implies that Src requires actin stress fibers to incorporate 
into focal adhesions or into smaller focal complexes at 
lamellipodia or filopodia, depending  on the balance of 
specific Rho G T P ase  signals within the cell. As yet. little 
is known of the mechanism involved in the transport of 
Src from the perinuclear region to the cell periphery. We 
and others have demonstrated that it is not dependen t 
on the catalytic activity of  c-Src but does require the Src 
SH3 domain [4, 6, 7]. In vitro experim ents have dem on­
strated that the Src SH3 domain binds to a num ber  of
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Figure 7
Phosphorylation of FAK is suppressed  in cells 
expressing kinase-defective Src. (a ) Cells 
were placed in serum-free conditions 
overnight and then stimulated with PDGF. 
Control cells were not stimulated with PDGF. 
FAK phosphorylated on tyrosine 925 was 
immunoprecipitated (IP) from extracts of cells 
infected with SrcMF or the empty vector 
using a phospho-FAK-Y925-specific antibody. 
The proteins were resolved by SDS-PAGE, 
and the levels of phosphorylated FAK were 
detected  following blotting with an anti-FAK 
antibody (blot), (b ) Expression of FAK and 
SrcMF in the SrcMF and vector-infected cells 
was determined in whole-cell extracts using 
an anti-FAK antibody (top panel), and 
exogenously expressed SrcMF was visualized 
using the chicken-specific Src EC10 
antibody (bottom panel).
(a)
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cellular partners and that the regulatory subunit of phos- 
phatidylinositol 3-kinase (PI 3-kinase) is one binding part­
ner of the v-Src SH3 domain that is important for its 
peripheral targeting [7]. Although the catalytic activity of 
Src is not required for its targeting, a num ber of stimuli 
that induce its peripheral targeting also activate Src kinase 
activity (e.g., P D G F  and bradykinin). T h e se  stimuli can 
therefore release constraints on both the kinase domain 
and the SH3 domain of c-Src, ensuring that the activated 
protein is not aberrantly localized within the cell.
Regulation of cell motility requires coordinated activity 
of Rho GTPases and Src
Involvement of RhoA, Racl, and Cdc42 in cell motility 
is undoubted ly  linked to their ability to rearrange the 
actin cytoskeleton. However, a secondary consequence of 
this actin remodeling is apparently to target other cellular 
proteins, such as c-Src, to these peripheral sites. We show 
here that once located at the cell periphery c-Src acts in 
concert with the Rho G T Pases  to regulate cell polarity and 
motility. Several s tudies have suggested that Src family 
kinases play a role during cell motility. For example, c-Src- 
deficient fibroblasts have a decreased random migration 
[21 ], and cells deficient in all three ubiquitously expressed 
family m embers, Src, Fyn, and Yes, are unable to migrate 
into a wound [25]. Furtherm ore, c-Src kinase activity is 
required for growth factor-induced migration and scatter­
ing in a n um ber o f  cell types [26-28]. T h e  ability of Src 
to influence cell motility in fibroblasts has been linked 
to the regulation o f  focal adhesion turnover. Cells lacking 
Src family m em bers  are able to assemble focal adhesions 
[25], indicating that Src is not required for their formation. 
However, cells in which kinase-defective mutants  of Src 
are expressed have enlarged focal adhesions [4, 6], sugges­
tive of a role for Src kinase activity in the turnover of 
these structures that is needed  for cells to move [6]. T h e  
presence of functional SH2 and SH3 domains in these
Src proteins suggests that, in addition to phosphorylatin 
key substrates, Src may be acting as an adaptor protei 
allowing its recruitment into focal adhesion structures ant 
or to recruit cellular partners to these sites. One sue 
candidate is FAK, as there is considerable evidence link 
ing Src activity to FAK-regulated cell motility [8, 29]. 1: 
is known that in fibroblasts lacking the FAK protein ther 
is an increased num ber of focal adhesions and an impaire 
ability to move, suggesting that FAK is required for th 
turnover of focal adhesions during cell motility [30], whii 
the ability of Src to induce adhesion turnover has bee 
linked to the phosphorylation and possibly subsequer 
proteolysis of FAK [6, 8], In this study, we have show 
that phosphorylation of FAK on tyrosine 925, which is 
site known to be phosphorylated by Src [23], is suppresses 
in cells w'hich are unable to remodel their peripheral adht 
sions after P D G F  treatment, correlating with impaire 
cell motility and polarity. T hus ,  SrcMF expression sup 
presses both Src-dependent phosphorylation events at th 
cell periphery and stimulus-induced adhesion remoci 
eling.
A key com ponent of the coordinated m ovem ent of cell 
is their ability to polarize toward different migratory sig­
nals, and we addressed the role of c-Src in this process. 
T h e  formation of R ac i-dependen t lamellipodia at the 
leading edge is required for cell motility [19, 20, 31]. In 
addition, while Cdc42 is not essential for cell movement 
per se, it is required for directionality and the maintenance 
of cell polarity [19, 20, 32]. W e have shown that c-Src 
kinase activity is required for cells to polarize and form 
a leading edge, and we propose that the ability of die 
Rho G T Pases  to direct the localization of Src to these 
peripheral sites is required for the remodeling of the more 
static focal adhesions into smaller more dynamic focal 
complexes found at the leading edge of motile cells.
Research Paper Requirem ent of Src for Rho family activity Timpson et al. 1845
I he involvement of Src kinases in the regulation of integ- 
lin-ECM interactions has been reported in a number of 
studies [25, 33, 34], Specifically, Src can regulate the gen­
eration of contractile force between the actin cytoskeleton 
and integrins, thus modulating cell motility [33], In addi- 
lion, c-Src can transiently inhibit integrin-induced activa­
tion of Rho G'l Pase activity [34], and oncogenic v-Src 
can antagonize RhoA activity via mechanisms involving 
activation of pl90RhoGAP [35, 36]. Thus, Src may act to 
regulate the turnover of Rho-mediated adhesions, which 
is critical to the migratory process. In addition to adhesion 
emodeling, Src facilitates the turnover of actin filaments 
which stabilize focal adhesion sites [7, 36], and this may 
lartially explain the reduction of random migration ob- 
.erved in our study in cells expressing kinase-defective 
Src mutants (Figure 6a) and also cells lacking Src and the 
other family members Fvn and Yes [25]. More recently, 
he mDia family of Rho effectors, which cooperate with 
ROCK in the formation of bundled stress fibers, have 
oeen shown to bind to Src, and Src kinase activity is 
'equired for the cooperative effect of mDia on stress fiber 
formation [37]. 'Thus, c-Src can have both positive and 
legative effects on Rho-mediated stress fiber and adhe­
sion formation and may act at a pivotal point between 
heir assembly and disassembly, placing it in a central 
oosition from which to coordinate the multifaceted pro­
cess of cell motility.
The major challenges are now to determine (1) how motile 
cells integrate different signals that regulate the activity 
if RhoA, Racl, and Cdc42, which in turn regulate the 
localization of c-Src and possibly other Src family kinases 
within the cell, and (2) how Src-dependent tyrosine phos­
phorylation regulates adhesion remodeling in response to 
oiological stimuli that induce directed cell migration.
Materials and methods
Cells and plasmids
CA10-Src251 -GFP and CA10-Src were kind gifts from P. Schwartzberg 
NIH, Bethesda, Maryland), and CA10-SrcY527F and CA10-SrcMF 
K295M,Y527F) were a kind gift from K. Kaplan (MIT, Cambridge, M assa­
chusetts). pEGFP (Clontech, Basingstoke, UK) was used for expression 
Df GFP. N19- and V14RhoA, V12- and N17Cdc42, and L61- and 
M1 7Rac, all in the pRK5myc plasmid, were kindly provided by Alan Hall 
(UCL, London, UK). Swiss 3T3 cells were routinely grown in DMEM 
supplemented with 10% fetal calf serum. Plasmids were introduced into 
the cells by nuclear microinjection or transient transfection as indicated 
in the text, with further details given in the Supplementary materials.
Immunofluorescence
Cells were plated onto glass chamber slides 24 hr prior to transfection 
or onto glass coverslips 24 hr prior to microinjection. For experiments 
in which cells were serum starved to remove stress fibers prior to expres­
sion of the proteins, the cells were grown for 48 hr in serum-free condi­
tions prior to microinjection of the appropriate plasmids and analysis 
carried out 3 -5  hr later after expression of the proteins. For all other 
experiments, the proteins were expressed by transient transfection. 
Growth factor treatment of the cells were as follows: 10% serum for 
30 min, PDGF, 25 ng/ml 1 for 30 min (TCS Biologicals, Botolph Claydon, 
UK), bradykinin, 100 nM for 5 min or LPA 200 ng/ml 1 for 30 min
(both Sigma, Poole, UK). Y-27632 (10 ( j l M ,  Welfide Corporation, Japan), 
cytochalasin D (0.1 ng/m l-1), or emetine (55 (xg/ml \  both Sigma, Poole, 
UK) were added as indicated. Cells were fixed in 3% paraformaldehyde, 
washed PB S/100 nM glycine, then permeabilized with PB S/0.1% sapo­
nin/20 mM glycine. After blocking with PBS/0.1 % saponin/10%  fetal 
calf serum, cells were incubated with anti-Src mAb EC10 to detect the 
exogenously expressed chicken Src proteins (Upstate Biotechnology, 
Lake Placid, New York), anti-Src monoclonal antibody N2-17 to detect 
endogenous Src protein (a kind gift from T. Hunter, Salk Institute, Califor­
nia), anti-vinculin mAb, rhodamine-conjugated phalloidin (both Sigma, 
Poole, UK), or rhodamine-conjugated paxillin antibody (Research Diag­
nostics, Flanders, New Jersey). Nonconjugated antibody detection was 
by reaction with species-specific TRITC-conjugated antibodies (Sigma. 
Poole, UK). Cells were visualized using a confocal microscope (MRC 
600; BioRad Labs, Hercules, California).
FAK phosphorylation
Cells infected with pBABEpuro or pBABEpuro-SrcMF were trypsimzed 
and plated at 2.5 x 106 onto 100 mm culture plates in growth medium 
for 24 hr. The cells were then serum starved for 24 hr prior to stimulation 
with 25 ng/ml-1 PDGF. Cell extracts were prepared in 50 mM Tris (pH 
7.4), 150mM NaCI, 1% Triton X-100, 0.5%  deoxycholate, 0.1% sodium 
dodecyl sulfate, 1 mM EDTA, 1 mM EGTA, 10 mM sodium pyrophos­
phate, 0.5 mM sodium fluoride, 1 mM PMSF, 10 |j.g/ml 1 aprotinin, and 
100 |j.M sodium orthovanadate, and 1 mg of cell lysate incubated with 
2 pg of phospho-FAK-Y925 rabbit polyclonal antibody. Generation of 
this antibody was as described in [38] using the peptide NDKVYENVT 
GLVKA(C), which corresponds to residues 9 2 1 -9 3 4  in FAK, in which 
tyrosine 925 has been chemically phosphorylated. The immune com­
plexes were collected with protein A sepharose and the proteins resolved 
by SDS-PAGE. FAK phosphorylated on tyrosine 925 was detected fol­
lowing incubation with anti-FAK monoclonal antibody (Transduction Lab­
oratories, BD Biosciences, Oxford, UK) using ECL detection.
Cell migration and polarization
Cells were transfected with Src251 -GFP or GFP or cotransfected with 
SrcY527F and GFP or SrcMF and GFP to allow detection of the trans­
fected cells. To monitor polarization, cells were trypsinized 24 hr post­
transfection and plated onto coverslips for 1 hr. Cells were then serum 
straved for 1 hr and mounted on Dunn cham bers with PDGF 10 ng/ml -1 
as chemoattractant [19]. For m easurement of both random migration 
and polarization, microscopic images of the cells were acquired from a 
charged couple device camera (Hamamatsu C4742) and captured by 
Open Lab (Improvision Software, UK) every 15 min over a 5 hr period. 
Details of how the mean cell speed  was calculated and the criteria used 
to determine cell polarity are given in the Supplementary materials.
Supplementary material
Further experimental details on the different methods used for the intro­
duction of plasmids into the cells and the rationale for their use can be 
found in the Supplementary material online at http://im ages.cellpress. 
com/supmat/supmatin.htm. More detailed descriptions are also given 
for the measurement of cell migration and polarity.
Additional data are provided in which we have used the kinase inhibitor 
PP2 as further confirmation of the requirement of Src kinase activity for 
efficient remodeling of cellular adhesions in response to PDGF, and data 
are also presented which dem onstrates that bradykinin-induced focal 
adhesion remodeling to produce focal complexes was also impaired in 
Src251-GFP-expressing cells. W e also provide further evidence that 
Src kinase activity is required for the turnover of focal adhesions in 
experiments where treatment of cells expressing Src251-GFP with the 
ROCK inhibitor results in the stabilization of focal adhesions which are 
normally broken down in the absence of a Rho signal.
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